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The work conducted in this thesis is a part of a project whose main goal is to develop oral 
vaccines for humans with Lactobacillus as a vaccine delivery vector. Lactic acid bacteria can 
potentially produce therapeutic heterologous proteins and deliver them to mucosal sites. L. 
plantarum is an interesting candidate for this purpose because it is resistant to bile and low pH 
and it is a versatile bacterium with GRAS-status (generally regarded as safe). One approach 
that could make the bacteria a better oral vaccine is to make them target specific receptors 
(like β1-integrin) on the apical surface of M-cells by surface display of proteins such as 
invasin. This could promote transport of the bacterium by the M-cells, from the lumen of the 
intestine, across the epithelial barrier into organized lymphatic system below, which may 
promote an effective immune response. The work described in this thesis was aimed at 
secretion and anchoring of invasin from Yersinia pseudotuberculosis in Lactobacillus 
plantarum, using an inducible gene expression system formerly developed for efficient 
intracellular protein production. 
 
Invasin is a membrane protein with an extracellular region that binds host cell integrin 
receptors and promotes uptake of the bacteria. This C-terminal extracellular region comprises 
five domains (referred to as Inv in this thesis), and it has been shown that the two domains 
(referred to as InvS) at the C-terminus comprises the shortest fragment of invasin that is 
capable of binding and inducing uptake. Both versions of invasin were expressed in L. 
plantarum WCFS1. To anchor these invasin proteins, lipo-anchors from the lipoproteins 
Lp_1261 and Lp_1452 from L. plantarum WCFS1 were selected. Five plasmids were 
constructed, pLp_1261InvS, pLp_1261Inv, pLp_1452InvS, pLp_1452Inv and pCytInv 
(invasin without anchor), that all were transformed into L. plantarum WCFS1. L. plantarum 
strains harbouring the pLp_1452InvS or pLp_1452Inv constructs showed strongly reduced 
growth upon induction of gene expression, whereas L. plantarum harbouring the Lp_1261-
based constructs showed normal growth. All L. plantarum harbouring the different invasin 
constructs produced invasin, which could be detected intracellularly and for bacterial strains 
with an anchor, in the culture supernatant. Despite testing and optimization of various 
approaches to do so, it was difficult to convincingly demonstrate anchoring of invasin to the 
bacterial surface. However, several experiments did indicate anchoring. Experiments with 
Caco-2 cells did not convincingly show internalization of invasin-expressing bacteria, but 
clearly showed that several of the recombinant bacterial strains had increased affinity for the 
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Caco-2 cells. In conclusion, the work described in this thesis shows that L. plantarum is able 
to produce, secrete, and most likely anchor invasin to the surface of the bacteria, by using 
lipo-anchors. The results further indicate that there is a need to optimize the anchoring 
strategy to make invasin more available on the surface of L. plantarum. The latter is likely to 

































Arbeidet som ble utført i denne masteroppgaven er en del av et prosjekt som har som mål å 
utvikle orale vaksiner for mennesker med Lactobacillus som en leveringsvektor av vaksinen. 
Melkesyrebakterier kan potensielt produsere terapeutiske heterologe proteiner og levere dem 
til mukosa. L. plantarum er en interessant kandidat til dette formålet fordi den er 
motstandsdyktig mot galle og lav pH, og den er en allsidig bakterie med GRAS-status 
(generelt betraktet som trygg). En fremgangsmåte som kan gjøre bakterien til en bedre oral 
vaksine er å få bakterien til å binde spesifikke reseptorer (som β1-integrin) på oversiden av M-
celler ved at proteiner som invasin er lokalisert på overflaten av bakterien. Dette kan fremme 
transport av bakterien fra tarmlumen, gjennom epitelbarrieren, til det underliggende 
organiserte lymfesystemet som kan fremme en effektiv immunrespons. Arbeidet beskrevet i 
denne masteroppgaven hadde som hensikt å få til sekresjon og ankring av invasin fra Yersinia 
pseudotuberculosis i Lactobacillus plantarum, ved å utnytte et induserbart uttrykningssystem 
tidligere utviklet for effektiv intracellulær protein produksjon. 
 
Membranproteinet, invasin, har en ekstracellulær region som binder til vertcellens integrin 
reseptorer og fremmer opptak av bakterien. Denne C-terminale ekstracellulære regionen 
består av fem domener (forkortet som Inv i denne oppgaven), og de to domene (forkortet som 
InvS) i den C-terminale enden er demonstrert til å være det korteste fragmentet av invasin 
som kan binde og indusere opptak. Begge versjonene av invasin er uttrykt i L. plantarum 
WCFS1. For å ankre disse invasin proteinene ble lipoankrer fra lipoproteinene Lp_1261 og 
Lp_1452 fra L. plantarum WCFS1 valgt ut. Det ble konstruert fem plasmider, pLp_1261InvS, 
pLp_1261Inv, pLp_1452InvS, pLp_1452Inv og pCytInv (invasin uten anker), som alle ble 
transformert inn i L. plantarum WCFS1. L. plantarum med pLp_1452InvS eller pLp_1452Inv 
plasmidet viste redusert vekst etter induksjonen av invasin produksjon, mens L. plantarum 
med Lp_1261-baserte konstrukter viste normal vekst. L. plantarum med de forskjellige 
invasin plasmidene produserte invasin, som kunne detekteres intracellulært og for 
bakteriestammer med et anker, i supernatanten til kulturen. Selv med testing og optimalisering 
av flere metoder var det vanskelig å bevise helt sikkert at invasin var ankret til den bakterielle 
overflaten, men flere eksperimenter indikerte ankring. Eksperimenter med Caco-2 celler viste 
ikke noen overbevisende resultater for internalisering av invasin uttrykkende bakterier, men 
viste at flere av de rekombinante bakteriestammene hadde økt affinitet for Caco-2 celler. Ut i 
fra arbeidet beskrevet i denne masteroppgaven ble det konkludert at L. plantarum kan 
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produsere, sekretere, og mest sannsynlig ankre invasin til overflaten av bakterien, ved bruk av 
lipoankrer. Resultatet indikerer også at det er nødvendig å optimalisere ankrestrategien for å 
gjøre invasin mer tilgjengelig på overflaten til L. plantarum. Dette vil mest sannsynlig 
forbedre evnen til å detektere proteinet på overflaten av bakterien og sannsynligvis forbedre 
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Lactic acid bacteria (LAB) are commonly used in food products and several species are 
believed to have positive effects on human health. Many LAB species are a natural part of the 
gastrointestinal (GI) tract of humans and animals and they are generally regarded as safe 
(GRAS) organisms. Several systems for heterologous expression of genes have been 
developed for LAB and these systems may be exploited to develop LAB as in situ delivery 
vehicles for interesting therapeutic proteins and peptides. This thesis deals with the expression 
and anchoring of a heterologous protein, invasin, in L. plantarum, with the aim of improving 
this bacterium’s potential as a vaccine delivery vector.    
  
1.1 Lactic acid bacteria 
Lactic acid bacteria (LAB) are a group of Gram-positive, non-pathogenic, non-invasive, non-
sporulating, usually non-motile, bacteria, which are defined by their ability to produce lactic 
acid as an end product from carbohydrate fermentation. Lactobacillus, Lactococcus, 
Streptococcus, Enterococcus, Leuconostoc and Pediococcus are examples on LAB (Tao et al. 
2011; Willey et al. 2008). Generally, LAB are fastidious organisms with limited biosynthetic 
capabilities that needs to get vitamins, amino acids, purines and purimidines supplied. They 
lack cytochromes, so they generate energy by substrate-level phosphorylation (Willey et al. 
2008). LAB are used in the food industry, mainly in food fermentation and preservation of 
milk, vegetables and meat. They have for a long time been generally regarded as safe (GRAS) 
for humans and some strains have also health promoting effects (Ahrne et al. 1998; Leroy & 
De Vuyst 2004). LAB occupy a range of ecological niches, including, in addition to food 
products, the oral cavity, gastrointestinal tract and vagina of vertebrates (Tao et al. 2011; 
Wells & Mercenier 2008).  
 
1.2 Lactobacillus 
The genus Lactobacillus contains non-sporing rods and sometimes coccobacilli, that lack 
catalase and cytochromes and are usually facultative anaerobic or microaerophilic. They 
prefer slightly acidic conditions and show optimal growth when the pH is between 4.5 and 6.4 
(Willey et al. 2008). This is a genus with a considerable number of different species that 
display a relatively large degree of diversity (Kleerebezem et al. 2010). Some strains of 






GI tract. The way lactobacilli interacts with their hosts and influence different factors 
encountered within the GI tract is dependent on their extracellular characteristics. For 
instance, lactobacilli produce lactic acid that lowers the pH and inhibits growth and adhesion 
of pathogenic microorganisms (Lebeer et al. 2008; Marco et al. 2006; Seegers 2002). Also as 
a part of their probiotic contribution to the host, some strains produce antimicrobial peptides 
(bacteriocins) that inhibits pathogens such as Listeria (Diep et al. 2009b; Eijsink et al. 2002). 
Other probiotic mechanisms are resistance to bile salt and acid (Marco et al. 2006; Seegers 
2002), the capacity to attach to or colonize the intestinal tissue, at least temporarily, to prevent 
attachment of pathogens, and competition with pathogens for the same receptors (Styriak et 
al. 2003; Vaughan et al. 2002; Velez et al. 2007). Even though probiotic bacteria are 
considered to have health-promoting effects, the molecular mechanisms promoting these 
effects are largely unknown (Kleerebezem et al. 2010; Marco et al. 2006). Lactobacilli seem 
to contribute to maintaining the balance of the intestinal microflora, and it appears that they 
also modulate the intestinal immune system, detoxify colonic toxins, promote lactose 
tolerance, lower serum cholesterol levels, and produce metabolites that are essential to the 
function of intestinal epithelial cells (Liu et al. 2010).  
 
Of the Lactobacillus species, Lactobacillus plantarum is one of the most studied and best 
understood, and L. plantarum WCFS1 was the first strain of L. plantarum to have the 
complete genome sequence determined (Klaenhammer et al. 2002; Kleerebezem et al. 2003). 
L. plantarum is versatile, which is reflected by its relatively large number of regulatory and 
transport functions and the fact that this bacterium has one of the largest genomes known 
among LAB (Daniel 1995; Kleerebezem et al. 2003). L. plantarum strains vary considerably 
in their ability to induce pro- and anti-inflammatory cytokines (Meijerink et al. 2010), in 
intestinal survival rates and in their ability to adhere to epithelial cells. One promising strain is 
L. plantarum NCIMB8826, which was originally isolated from human saliva, and which has 
high survival capacity in the intestine (Vesa et al. 2000). L. plantarum WCFS1 is a single 
colony isolated from the NCIMB8826 strain (Kleerebezem et al. 2003) and it has been shown 
that this bacterium has several genetic loci that influence the human immune system. The 
predicted exoproteome of this strain contain at least twelve proteins putatively involved in 
adherence to host components such as collagen and mucin (Kleerebezem et al. 2010; 
Meijerink et al. 2010). Generally, L. plantarum WCFS1 is a good candidate to utilize in oral 
vaccination due to its resistance to bile acid and its persistence in the GI tract. 





1.3 LAB as delivery vectors for therapeutic proteins 
LAB have several advantages for surface display applications, including a common 
mechanism for surface anchoring of proteins. Furthermore, several LAB surface proteins are 
known to be relatively permissive for the insertion of extended sequences of foreign proteins, 
giving interesting engineering opportunities. The thick cell wall that covers the bacteria makes 
it more resistant to rigorous manipulation conditions. Finally, since LAB are Gram-positive 
microorganisms with just a single cell membrane, theoretically protein secretion should be 
relatively easy to achieve (Motin & Torres 2009; Samuelson et al. 2002). Due to these 
features several adequate cloning system have been developed where the key quality for 
delivering of antigens involve promoter sequences that allow either constitutive or induced 
expression (Kleerebezem et al. 1997; Sørvig et al. 2003). Vectors for gene expression may 
also contain secretion and anchoring signals that allow targeting of proteins to different cell 
compartments (Reveneau et al. 2002). Plasmid based expression system are generally used 
because plasmids are easy to manipulate. Systems based on chromosomal integration can also 
be used, but are more complicated to develop and use. In every expression system, the 
promoters can have different activity levels in different Lactobacillus strains, and plasmid 
copy numbers (i.e. gene dosages) can also differ (McCracken & Timms 1999; Seegers 2002). 
 
LAB are less exploited as vaccine delivery vectors than attenuated pathogens such as 
Salmonella, Listeria, and Shigella (Detmer & Glenting 2006; Guimaraes et al. 2005). LAB are 
safer than attenuated pathogenic bacteria, because there is a potential risk of reversion to the 
virulent wild-type for the latter (Tao et al. 2011). It is already known that LAB can generate 
antigen immune responses. LAB have successfully been used as delivery vector of several 
antigens (Cortes-Perez et al. 2007; Detmer & Glenting 2006). Initially, L. lactis was the most 
common LAB used as a delivery vehicle, because this LAB was the first one that had a 
genetic toolbox available and its genome sequence determined (Bolotin et al. 2001; 
Klaenhammer et al. 2002; Mierau & Kleerebezem 2005). L. lactis is a well studied organism 
and some landmark studies been developed from work on lactococci (Diep et al. 2009a). 
Lactococci have successfully been used to produced diverse molecules, such as tetanus 
antigen (Robinson et al. 1997), cancer antigen (Bermudez-Humaran et al. 2002; Cortes-Perez 








One landmark study concerns an engineered L. lactis strain that expresses interleukin-10 (IL-
10), to treat Crohn’s disease. The first human trial with this method of treatment has been 
completed (Braat et al. 2006). Crohn’s disease is a type of inflammatory bowel disease which 
is a chronic intestine inflammation (Bouma & Strober 2003). According to scientific 
literature, IL-10 is a good candidate for inflammatory bowel disease treatment, but injection 
of IL-10 induces side effects. Delivery of IL-10 in situ by using a genetically modified 
bacterial carrier was expected to give a better response, but this method raised concerns about 
the bacterium’s survival and possible propagation in the environment (Steidler et al. 2003).  
Spreading of antibiotic selection markers and other genetic modifications from recombinant 
strains to other microorganisms in nature is not desirable. Steidler et al. (2003) replaced the 
thyA gene of L. lactis with the hIL10 gene, resulting in bacteria that are dependent on 
extracellular thymidine or thymine and are unable to survive outside the human body. The 
result of the human trial with the L. lactis strain lacking the thyA gene, but secreting IL-10, 
indicated that this strategy is beneficial for the patient and that the bacteria can be biologically 
contained (Braat et al. 2006; Steidler et al. 2003; Wells & Mercenier 2008).    
 
More recently, L. plantarum has become another important species for use as a delivery 
vector, mainly because many genetic tools and the genome sequence are now available 
(Kleerebezem et al. 2003; Seegers 2002; Sørvig et al. 2003). When used for in situ protein 
delivery L. plantarum can have an advantage compared to L. lactis, because L. plantarum has 
a high tolerance against bile acid and low pH. They will survive the passage of the gut, and 
they have an intrinsic immunogenicity (Seegers 2002). The increasing numbers of papers 
about expression of medicinal proteins in lactobacilli indicate that L. plantarum strains tend to 
give better immune responses than L. lactis strains when they present the same antigen. For 
instance, Cortes-Perez et al. (2007) showed that L. plantarum expressing E7 antigen was more 
immunogenic than L. lactis producing the same antigen. Grangette et al. (2002) compared L. 
plantarum and L. lactis strains producing equivalent amounts of the tetanus toxin fragment C 
(TTFC) in an oral immunization study, and found that L. plantarum gave a better immune 
response.   









1.4 Inducible gene expression in L. plantarum using the SIP-system  
LAB and many other bacteria produce antimicrobial peptides, often referred to as 
bacteriocins, to combat competing Gram-positive bacteria. Bacteriocins differ from antibiotics 
in that they are more strain specific and more powerful against target bacteria than antibiotics. 
In addition bacteriocins are ribosomally synthesized while antibiotics are made by multi-
enzyme complexes (Diep et al. 2009b; Nes et al. 2007). Production of bacteriocins is often 
strictly regulated via quorum-sensing mechanisms mediated by a secreted peptide-pheromone, 
a membrane located pheromone sensor (histidine protein kinase) and a cytoplasmic response 
regulator (Eijsink et al. 2002; West & Stock 2001). The discovery of these regulatory systems 
in lactobacilli (Diep et al. 1995; Eijsink et al. 1996), and the discovery of an analogous 
“nisin”-system in lactococci (Kuipers et al. 1995; Mierau & Kleerebezem 2005), have been 
extremely important for development of gene expression systems in LAB. Use of these 
regulated promoters, which are very strong when induced, allows gene expression to be both 
highly efficient and strongly regulated, and has been exploited to make strictly regulated gene 
expression system in lactobacilli (Diep et al. 2009a). 
 
The quorum-sensing mechanism is a method where the bacterium can monitor its own 
growth.  It involves a secreted peptide pheromone (induction peptide) that functions as a 
sensor for cell density. During growth there is a low constitutive expression of genes required 
for production of the induction peptide (IP) and the IP slowly accumulates in the medium over 
time. At a certain cell density, the accumulated IP reaches a critical threshold concentration 
and will bind to and activate the histidine protein kinase (HPK), through a highly specific 
interaction (Figure 1.1). Interaction of IP with the HPK receptor leads to autophosphorylation 
of the HPK. Subsequently, the phosphate group is transferred from the HPK to an intracellular 
response regulator (RR), which then binds to specific promoter elements and activates 









Sørvig et al. (2003) constructed vectors for an 
inducible expression system in lactobacilli. A 
schematic overview of their basic pSIP vector 
is shown in Figure 1.2 These pSIP expression 
vectors are based on promoters and regulatory 
genes involved in the production of the class II 
bacteriocins sakacin A (sap gene cluster) or 
sakacin P (spp gene cluster). Three genes are 
responsible for the regulation of this system, as 
explained above. One gene codes for a peptide 
whose primary function is to act as a 
pheromone. One gene codes for a membrane 
Figure 1.1: Schematic illustration of pheromone regulated bacteriocin production. (1) Low amounts of the 
constitutively produced induction peptide (IP) are produced as the cell grows, and transported out of the cells by 
an ABC transporter. The IP concentration increases as the cell density increases. (2) At a certain threshold, the 
concentration of IP will reach a level that makes the IP bind to the receptor histidine protein kinase (HPK). (3) 
This results in autophosporylation of a conserved histidine residue in the HPK. (4) The phosphoryl-group is 
transferred to the response regulator (RR) through interaction with the HPK. (5) The phosphorylated RR binds 
to DNA and (6) activates transcription of all genes involved in bacteriocin production (Mathiesen 2004; Nes & 
Eijsink 1999). The genes involved in bacteriocin production are often spread over several operons, each of 
which is preceded by a promoter that is activated by binding of the activated RR (Brurberg et al. 1997; Risøen et 
al. 2000). The figure is modified from Mathiesen (2004) 
Figure 1.2: The pSIP vector expression system, 
illustrated by a schematic picture of the 
pSIP400 vector series. The sppK and sppR genes 
encode for the HPK and RR from the spp regulon, 
respectively. SppA/sppQ are regulated promoters 
that drive expression of the gene of interest. ermB 
is erythromycin resistance marker. The vector has 
unique restriction sites for easy exchange of 
different parts (Diep et al. 2009a). The figure is 
taken from Diep et al. (2009a).  





located HPK that senses the pheromone, and one gene encode a cognate RR protein. pSIP-
vectors have the genes for HPK and RR, but the gene for the IP is deleted in the plasmid. 
When IP is added to the medium it will interact with HPK and induce the expression system, 
as described above (Sørvig et al. 2003; Sørvig et al. 2005). 
 
1.5 Protein secretion in bacteria 
All proteins that have a task outside the bacterium need to be transported out of the cell to 
their final destination.  In Gram-positive bacteria seven main protein secretion pathways have 
been characterized (Kleerebezem et al. 2010): 
 The secretion pathway (Sec) 
 Fimbrilin-protein exporter (FPE) 
 Peptide efflux ABC 
 Holin (pore-forming) 
 Twin-arginine translocation (Tat) 
 Flagella export apparatus (FEA) 
 WXG100 secretion system (Wss) 
 
Published Lactobacillus genomes indicate that lactobacilli contain genes for the Sec, FPE, 
peptide-efflux ABC, and holin secretion systems (Kleerebezem et al. 2010). Of these 
pathways, the secretion (Sec) pathway, is the most commonly explored in genetic 
engineering. The Sec pathway is also the naturally most commonly used system for protein 
transport across and into the cytoplasmic membrane. This secretion pathway is steered by the 
Sec translocase, as shown in Figure 1.3. The Sec translocase consists of a protein-conducting 
channel, the SecYEG (SecY, SecE and SecG) complex, which is membrane-embedded. It also 
consists of an ATPase motor protein (SecA), which is peripherally associated and deliver the 
energy to the process. In addition the proteins SecDF(yaiC) (the SecD, SecF and YajC 
proteins) and YidC are normally associated with Sec translocase. SecDF(yaiC) stimulates 
preprotein translocation and YidC facilitates the insertion of a some membrane proteins into 
the cytoplasmic membrane, in cooperation with the Sec-system or on its own (Driessen & 







Proteins that are going to be secreted or anchored as lipoproteins need to be recognized and 
targeted to the Sec translocase. Therefore, all secretory proteins and lipoproteins are 
synthesized with a characteristic N-terminal extension, called signal sequence or leader 
peptide. The signal peptide is removed by a signal peptidase after translocation (Driessen & 
Nouwen 2008). Signal sequences usually have three distinct domains, the N-terminal region 
(1-5 residues) with positively charged amino acids, the H region (7-15 residues) which is a 
central region with hydrophobic residues, and the C-terminal region (3-7 residues) with a 
more polar character (von Heijne 1990). Even though signal peptides show little sequence 
conservation, their presence can be predicted on the basis of protein sequences with computer 
algorithms such as SignalP (Bendtsen et al. 2004).   
Figure 1.3: Protein targeting to the Sec translocase. The bacterial Sec translocase spans the cytoplasmic 
membrane (CM) and consists of the protein conducting channel SecYEG (SecY, SecE and SecG) (here in 
orange) and SecA (green) which acts as the peripheral motor protein. Other accessory proteins interacting 
with the translocase include SecDF (pink) and YidC (red). On the periplasmic side the signal sequence is 
cleaved by the membrane-bound Signal peptidase (SPase). There are three options: (a) After the protein is 
translated by the ribosome (yellow) they bind to the Sec translocase by their signal sequence, which is 
recognized directly by SecA or the molecular chaperone SecB (blue). (b) The signal sequence of the 
nascent protein chain binds to the signal recognition particle (SRP) and then to the SRP receptor FtsY 
(purple). Afterwards, the whole ribosome-FtsY complex binds to the Sec translocase. (c) Some membrane 
proteins insert into the CM via YidC (Driessen & Nouwen 2008). The figure is taken from Driessen & 
Nouwen (2008). 





The preprotein with the N-terminal signal sequence is targeted to the Sec translocase by the 
molecular chaperone SecB or together with the ribosome by the signal recognition particle 
(SRP), as shown in Figure 1.3. If the signal sequence displays a high level of hydrophobicity 
and helicity the SRP will bind tightly to the ribosome nascent chain (Figure 1.3, b). This 
complex will bind to the membrane-associated signal-particle receptor, FtsY. The GTPase 
activity is activated and the ribosome nascent chain is transferred to the translocon pore, 
where the ribosomal exit tunnel makes close contact with the pore. Then the elongation of the 
polypeptide chain provides the energy for the insertion of the protein into the SecYEG 
complex. If the signal sequence does not display a high level of hydrophobicity, the 
polypeptide will be translated to its full length by the ribosome and released in cytosol. The 
still unfolded preprotein is recognized directly by SecA or by the molecular chaperone SecB 
(Figure 1.3, a). If the protein binds to SecB, this complex will target to the translocon where it 
binds SecA, leading to transfer of the preprotein and release of SecB (Driessen & Nouwen 
2008; du Plessis et al. 2011).    
 
After contact between the preprotein and the Sec system has been established, protein 
translocation starts with the binding of ATP to SecA. This provides energy that allows the 
insertion of the signal sequence, which adopts a hairpin-like loop structure, into the 
translocation pore. ATP hydrolysis results in release of the bound preprotein from SecA. 
Subsequently, SecA can either rebind to the preprotein located in the SecYEG pore or it can 
dissociate from SecYEG. The stepwise translocation of the preprotein is driven by multiple 
rounds of ATP binding and hydrolysis by SecA (Driessen & Nouwen 2008; du Plessis et al. 
2011).  
 
After the N-terminal signal peptide has initiated translocation of the protein across the 
cytoplasmic membrane, signal peptidases (SPases) remove the signal peptide. SPase is a 
membrane-bound enzyme, and different SPases recognize unique cleavage sites (Driessen & 
Nouwen 2008; Kleerebezem et al. 2010). The lipobox cleavage site, L-x-x-C, is recognized by 
Type-II SPase and its cleavage is linked to coupling of a lipo-anchor (for more details, see 
below) (Sutcliffe & Harrington 2002). The AxA-like cleavage site typical for regular Sec-








1.5.1 Heterologous protein secretion  
Studies with Gram-positive bacteria have shown that the secretion efficiencies of 
heterologous proteins depend on the signal peptide, the secreted protein, and the host 
organism. It is difficult to predict which combination of these factors will lead to efficient 
secretion (Brockmeier et al. 2006; Mathiesen et al. 2008; Perez-Martinez et al. 1992). The 
genome of L. plantarum WCFS1 is predicted to encode many proteins with signal peptides 
that can direct secretion of a heterologous target protein (Kleerebezem et al. 2003). There are 
over 200 genes that are predicted to encode proteins with an N-terminal signal peptide, and 
approximately 100 of these are likely to contain a signal peptidase I cleavage site (Boekhorst 
et al. 2006; Kleerebezem et al. 2003). Currently, signal peptides derived from the lactococcal 
Usp45 protein (Cortes-Perez et al. 2005; Dieye et al. 2001; Slos et al. 1998), the M6 protein 
from Streptococcus pyogenes (Hols et al. 1997; Reveneau et al. 2002; Slos et al. 1998) and the 
S-layer protein from Lactobacillus brevis (Oh et al. 2007; Savijoki et al. 1997) are the most 
exploited for heterologous protein secretion in Lactobacillus/Lactococcus. In a recent study, 
Mathiesen et al. (2009), studied 78 signal peptides from L. plantarum WCFS1 for their 
efficiency in secretion of heterologous protein and identified several promising candidates.  
 
1.6 Protein anchoring in Gram-positive bacteria 
After translocation some secreted proteins are attached to the bacterial cell surface through 
covalent or non-covalent binding to the cell wall or membrane (Boekhorst et al. 2006). These 
surface-exposed proteins are considered to play an important role in the interaction between 
the bacterium and the environment, including processes such signal transduction, recognition, 
binding and degradation of complex nutrients, nutrient uptake, cell-cell recognition, 
colonization and surface adherence (Boekhorst et al. 2006; Samuelson et al. 2002). Proteins 
that are usually coupled to the cell surface can be divided into four major types (Desvaux et 
al. 2006): 
 Transmembrane proteins (single or multiple) 
 Lipoproteins 
 Cell wall binding proteins  
 LPXTG-like proteins  
 
Transmembrane proteins are proteins anchored to the cytoplasmic membrane by one or 
several hydrophobic transmembrane helixes, often located N- or C- terminally. Lipoproteins 





are covalently attached to a lipid in the cell membrane through a conserved cysteine in the 
lipobox sequence. Cell wall binding proteins have specific domains that recognize some cell 
wall components. They can bind non-covalently using domains/motifs called LysM, SLH or 
WXL. LPXTG-like proteins have a Sec-dependent N-terminal signal peptide, a Type-I SPase 
cleavage site, and a LPXTG-like motif in the C-terminal end drives covalently attachment of 
the protein to peptidoglycan by a enzyme sortase (Desvaux et al. 2006; Kleerebezem et al. 
2010).  
 
The most commonly applied anchor for cell surface display in biotechnology is the LPXTG 
motif (Leenhouts et al. 1999). However, there are problems with using LPXTG motif for cell 
surface display. Firstly, differences in sortase activity between strains can cause problems and 
result in insufficient display of the target protein (Kim et al. 2008). Secondly, the LPXTG 
motif is in the C-terminal region (Boekhorst et al. 2005), meaning that proteins can only be 
attached in one orientation (with their N-terminal end protruding); this can be a problem when 
the to-be-displayed proteins have their functional sites close to the C-terminal domain or need 
to be oriented with a protruding C-terminus (such as in the case of invasin, described below). 
 
1.6.1 Lipoproteins  
Lipoproteins are an important class of membrane bound proteins with many different 
functions. They typically represent ca. 2% of the bacterial proteome and can be involved in 
adhesion, sensory processes, nutrient uptake, signal transduction, conjugation, sporulation, 
antibiotic resistance, and cell-envelope homeostasis, as well as in protein secretion, folding 
and translocation, especially extracytoplasmic protein folding (Kleerebezem et al. 2010; 
Kovacs-Simon et al. 2011; Rahman et al. 2008). In Gram-positive bacteria about 40% of the 
putative lipoproteins are ABC transporters (Hutchings et al. 2009).  
 
Lipoproteins have a signal peptide with a lipobox sequence (Figure 1.4) that directs them to 
the Sec machinery. All lipoproteins contain a cysteine directly downstream of the signal 
peptidase cleavage site, which is part of a well conserved lipobox. A typical lipobox motif is 
[LVI][ASTVI][GAS]C (Kovacs-Simon et al. 2011). After translocation of the pre-
prolipoprotein through the Sec pathway, a prolipoprotein diacylglyceryl transferase (Lgt) will 
add the diacyl glyceryl group from a glycerophospholipid to the SH-group of the cysteine 






because the diacylglyceryl group is now inserted into the lipid bilayer of the cytoplasmic 
membrane (Desvaux et al. 2006). This is followed by an N-terminal cleavage of the signal 
peptide by lipoprotein signal peptidase (Lsp or SPase II), leaving the lipid-modified cysteine 
at the N-terminus of the mature lipoprotein. Thus the protein is anchored to the membrane via 
a thioether linkage (Hutchings et al. 2009; Tjalsma et al. 2000) (Figure 1.4). In Gram-negative 
bacteria and some Gram-positive bacteria, the prolipoprotein is amino-acylated at the N-
terminal cysteine residue, by lipoprotein N-acyl transferase, adding an amide-linked fatty acid 
at the N-terminal cysteine residue. In those cases, the lipoprotein is anchored to the membrane 
by both the diacylglyceryl group and the amino-terminal acyl group (Kovacs-Simon et al. 
2011).  
Figure 1.4: Biosynthesis of bacterial lipoproteins. (A) The pre-prolipoprotein has an N-terminal signal peptide 
with a characteristic consensus lipobox sequence. (B) The thiol group of the indispensable cysteine in the 
lipobox is modified by a diacylglyceryl moiety by lipoprotein diacylglyceryl transferase (Lgt). (C) The signal 
peptide is cleaved of by lipoprotein signal peptidase (Lsp) or Spase II, and the cysteine is left as the new amino-
terminal residue forming the mature lipoprotein in Gram-positive bacteria. (D) In Gram-negative and some 
Gram-positive bacteria an additional amide-linked fatty acid is added to the mature lipoprotein at the N-terminal 
cysteine residue by lipoprotein N-acyl transferase (Lnt) (Kovacs-Simon et al. 2011). The figure is taken from 
Kovacs-Simon et al. (2011)   





After the lipoprotein in Gram-positive bacteria is translocated across the cytoplasmic 
membrane and modified, the lipoprotein is anchored to the outer leaflet of the plasma 
membrane. In some pathogenic bacteria lipoproteins function as virulence factors in the host-
pathogen interaction (Kovacs-Simon et al. 2011). Lipoproteins have attracted attention as 
vaccine candidates and many lipoproteins from different pathogenic bacteria have been 
evaluated (Ayalew et al. 2009; Erdile et al. 1993; Luo et al. 2009; Pimenta et al. 2006; 
Sardinas et al. 2009). 
 
1.7 Bacteria and the immune system in the gut 




 organisms and it is 
suggested that more than 1000 commensal species habitat the gastrointestinal tract (Velez et 
al. 2007). The immune system structure and function development are affected by the 
intestinal microflora (O'Hara & Shanahan 2006; Winkler et al. 2007). The mucosal immune 
system forms the largest part of the entire immune system, with about three-quarters of all 
lymphocytes, and it is the main site for host-microbe interactions (Didierlaurent et al. 2002; 
Shanahan 2002). There is a bi-directional adapted exchange between host and bacteria in the 
intestine, and the immune system has to discriminate between pathogenic and commensal 
microorganisms (Didierlaurent et al. 2002; Grainger et al. 2010; O'Hara & Shanahan 2006). 
   
Intestinal epithelial cells form a barrier that functions as the first sensory line of defense and 
separates the bacterial community from the internal milieu (Figure 1.5) (Niedergang et al. 
2004; O'Hara & Shanahan 2006). This constantly exposed barrier is covered by a protective 
layer of mucus (see Figure 1.5), which contains various protective and antimicrobial 
substances that are secreted by epithelial cells and have a broad spectrum of activities (Velez 
et al. 2007). In addition to protecting the host against bacterial invasion, the mucus layer 
digests and absorbs nutrients, and comprises a habitat for symbiotic bacteria (Deplancke & 







There are three main types of immunesensory cells in the intestine: surface enterocytes, 
Microfold (M)-cells and intestinal dendritic cells (DCs). These cells are responsible for 
recognizing and active sampling of bacteria and antigens present in the gut (O'Hara & 
Shanahan 2006). Surface enterocytes are cells that secrete chemokines and cytokines that lead 
and alert innate and adaptive immune responses to the infected site (O'Hara & Shanahan 
2006; Shanahan 2005). Polymeric immunoglobulin A (IgA) is secreted to the lumen and can 
potentially play a role in controlling bacterial persistence and uptake (Cerutti & Rescigno 
2008; Wells & Mercenier 2008). M-cells are one type of cells that are responsible for 
transport of proteins and microbes across the epithelium cells layer to subadjacent DCs and 
other antigen-presenting cells (APC) (Figure 1.5). M-cells are found in the follicle-associated 
epithelium (FAE), above mucosal lymphoid tissue (Corr et al. 2008). Specialized 
Figure 1.5: An overview of interactions between bacteria and the immune system in the intestinal tract. 
After their introduction into the intestinal tract, bacteria end up in the lumen or trapped in the mucus layer. (1) 
Bacteria and their secreted proteins or proteins from lysed cells will come into contact with the mucosal 
epithelium. (2) Immunoglobulin A (IgA) is secreted into the gut lumen. (3) Dendritic cells (DCs) can sample 
bacteria that are in contact with the apical surface, because DCs can extend between surface enterocytes without 
destroying the tight junctions. (4) M-cells are responsible for transporting luminal bacteria and antigens across 
the epithelium to cells of the immune system below. (5) Peyer’s patches are sites where bacteria and different 
molecules can gain increased access to the epithelium that is located above the mucosal lymphoid follicles. 
Peyer’s patches contain many DCs which can phagocytose bacteria and may move to mesenteric lymph nodes, 
where they can present antigens that are derived from the bacteria and then directly prime T-cell responses 
(Wells & Mercenier 2008). The picture is taken from Wells & Mercenier (2008).  





accumulations of lymphoid cells in one place are called lymphoid follicles where B-cells, T-
cells and DCs are located. Lymphoid follicles are spread through the human intestine; part of 
these follicles are grouped in larger aggregates, referred to as Peyer’s patches (Keita et al. 
2006; Niedergang et al. 2004) (Figure 1.5). DCs do not only occur in Peyer’s patches but also 
at other locations in the intestine. Several DCs have direct sensory roles, as illustrated in the 
left part of Figure 1.5. DCs are important cells because they can sample antigens directly from 
the lumen (O'Hara & Shanahan 2006) (Figure 1.5), and they are responsible for appropriate 
immune responses to commensal and pathogenic bacteria. DCs can stimulate any kind of 
response by phagocytosis of the bacteria, move to mesenteric lymph nodes where they present 
antigens that are derived from the bacteria to T-cells, and directly prime T-cell responses 
(Niedergang et al. 2004; Pasetti et al. 2011; Wells & Mercenier 2008).  
 
Lymphoid microcompartments such as the Peyer’s patches, the mesenteric lymph nodes, the 
appendix and isolated lymphoid follicles in the intestine constitute the mucosa-associated 
lymphoid tissue (MALT). The MALT consists of phenotypically and functionally distinct B-
cells, T-cells and accessory cell subpopulations. The immune response in mucosal tissue is 
dependent on the nature of the antigen, the type of professional antigen-presenting cells 
(APC) involved and the local microenvironment. APCs include DCs, B lymphocytes and 
macrophages, and they present the antigen via their cell membrane-anchored major 




 T-cells which 
generate different responses (Holmgren & Czerkinsky 2005).  
 
The MHC proteins play an important role in the immune system. The MHC proteins act as an 
“bulletin board" that serves to alert the immune system if foreign material is present inside a 
cell. They achieve this by displaying fragmented pieces or antigens on the host cell's surface 
(Lea 2006). The MHC class I molecules are found on almost every nucleated cell of the body 
and usually present peptides derived from endogenous proteins (proteins from cytosol in the 
cell). MHC class II molecules are found only on APC and usually present exogenous proteins 
(proteins from endocytose; from the environment around the cell). Cells of the epithelial 
mucosa mainly express MHC class I molecules, and only low amounts of MHC class II 
molecules. Antigens presented on MHC class I can activate CD8
+
 T cytotoxic cells, which 
subsequently kill the host cells infected with intracellular microorganisms. Antigens presented 
on MCH class II can activate CD4
+






depending on several factors including the dose of the antigen. Inflammatory reactions are 
normally associated with the TH1 response, whereas TH2 responses are normally associated 
with allergic responses and parasite clearance. Another class of cells, Treg cells, prevents 
overreactions by downregulating the immune response (Lea 2006; Ryan et al. 2001; Winkler 
et al. 2007). 
 
1.8 Mucosal delivery of therapeutic and prophylactic molecules 
A mucosal route of vaccination is in theory a very promising strategy because most infections 
start at mucosal surfaces (Wells & Mercenier 2008). With mucosal immunization the result is 
not always just a local immune response, since additional effects include production of 
mucosal-IgA antibodies at distant mucosal effectors sites. Furthermore, mucosal 
immunization stimulates systemic immune responses and T-cells activities to defeat infections 
(Cortes-Perez et al. 2007). One drawback of mucosal delivery is that the mucus layer 
probably limits the antigen uptake that is important for induction of adequate immune 
responses.  
 
The immune responses of vaccines delivered through mucosal tissue are influenced by several 
different parameters, including the choice of bacterial host and the final subcellular location 
of the expressed foreign antigen (cytoplasmic, secreted or anchored to the cell wall or 
membrane). Active bacteria with de novo synthesis of the antigen can influence the immune 
response.  It is not clear if a non-replicating vaccine would be as effective as a live bacterium 
and give the same immune responses (Wells & Mercenier 2008). This means that productions 
of antigens from active bacteria could be a good vaccine choice. The host does not necessarily 
have to be a bacterium, plant-based oral vaccines have also been considered (Tacket et al. 
1998; Walmsley & Arntzen 2000). Other possible oral vaccine delivery vehicles are 
liposomes (Amin et al. 2009), dendrimers, multiple emulsions, immune stimulating 
complexes and biodegradable polymers (Azizi et al. 2010). The best mucosal route for 
delivering of the therapeutic molecules is also an issue. Delivering through genitals or rectum 
has demonstrated to be unpractical in human trials (Kozlowski et al. 1997). Oral and nasal 
administrations seem to be better alternatives when it comes to mucosal vaccines for humans 
(Azizi et al. 2010).       
 





Oral delivery is considered as the preferred route of administration for a vaccine. This 
delivery has several advantages including easy administration (needle free), reduced risk of 
infection and possible contamination by the medical personnel, easy mass production, and 
potentially, low costs (Kim et al. 2010; Rieux et al. 2005). The drawbacks are related to 
difficulties in the delivery of active molecules to the mucosa because of the harsh digestion 
conditions in the GI tract (Critchley-Thorne et al. 2006; Kim et al. 2010). Several efforts have 
been made to handle this, such as the use of live organisms or viral carriers, and coating of the 
antigen (Palumbo & Wang 2006).  
 
1.9 Delivery of vaccines to the immune system via M-cells 
M-cells are considered a promising target for oral 
vaccination because they transport antigens, 
particles, viruses and bacteria from the lumen of the 
intestine, across the epithelial barrier into organized 
lymphoid structures below, where T cells, B cells 
and macrophages are ready to process any antigen 
present (Figure 1.6) (Corr et al. 2008; Gullberg et al. 
2006). M-cells are located throughout the GI tract. 
They are found in the FAE of intestinal Peyer’s 
patches, in isolated lymphoid follicles, in the 
appendix, as well as in mucosal-associated 
lymphoid tissue (MALT) sites outside the GI tract 
(Clark et al. 2001; Corr et al. 2008). 
 
Many pathogens exploit M-cells in invasion of the 
host, even though M-cells are specialized on antigen 
sampling. The invasion strategies used by pathogens 
have been examined in several studies, one reason 
being that their invasive abilities perhaps could be 
exploited for delivery of vaccines (Clark et al. 2001; Kraehenbuhl & Neutra 2000; Sansonetti 
& Phalipon 1999). However, the mechanisms involved in the uptake and transport of 
microorganisms by M-cells are poorly understood, primarily because M-cells are difficult to 
work with (Tyrer et al. 2007). Specific markers for M-cells are not completely known and the 
Figure 1.6: Overview of M-cell location 
found in the follicle-associated epithelium 
of Peyer's patches. The picture is taken from 






result from in vivo studies using M-cells are not always relevant because there are a high 
variability in proportion and phenotype of M-cells among different species (Brayden & Baird 
2001). Since M-cells are difficult to work with in vivo, in vitro models of M-cell/FAE are 
developed, which maintain the phenotypic and physiological features of the FAE and M-cells 
(Gullberg et al. 2000).  
 
Translocation of antigens, particles, viruses and bacteria by M-cells is a very efficient and 
rapid process. The mechanisms involved when M-cells take up microorganisms and 
molecules are different and vary according to the nature of the material. Several factors of the 
material influence the transport mechanism, including size, local surface pH, surface charge, 
hydrophobicity, concentration, temperature and the presence or absence of an M-cell specific 
receptor (Corr et al. 2008; Ragnarsson et al. 2008; Rieux et al. 2005). It is assumed that M-
cells contain many different surface receptors but only a limited number of receptors and their 
ligands have been identified.  Most of the identified receptors are not only found on M-cells 
but in neighboring enterocytes as well (Azizi et al. 2010). β1-integrin is a receptor found on 
the apical surface of M-cells, but not on the apical surface of enterocytes (Gullberg et al. 
2006). Interesting, a protein from Yersinia pseudotuberculosis called invasin interacts with β1-
integrin with a higher affinity than the natural ligands (fibronectin, collagen, laminin and 
vitronectin) and can be used to target M-cells (Palumbo & Wang 2006; Ragnarsson et al. 
2008). 
 
Figure 1.7: β1-integrin dependent antigen transcytosis of invasin expressing bacteria.  β1-integrin 
expressed on the apical surface of M-cells functions as transcytotic receptor for invasin expressing bacteria. 
The bacterium is transcytosed across FAE to the APCs underneath, such as DCs (Azizi et al. 2010). The figure 
is modified from Hase et al. (2009). 





Y. pseudotuberculosis is a Gram-negative enteropathogenic 
bacterium that causes gastroenteritis in humans. The bacterium 
crosses the intestinal epithelium by translocation across M-cells to 
enter Peyer’s patches (Hamburger et al. 1999). Invasin is the 
protein that promotes bacterial entry by binding to host cell β1-
integrin receptors (Leo & Skurnik 2011; Niemann et al. 2004; 
Palumbo & Wang 2006). The invasin gene, inv, of Y. 
pseudotuberculosis encodes a 986-residue protein (Grassl et al. 
2003). About 500 amino acids in the N-terminal part are thought 
to anchor the protein in the outer membrane and this part is 
believed to form a β-barrel (Niemann et al. 2004). The C-terminal 
part of invasin comprises 497 amino acids that make up the 
extracellular region that binds to host cell β-integrin receptors and 
promotes uptake of the bacteria (Grassl et al. 2003; Hamburger et 
al. 1999). The crystal structure of this fragment shows five 
tandem domains with an elongated, rod-like structure (Figure 1.8) 
(Niemann et al. 2004). A fragment comprising the last 192 
residues of this C-terminal fragment is the shortest fragment of 
invasin that is capable of binding integrins and inducing 
bacterial uptake by mammalian cells (Grassl et al. 2003; 
Hamburger et al. 1999). This C-terminal integrin binding 
fragment consists of domain D4 and D5 (Figure 1.8). The remaining domains, D1, D2 and D3 
strengthen the binding further and enhance the efficiency of cell uptake (Palumbo & Wang 
2006). The first four domains (D1, D2, D3 and D4) consist almost exclusively of β-strands, 
whereas the fifth domain (D5) has both α helices and -strands. The D4 and D5 domains that 
are essential for binding have an interface that is predominantly hydrophobic, but several 
hydrogen bonds are also present (Hamburger et al. 1999). 
 
The invasin protein is very attractive to utilize in oral delivery of molecules because of its 
efficiency and specificity (Palumbo & Wang 2006). In addition, it is now believed that 
invasin has more effect than just integrin binding and induction of uptake. It is believed that 
binding of invasin results in the activation and production of pro-inflammartory cytokines 
(Grassl et al. 2003; Leo & Skurnik 2011; Palumbo & Wang 2006). Invasin is also able to 
Figure 1.8: The 497 residues in 
the C-terminal end of invasin 
from Y. pseudotuberculosis 
shown as a ribbon diagram 
(Hamburger et al. 1999). The 
figure is taken from Hamburger 






activate B- and T-lymphocytes directly, because non-activated leukocytes express β1-integrin, 
and invasin binds efficiently to these cells because of its high affinity for this receptor (Grassl 
et al. 2003). Bacteria coated with invasin have been used to deliver either proteins or genes to 
mammalian cells in several experiments (Acheson et al. 1997; Critchley-Thorne et al. 2006; 
Harms et al. 2009; Suzuki et al. 2006).  
 
1.10 Goals of this study 
This study is part of a project where the long term goal is to develop oral vaccines based on L. 
plantarum, for example vaccines against cancer or tuberculosis The aim of the present study 
was to achieve production, secretion and cell membrane anchoring of the M-cell binding 
protein invasin from Y. pseudotuberculosis in L. plantarum WCFS1, by using an inducible 
gene expression system previously developed for efficient intracellular protein production 
(Sørvig et al. 2003). M-cells are considered a promising target for oral vaccination because 
they transport antigens, particles, viruses and bacteria from the lumen of the intestine, across 
the epithelial barrier into the organized lymphoid structures called Peyer’s patch (Corr et al. 
2008; Gullberg et al. 2006). It is also of great basic interest to investigate the immunological 
changes induced when a probiotic organism such as L. plantarum is translocated to the 
Peyer’s patches in the gut, even when there is no additional vaccine antigen present. L. 
plantarum WCFS1 is an interesting candidate to utilize as an oral vaccine because it is 
resistant to bile and has shown high survival capacity in the intestinal tract. In addition, it is a 
versatile bacterium with GRAS-status and genetic tools for strain engineering are available. 
As to these tools, an additional goal of the present study was to evaluate the possibilities for 
expressing and secreting proteins as complex as the invasin in lactic acid bacteria and to study 
the use of lipo-anchors for protein anchoring.  
 
In the present study, lipoprotein anchors with an N-terminal signal peptide and a lipobox 
motif (Kovacs-Simon et al. 2011) were tested to anchor invasin to the cell membrane of L. 
plantarum. It was necessary with an anchor in the N-terminal end of invasin since the active 
binding-domain is located at the C-terminal end (Hamburger et al. 1999). Since it was 
uncertain which length of the anchor would optimally expose the invasin protein for binding 
to β1-integin receptors, two different lipo-anchors with variable lengths were tested. Likewise, 
it was not known which form of invasin would give the best result. Two versions of the 
invasin consisting of five (Inv, comprising D1-D5) or two domains (InvS, comprising D4-D5) 





was therefore studied. Thus at the start of the project, four different types of anchoring 
constructs were envisaged containing different combination of two lipo-anchors and two 
invasin forms (for details see Result section).  
 
In short the experimental work of this study consisted of the following five parts: 
 Construction of invasin expression vectors, including controls. 
 Transformation of expression vectors into L. plantarum WCFS1. 
 Analysis of invasin production in the different recombinant L. plantarum strains. 
 Analysis of secretion and anchoring of invasin in L. plantarum (localization studies).  
 Analysis of internalization of L. plantarum strains harbouring different invasin 




























2.1 Laboratory equipment 
Laboratory equipment      Supplier 
 
2 ml tubes        Axygen 
13 ml tubes, PP       Sarstedt 
15 ml cellstar tubes, PP      Greiner bio-one 
50 ml cellstar tubes, PP      Greiner bio-one 
Automatic pipettes       ThermoLabsystems 
Cuvettes 
 Disposable cuvettes, 1.5ml     Brand 
 Electroporation cuvettes     Bio-rad   
Eppendorf tubes       Axygen 
FastPrep ® Tubes       MP 
Mikro tube 2 ml, PP       Sarstedt 
NuPAGE SDS-gels and buffers     Invitrogen 
Qubit assay tubes       Invitrogen 
Sterile filters, 0.22 µm pore size     Millex GP 
Vortex-machine       Ika 
Various glass equipments      Labsystems 
Waterbaths        Julabo 
Western blot equipment 
Immun-Blot PVDF Membrane     Bio-Rad 
 Trans-blot Transfer Medium, Nitrocellulose membrane BioRad 




 18x24 cm    Kodak 
 
 




PRISM 3100 DNA Sequencer     AME Bioscience 
BioPhotometer       Eppendorf 
Cell density meter       Swab 
Centrifuges 
 Table centrifuge      VWR/Biofuge 
 Cooling centrifuge      Eppendorf  
 Vacuum centrifuge      Savant 
 Centrifuge 5430R      Eppendorf 
CertoClav CV-EL       One-Med 
CP124S weight       Sartorius 
Electrophoresis equipment 
 Agarose gel: Power Pac 300 and Basic gel driver  Bio-rad 
 SDS-PAGE: Xcell Surelock
TM
 Mini-Cell   Invitrogen 
FastPrep-24 tissue and cell homogenizer    MP 





Gel electrophoresis        Bio-rad 
iBlot machine        Invitrogen 
LC 621P weight       Sartorius 
LEICA DMIL microscope       Leica 
MACSQuant
®
 Analyzer & MACSQuantify
TM 
Software  MACS Miltenyl Biotec 
Multi RS-60, Programmable rotator mixer    BIOSAN 
Multitron eco incubator      Infors 
PCR-machine 
 Mastercycler gradient      Eppendorf 
 VWR        VWR 
RCT classic stirrer        IKA 
pH-meter, 827 pH lab      Metrohm 
Qubit fluorometer       Invitrogen 
Rotamax 120 rotate       Heidolph 
SNAP i.d. Protein Detection System     Millipore 
Steri-Cycle CO2 Incubator, HEPA CLASS 100   Thermo Scientific 
Telstar AV-100 sterile bench      Telestar 
Universal Hood II, gel image      Bio-rad 
 
 
Software    Source 
ExPASy Proteomics Server  http://au.expasy.org/ 
LipoP 1.0    http://www.cbs.dtu.dk/services/LipoP/  
NCBI     http://www.ncbi.nlm.nih.gov/guide/ 
pDRAW32    http://www.acaclone.com/ 




Chemicals        Supplier 
1,10-phenanthroline, C12H8N2     Sigma-Aldrich  
Acetic acid, C2H4O2       Merck 
Acetone, CH3COCH3       Prolabo 
Agar         Merck 
Agarose Nusieve GTG      Cambrex 
Agarose Seakem LE agarose      Promega 
Ampicillin        Sigma 
Bromphenol blue, C19H10Br4O5S     Kodak    
Calcium chloride, CaCl2      sds 
EDTA, C10H16N2O8       Sigma 
Erythromycin, C37H67NO13      Sigma-Aldrich 
Ethanol, C2H5OH       Arcus 
Ethidium Bromide, EtBr      Sigma 
Gentamicin        Sigma 
Glass Beads, acid-washed      Sigma 
Glycerol, C3H8O2       Merck 






Kalium chloride, KCl       Merck 
Kanamycin        Sigma-Aldrich 
Magnesium chloride, MgCl2      Merck 
Metanol, CH3OH       Merck 
Monopotassium phosphate, KH2PO4     Merck    
Pepstatin A         Sigma 
Polyethylen glycol, PEG1450      Sigma  
Sodium acetate, NaC2H3O2x3H2O     Novagen 
Sodium chloride, NaCl      Merck 
Sodiumdihydrogenphosphate monohydrate, Na2HPO4  Merck 
Sodium hydroxide, NaOH      Merck 
Sucrose, C12H22O11       VWR Prolabo 
Tris-base, C4H11NO3       Sigma 
Trichloroacetic acid (TCA), C2HCl3O2    Sigma 
Tris-HCl        Sigma 
Tween-20        Sigma-Aldrich 
 
2.3 Proteins and enzymes 
Protein/enzyme        Supplier 
Antibodies 
 pAb invasin PAS Bleed #2 and Bleed #3     ProSci incorporated 
(Animal (Rabbit) ID 13619, 13620) 
Recognizes the C-terminal epitopes:  
YSSDWQSGEYWVKK and NGQNFATDKGFPKT    
 HRP-Goat Anti-Rabbit IgG (H+L)     Invitrogen 
 Anti-Rabbit IgG (whole molecule)- FITC    Sigma 
Bovine Serum Albumine (BSA)      Sigma-Aldrich 
Lysozyme         Sigma 
Mutanolysin from Streptomyces globisporus     Sigma 
Phusion High Fidelity DNA polymerase (with 5x Phusion HF buffer) Finnzymes 
Proteinase K         Sigma-Aldrich 
Quick T4 DNA ligase (with 2x Quick ligation reaction buffer)  Biolabs 
Ribonuclease A (RNAse A)       Sigma 





T4 DNA ligase (with 10x ligase reaction buffer)    Biolabs 











2.4 DNA & nucleotides 
DNA         Supplier  




 1 kb DNA ladder     Fermentas 
100 bp DNA ladder      NEB 
 
2.5 Primers 
Primers for traditional cloning and In-Fusion cloning are included in this study. Because 
traditional strategies were not successful to construct invasin expressing vectors, focus was 
shifted towards using In-fusion cloning technologies. Therefore, only primers for traditional 
cloning of a plasmid with the intracellular version of invasin (pCytInv) and a plasmid 
containing the Lp_1261 lipo-anchor (pLp_1261) were made before In-Fusion cloning were 
used instead.   
 
Table 2.1: Primers by name and sequence 
Restriction sites in sequence are indicated in italic and the linker sequences (see section 4.3) are indicated in 






Name Sequence Restriction 
site in 
sequence 
 Primers for use in traditional cloning  
CytInvF CATATGAGCGTCACCGTTCAGCAGC NdeI 
InvR GAATTCTTATATTGACAGCGCACAGAGC EcoRI 
Lp_1261F CATATGAATTTCAAAACAGCTGCAAAAGT NdeI 
Lp_1261R GTCGACCGCCGCGATAGTACCCCCGTTCTTACCGAGACGGTATAAC SalI 
 Primers for use in In-Fusion cloning  
HR1261F GGAGTATGATTCATATGAATTTCAAAACAGCTGCAA NdeI 
1261R GTCGACCGCCGCAATCGTGCCCCCGTTCTTACCGAGACGGT SalI 
HR1452F GGAGTATGATTCATATGAAGAAATGGCTCATTGCC NdeI 
1452R GTCGACCGCCGCAATCGTGCCTTGAACCGTGACTTTAGGTTCGT SalI 
SOE1261InvSF CGGGGGCACGATTGCGGCGGTCGACACGCTGACCGGTATTCTGGT SalI 
SOE1261InvF CGGGGGCACGATTGCGGCGGTCGACAGCGTCACCGTTCAGCAGC SalI 
SOE1452InvSF TCAAGGCACGATTGCGGCGGTCGACACGCTGACCGGTATTCTGGT SalI 
SOE1452InvF TCAAGGCACGATTGCGGCGGTCGACAGCGTCACCGTTCAGCAGC SalI 
HRCytInvF GGAGTATGATTCATATGAGCGTCACCGTTCAGC NdeI 
HRInvR CCGGGGTACCGAATTCTTATATTGACAGCGCACAGAGC EcoRI 
 Primers for use in sequencing  
SeqInvF CTTGGCTGATGGCACGATGAGT  
SeqInvR TCGCCGTCACAGCCACTT  
psecF GGCTTTTATAATATGAGATAATGCCGAC  
secInvF GTCGACAGCGTCACCGTTCAGCAGCCT  
psecAcc65IR TGGCTATCAATCAAAGCAACACGT  







 Table 2.2: Primers by name and description 
 
 
2.6 Bacterial strains and plasmids 
 








 Primers for use in traditional cloning 
CytInvF Forward primer for the long version of invasin (the D1-D5 domains) 
InvR Reverse primer for the invasin sequence 
Lp_1261F Forward primer for the lipo-anchor sequence from Lp_1261 in L. plantarum WCFS1 
Lp_1261R Reverse primer with linker (without silent mutations) for the lipo-anchor sequence from 
Lp_1261 in L. plantarum WCFS1. 
 Primers for use in In-Fusion cloning 
HR1261F Forward primer for the lipo-anchor sequence from Lp_1261 in L. plantarum WCFS1, 
including an overlapping sequence with the vector.  
1261R Reverse primer for the lipo-anchor sequence from Lp_1261 in L. plantarum WCFS1.  
HR1452F Forward primer for the lipo-anchor sequence from Lp_1452 in L. plantarum WCFS1, 
including an overlapping sequence with the vector.  
1452R Reverse primer for the lipo-anchor sequence from Lp_1452 in L. plantarum WCFS1.  
SOE1261InvSF Forward primer for the short version of invasin (the D4 and D5 domains) including a 
linker sequence (with silent mutations) and an overlap sequence with the Lp_1261 lipo-
anchor.  
SOE1261InvF Forward primer for the long version of invasin (the D1-D5 domains) including a linker 
sequence (with silent mutations) and an overlap sequence with the Lp_1261 lipo-anchor.   
SOE1452InvSF Forward primer for the short version of invasin (the D4 and D5 domains) including a 
linker sequence (with silent mutations) and an overlap sequence with the Lp_1452 lipo-
anchor.   
SOE1452InvF Forward primer for the long version of invasin (the D1-D5 domains) including a linker 
sequence (with silent mutations) and an overlap sequence with the Lp_1452 lipo-anchor.  
HRCytInvF Forward primer for the long version of invasin (the D1-D5 domains) including an 
overlapping sequence with the vector.  
HRInvR Reverse primer for invasin (both short and long version) including an overlapping 
sequence with the vector.  
 Primers for use in sequencing 
SeqInvF Forward primer for the sequencing of the invasin  
secInvF Forward primer for the sequencing of the invasin  
SeqInvR Reverse primer for  the sequencing of the invasin  
psecF Forward primer for the sequencing of inserts in the p2588sAmy-based vectors  
psecAcc65IR Reverse primer for the sequencing  of inserts in the p2588sAmy-based vectors 
pSipSecR Reverse primer for the sequencing of inserts in the p2588sAmy-based vectors 
Strain Source or reference 
Escherichia coli TOP10 Invitrogen 
Lactobacillus plantarum WCFS1 (Kleerebezem et al. 2003) 






Table 2.4: Plasmids 
  
 
2.7 Kits         
Kit         Supplier 
          
Big Dye
®
 Terminator v3.1 Cycle Sequencing Kit   Applied Biosystems 
 Big Dye
®
 Terminator v3.1 Ready Reaction Premix 
 Big Dye
®




 Background eliminator Kit    Pierce 
 Erase-It reagens A 




 bacterial DNA kit     Omega 








Plasmid Description Source or reference 
pCR-BluntII-TOPO Vector for cloning of PCR fragments; Kan
r
. Invitrogen 
pLp_0373sNucA pSIP401-derivative for secretion of NucA using the 
Lp_0373 signal peptide and the sakacin P promoter (PsppA) 
for nucA expression. 
(Mathiesen et al. 2008) 
p2588sAmy pSIP401-derivative for secretion of Amy using the 2588 
signal peptide and the sakacin P promoter (PsppA) for Amy 
expression. 
(Mathiesen et al. 2008) 
pTinvasin Vector containing the invasin gene. L. Fredriksen, 
unpublished 
pEV pSIP401-derivative lacking any target gene L. Fredriksen, 
unpublished 
pLp_1261 Vector containing anchor sequence from Lp_1261 in L. 
plantarum 
This work 
pCytInv p2588sAmy-derivative with invasin (Inv) instead of Amy. This work 
pLp_1261InvS p2588sAmy-derivative with a short sequence of Lp_1261 as 
anchor sequence and the D4 and D5 domains from invasin 
(InvS) instead of Amy. 
This work 
pLp_1261Inv p2588sAmy-derivative with  a short sequence of Lp_1261 
as anchor sequence and invasin (Inv)  instead of Amy. 
This work 
pLp_1452InvS p2588sAmy-derivative with  a short sequence of Lp_1452 
as anchor sequence and D4 and D5 domain from invasin 
(InvS)  instead of Amy. 
This work 
pLp_1452Inv p2588sAmy-derivative with  a short sequence of Lp_1452 









Advantage PCR Cloning Kit    Clontech 
In-Fusion enzyme 
5x In-Fusion reaction buffer 
pUC19 control vector, linearized (50ng/μl) 
2kb control insert (40ng/μl) 
 
JET Star, The Novel Plasmid Purification System  GENOMED  
Resuspension solution E1 
Lysis solution E2 
Neutralization solution E3 
Equilibration solution E4 
Wash solution E5 
Elution solution E6 
Nucleic Acid and Protein Purification, NucleoSpin Extract II Macherey-Nagel  
Binding Buffer NT 
Wash buffer NT3 
Elution Buffer NE 
Nucleic Acid and Protein Purification, NucleoSpin Plasmid Macherey-Nagel  
Resuspention Buffer A1 
Lysis Buffer A2 
Neutralization buffer A3 
Wash Buffer AW 
Wash Buffer A4 
Eluation buffer AE 
Qubit
TM
 dsDNA BR Assay Kits     Invitrogen 
QubitTM dsDNA BR reagent 
QubitTM dsDNA BR buffer 
QubitTM dsDNA BR standard #1 
QubitTM dsDNA BR standard #2 
 
 
2.8 Agars and media 
Medium          Supplier 
 
BHI (Brain-Heart-Infusion)        Oxoid 
 
 Medium: 37 g BHI 
   dH2O to 1 litre 
   Sterilized in a certoclave for 15 minutes at 115ºC 
 Agar:  BHI medium with 1.5% (w/v) agar 










MRS (de Man, Rogosa, Sharpe)       Oxoid 
 
 Medium: 52 g MRS 
   dH2O to 1 litre 
   Sterilized in a certoclave for 15 minutes at 115ºC 
 Agar:  MRS medium with 1.5% (w/v) agar 
   Appropriate antibiotics were added after cooling to ~60ºC  
 
 
MRSSM medium (1l) 
 
 MRS    52 g 
 Sucrose  (0.5 M) 171 g 
 MgCl2x6H2O   (0.1 M) 2.0 g 
 dH2O to 1 litre, filter sterilized (0.22 μm pore size)  
 
 
RPMI 1640 medium with L-glutamine and 10% fetal calf serum (FCS)  Invitrogen 
 
 
2xTY medium: 15 g tryptone 
   10 g yeast extract 
   5 g 10 mM NaCl 
   Sterilized in a certoclave for 15 minutes at 115ºC 
 









3.1 Growing of bacterial strains 
Diverse bacterial strains have different nutritional needs and require distinct growth 
conditions. Optimal growth can be obtained by ensuring that each bacterial strain receives 
what it requires. When the bacterium is used as a host for a plasmid construct harbouring an 
antibiotic resistance gene, antibiotics must be added to the growth medium to ensure stable 
maintenance of the plasmid.  
Escherichia coli cells were grown in BHI-medium (Brain-Heart-Infusion) either on solid agar 
plates or in liquid medium, and incubated overnight in a 37ºC heating cabinet (for plates) or in 
a shaker incubator (for liquid cultures). Appropriate antibiotics were added to the medium 
when growing E. coli strains harbouring plasmids, at the following concentrations: 
 Erythromycin  200 μg/ml in both agar plates and liquid medium 
 Kanamycin  50 μg/ml in both agar plates and liquid medium 
L. plantarum was grown either in MRS-medium (Man-Rogosa-Sharpe) or on solid MRS-agar 
plates. L. plantarum cultures were incubated overnight in a 30ºC or 37ºC heating cabinet 
without shaking.  L. plantarum cells containing plasmids harbouring an antibiotic resistance 
gene were grown in medium containing the appropriate antibiotic at the following 
concentrations: 
 Erythromycin  10 μg/ml in agar plates, 5-10 μg/ml in liquid medium 
 
3.2 Long-term storage of bacteria 
Glycerol enables bacterial cultures to be frozen for an indefinitely long time without harming 
the cells. Cultures of different bacterial strains of both E. coli and L. plantarum, harbouring 
different plasmids, were preserved by glycerol by making the following mixes: 
 1000 μl bacterial culture 
 300 μl glycerol (87% v/v, sterile) 
 After mixing, the glycerol stocks were kept at -80ºC.  





Bacterial cultures were grown from glycerol stocks by scraping small amounts of the frozen 
culture with sterile toothpicks and transferring the toothpicks to tubes containing appropriate 
growth medium.  
 
3.3 Plasmid isolation from Escherichia coli 
In order to isolate plasmids from E. coli the NucleoSpin Plasmid isolation kit was used. The 
procedure was performed according to the user manual provided by the manufacturer for 
“isolation of high-copy plasmid DNA from E. coli”.  
 
Materials: 
NucleoSpin Plasmid kit 
Resuspension Buffer A1 
Lysis Buffer A2 
Neutralization buffer A3 
Wash Buffer AW 
Wash Buffer A4 
Elution buffer AE 
 
Procedure: 
1. 1.5 ml overnight culture of E. coli containing the desired plasmid was centrifuged at 
11 000 x g for 1 minute in a microcentrifuge to pellet and harvest bacterial cells. The 
medium was poured off and as much of the liquid as possible was removed.  
2. 250 μl Buffer A1 was added and the pellet was resuspended by pipetting up and down. 
It was important to make sure that no cell clumps remained in the tube before addition 
of Buffer A2 
3. To lyse the cells, 250 μl Buffer A2 was added and the tube was gently inverted 6-8 
times. The lysis reaction was not allowed to proceed for more than 5 minutes and was 
carried out in room temperature.     
4. The lysed cell suspension was neutralized by adding 300 μl of Buffer A3, which stops 
the lysis reaction. The tube was gently inverted 6-8 times and precipitation of cell 
debris occurred.    
5. The tube was centrifuged at 16 100 x g for 10 minutes at room temperature, in order to 






6. The resulting supernatant was transferred to a column to bind DNA, while the pellet 
was not disturbed. The column was centrifuged for 1 minute at 11 000 x g and the 
flow-through was discarded.  
7. To wash the silica membrane in the column, 500 μl of the wash Buffer AW, preheated 
to 50ºC, was added. The column was centrifuged for 1 minute at 11 000 x g and the 
flow-through was discarded. Then the membrane was washed with 600 μl Buffer A4. 
The column was centrifuged for 1 minute at 11 000 x g and the flow-through was 
discarded. 
8. The column was centrifuged for another 2 minutes at 11 000 x g to dry the silica 
membrane and remove residual ethanol, a critical step for further applications because 
residual ethanolic wash buffer might inhibit enzymatic reactions. 
9. After placing the column in a clean eppendorf tube 50 μl Buffer AE was added 
followed by incubation on the bench for 1 minute. To elute the plasmid, the column 
was centrifuged for 1 minute at 11 000 x g.   
10. The eppendorf tube with plasmids were stored at -20ºC   
 
The midi kit from JET Star was used for plasmid isolation on a larger scale. The procedure 




JET Star, Midi kit  
 Resuspension solution E1 
 Lysis solution E2 
 Neutralization solution E3 
 Equilibration solution E4 
 Wash solution E5 
 Elution solution E6  
 
Procedure: 
1. The column was equilibrated before the cleared lysate was prepared, by adding 10 ml 
solution E4 to the column and allowing the column to empty by gravity flow.  
2. E. coli cells from 100 ml culture were pelleted by centrifugation at 5000 rpm for 5 
minutes. Afterwards, traces of medium were carefully removed. 





3. 4 ml of solution E1 was added to the pellet and the cells were resuspended by using 
the pipette until the suspension was homogeneous.  
4. 4 ml of solution E2 was added to the sample and the sample was mixed gently by 
inverting the tube until the lysate appeared to be homogeneous. The lysis reaction was 
incubated at room temperature for 5 minutes.     
5. The lysed cell suspension was neutralized by adding 4 ml of solution E3, which stops 
the lysis reaction. The suspension was mixed immediately by multiple inversions of 
the tube until a homogeneous suspension was obtained and no remainders of the 
viscous matter that appeared after cell lysis were left. The entire suspension was 
transferred to several 2 ml tubes, and centrifuged at 16 100 x g at room temperature 
for 10 minutes.  
6. The supernatant from step 5 was applied to the equilibrated column (from step 1), and 
the lysate was allowed to pass through the column by gravity flow. 
7. To wash the column, 10 ml of solution E5 was added twice and each time the wash 
solution was allowed to pass through the column by gravity flow. 
8. After placing the column in a clean tube, 5 ml of solution E6 was added to the column 
to elute the plasmid using gravity flow.   
9. After removing the column 3.5 ml isopropanol was added to the solution. The entire 
solution was transferred to several 2 ml tubes, and centrifuged at 16 100 x g at 4ºC for 
30 minutes. The supernatant was removed and 100 μl of 70% ethanol was added to 
each tube and the tubes were recentrifuged. The sample pellet was vacuum dried for 5 
minutes to remove residual ethanol and the pellet was redissolved in 10 μl of dH2O 
and stored at -20ºC.    
     
3.4 Isolation of genomic DNA from Lactobacillus plantarum WCFS1 
Isolation of genomic DNA from L. plantarum was performed according to the bacterial DNA 





Lysozyme (50 mg/ml) 






RNase A (10 mg/ml)  
 
E.Z.N.A bacterial DNA kit 
 DNA Wash Buffer 
 Buffer BTL 
 Buffer BDL 
 Buffer HB 
 Elution buffer 
 Equilibration Buffer 
 
Procedure: 
1. 1.5 ml overnight culture was centrifuged at 4000 x g for 10 minutes at room 
temperature. Afterwards, the medium was poured off and as much of the liquid as 
possible was removed.   
2. The pellet was resuspended in 180 μl sterile dH2O. 18 μl lysozyme was added and the 
suspension was incubated in a 30ºC water bath for 10 minutes. 
3. The suspension was centrifuged at 5000 x g for 5 minutes at room temperature. 
Afterwards, the supernatant was aspirated and about 10 μl of residual liquid was left in 
the tube. The cell pellet was resuspended by vortexing.  
4. 200 μl Buffer BTL was added to the suspension. The suspension was transferred to a 
tube with ~25 mg glass beads. The tube was placed in the FastPrep-24 tissue and cell 
homogenizer operated with the settings 6.0 m/s and 45 seconds for crushing the cells 
mechanically. The crushed cells were centrifuged at 13 000 x g for 1 minute and the 
supernatant was transferred to a new eppendorf tube. 
5. 20 μl Proteinase K was added to the supernatant, to break peptide bonds in proteins in 
the sample, and the sample was vortexed to mix it thoroughly.  
6. The sample was incubated in a 55ºC water bath for 1 hour and briefly vortexed every 
20 minutes during the incubation.  
7. 5 μl RNase A was added to the sample and the tube was inverted several times 
followed by incubation on the bench for 5 minutes. 
8. The sample was centrifuged at 10 000 x g for 5 minutes to pellet insoluble debris. 
Afterwards the supernatant was carefully aspirated and transferred to a new eppendorf 
tube, leaving behind any insoluble pellet. 





9. 220 μl Buffer BDL was added to the sample, the tube was briefly vortexed followed 
by incubation at 65ºC for 10 minutes. 
10. 220 μl 96% ethanol was added to the sample and the sample was mixed thoroughly by 
vortexing the tube at max speed for 20 seconds.  
11. A column for DNA binding was prepared by adding 100 μl Equilibration Buffer to it, 
followed by incubation for 4 minutes at room temperature in a collection tube. The 
column was then centrifuged at 13 000 x g for 1 minute.  
12. The entire sample from step 10 was transferred to the column, including any 
precipitate that might have formed, and the column was centrifuged at 10 000 x g for 1 
minute. The collection tube and the filtrate were discarded.  
13. The column was placed into a second collection tube and washed with 500 μl Buffer 
HB. The column was centrifuged at 10 000 x g for 1 minute and the flow-through was 
discarded. 
14. 700 μl DNA Wash Buffer diluted with ethanol was added to the column. The column 
was centrifuged at 10 000 x g for 1 minute and the flow-through was discarded. 
15. The wash step was repeated with a second 700 μl DNA Wash Buffer and the column 
was centrifuged as described in step 14. 
16. The column was centrifuged at 10 000 x g for 2 minutes to remove ethanol.  
17. After placing the column in a clean eppendorf tube 50 μl Elution Buffer, preheated to 
65ºC, was added followed by incubation for 5 minutes at room temperature.  
18. The column with the eppendorf tube was centrifuged at 10 000 x g for 1 minute to 
elute genomic DNA. Afterwards, the eppendorf tube was stored at -20ºC.       
 
3.5 Nucleic acid precipitation with Pellet Paint  
This method is based on using Pellet Paint Co-Precipitant which is a brightly colored (pink), 
dye-labeled carrier, designed specifically for use in alcohol precipitation of nucleic acids. 
Both RNA and DNA can be precipitated from solutions by alcohols and such a precipitation 
step can be used for cleanup or/and concentration of DNA, for example after a PCR reaction.  
 
Materials: 
 Pellet Paint Co-Precipitant 
 3M sodium acetate pH 5.2 







1. The tubes with Pellet Paint Co-Precipitant and 3M sodium acetate were put at room 
temperature. The Pellet Paint stock solution tube was inverted carefully several times, 
until a uniform suspension was achieved.  
2. 2 μl of Pellet Paint was added to the sample (independent of sample volume). 
3. 0.1 volumes of 3 M sodium acetate were added to the sample and the sample was 
mixed briefly. 
4. 2 volumes of 96% ethanol were added to the sample and the sample was mixed by 
vortexing the tube briefly for 5-10 seconds. 
5. The sample was incubated at room temperature for 2 minutes. 
6. The sample was centrifuged at 16 100 x g for 5 minutes, leading to a pink pellet 
containing the DNA becoming visible at the bottom of the tube. The supernatant was 
carefully aspirated.  
7. The pellet was rinsed with 500 μl 70% ethanol and the sample was briefly vortexed. 
The sample was recentrifuged, and the supernatant was carefully aspirated.  
8. The pellet was rinsed with 100 μl 96% ethanol. The sample was recentrifuged, and the 
supernatant was carefully aspirated.  
9. The sample pellet was vacuum dried for 5 minutes to remove residual ethanol.  
10. The dried pellet was solved in a desired volume of dH2O.  
 
3.6 Determination of DNA concentration with Qubit  
The Qubit method is a method for DNA quantification. Qubit
TM
 dsDNA BR Assay Kit is 
selective for double-stranded DNA and consists of a fluorescence-based dye that binds 
specifically to DNA. The fluorescent dye emits signals when it is bound to the specific target 
molecules. The standards included in the kit are used to make the standard curve which is 
used to determine the concentration of DNA in the samples. Common contaminants, such as 





 assay tubes 
Qubit
TM
 dsDNA BR Assay Kits 
 QubitTM dsDNA BR reagent 
 QubitTM dsDNA BR buffer 





 QubitTM dsDNA BR standard #1 
 QubitTM dsDNA BR standard #2 
 
Procedure: 
1. All reagents were at room temperature before use.  
2. The working solution was made by diluting the Qubit™ dsDNA BR reagent 1:200 in 
Qubit™ dsDNA BR buffer. The final volume in each assay tube was 200 μl. Each 
standard tube required 190 μl of the working solution, whereas each sample tube 
required from 180 μl to 199 μl (most often199 μl). A sufficient amount of working 
solution to accommodate all standards and samples were prepared. 
3. Standards were prepared by mixing 190 μl of the working solution with 10 μl of each 
Qubit
TM
 standard. The solutions were vortexed carefully, for 2-3 seconds, while 
avoiding formation of air bubbles.  
4. Samples were prepared by mixing 180-199 μl (most often 199 μl) working solution 
with 1-20 μl (most often 1 μl) DNA sample. The solutions were vortexed carefully for 
2-3 seconds, while avoiding formation of air bubbles. 
5. All tubes were incubated at room temperature for 2 minutes. 
6. The tubes were read in QubitTM fluorometer by selecting dsDNA BR assay type (the 
staining signal was stable for 3 hours).  
 
3.7 Polymerase chain reaction (PCR) 
The polymerase chain reaction (PCR) is a method for amplifying particular fragments of 
DNA in vitro. To amplify the desired DNA sequence, specific oligonucleotides (primers), a 
DNA polymerase and deoxynucleotides (dNTPs) are mixed. The DNA is first denatured at a 
high temperature, and then each strand of the target DNA will serve as a template for DNA 
synthesis. When lowering the temperature the primers will anneal to their target sequence in 
the template DNA. The DNA polymerase extends the two primers with available dNTPs. This 
reaction generates double-stranded DNA over the region of interest on both stands of DNA. 
Additional repeated cycles of denaturation and primer-directed DNA synthesis lead to 
exponential amplification of the region between the two primers. Several DNA polymerases 








3.7.1 Taq DNA Polymerase 
Taq DNA polymerase is purified from E. coli expressing a cloned Thermus aquaticus DNA 
polymerase gene. This enzyme has a 5’→ 3’ DNA polymerase and a 5’→ 3’ exonuclease 
activity but lacks a 3’→5’ exonuclease activity. Taq DNA polymerase was used to check if a 
plasmid contained the desired gene after transformation.   
 
Materials: 
 Taq DNA Polymerase 
 10X PCR Buffer, Minus Mg++ 
 50 mM Magnesium Chloride 
 dNTP-mix 
 Primers (see Materials, section 2.5) 
Procedure: 
1. PCR reactions were carried out as suggested by the Taq DNA polymerase suppliers 
(Invitrogen). The components listed in Table 3.1 (for making of master mix) or in 
Table 3.2 (for use of the ready-to-use master mix) were mixed in a sterile 0.5 ml 
microcentrifuge tube placed on ice. When a colony was examined directly 1 μl of 
template DNA was replaced with bacteria from the colony. A toothpick was used to 
pick a colony and transfer it to the bottom of the PCR tube. The PCR tube was placed 
in a microwave oven for 2 minutes at maximum intensity to lyse the bacterial cells. 
Subsequently, reactants were added.     
Table 3.1: PCR reagents in a Taq DNA polymerase reaction 
Components Volume Final Concentration 
Autoclaved distilled water (dH2O) To 100 μl  
10X PCR buffer minus Mg
++
 10 μl 1X 
10mM dNTP mixture 2 μl 0.2 mM each 
50mM MgCl2 3 μl 1.5 mM 
Primer mix (10μM each) 5 μl 0.5 μM each 
Template DNA 1 μl  
Taq DNA polymerase (5U/μl) 0.2-0.5 μl 1.0-2.5 unites 
   
 
Table 3.2: PCR reagents in a Red Taq DNA polymerase Master Mix reaction 
Components Volume Final Concentration 
Autoclaved distilled water (dH2O) To 50 μl  
Taq Master Mix RED 25 μl 1X 
Primer mix (10μM each) 3.5 μl 0.7μM each 
Template DNA 1 μl  
 





2. The reaction mixtures were placed in a thermal cycler and the settings shown in Table 
3.3 were applied. 
Table 3.3: PCR settings in a Taq DNA polymerase reaction 
Temperature Action Time Number of cycles 



















* The temperature was varied in order to be approximately 5ºC below the average melting point of the 
primers used. 
 
3.7.2 Phusion High-Fidelity DNA Polymerase 
Phusion DNA polymerase is a Pyrococcus-like enzyme with a processivity-enhancing 
domain. This enzyme has a 5’→ 3’ DNA polymerase activity and a 3’→5’ exonuclease 
activity. The Phusion DNA polymerase was used for PCR-amplification of the to-be-cloned 
DNA fragments because Phusion DNA polymerase has approximately a 50-fold lower error 
rate than Taq DNA polymerase.   
 
Materials: 
 Phusion DNA Polymerase 
 5x Phusion HF Buffer 
 dNTP-mix 
 Primers (see Materials, section 2.5) 
 
Procedure: 
1. PCR reactions were carried out as suggested by the Phusion DNA polymerase 
suppliers (Finnzymes). The components listed in Table 3.4 were added to a sterile 0.5 
ml microcentrifuge tube placed on ice. 
Table 4.4: PCR reagents in a Phusion DNA polymerase reaction 
Components Volume Final Concentration 
Autoclaved distilled water (dH2O) To 50 μl  
5X Phusion HF Buffer 10 μl 1X 
10 mM dNTP mixture 1 μl 0.2 mM each 
Primer mix (10 μM each) 2.5 μl 0.5 μM each 
Template DNA 1 μl  







2. The reaction mixtures were placed in a thermal cycler and the settings shown in Table 
3.5 were applied. 
Table 3.5: PCR settings in a Phusion DNA polymerase reaction 
Temperature Action Time Number of cycles 



















* The Tm calculator and instructions on Finnzymes website was used to determine the optimal annealing 
temperature.   
˟ For low complexity DNA (e.g. plasmid) was an extension time of 15 seconds per 1kb used. 
 
3.8 Agarose gel electrophoresis  
Agarose gel electrophoresis is a much used separation method to separate DNA fragments 
according to their size, i.e. the number of base pairs (bp), as well as for purifying DNA 
fragments. The fragments are separated by an electric current, since DNA is negatively 
charged and migrates to the positive pole at different speed, depending on size. It is possible 
to visualize these fragments on the gel due to the presence of the fluorescent dye ethidium 
bromide (EtBr), which binds to DNA. In the present study, fragments over 1000 bp were 
separated on 1.2% (w/v) agarose gels and DNA-fragments shorter than 1000 bp were 
separated on 2-3% (w/v) agarose gels. A special type of agarose (Nusieve GTG), specifically 
developed for separating smaller fragments, was used for analysis of fragments below 1000 
bp. 
 
3.8.1 Agarose gel electrophoresis  
 
Materials: 
Agarose Seakem LE agarose 
Agarose Nusieve GTG 
TAE-buffer (Tris-acetate), 50x: 242 g Tris-base 
     57.1 ml acetic acid  
     100 ml 0.5 M EDTA, pH 8.0 
     dH2O up to 1 l 
Ethidium bromide   10 mg/ml 
Loading dye (10x)   40% (w/v) sucrose 
     0.25% bromphenol blue 





     dH2O to 10 ml 
DNA ladders    See Materials, section 2.4 
 
Procedure: 
1. In order to make the 1.2% gels, 0.6 gram agarose was mixed with 50 ml 1xTAE buffer 
and heated in a microwave until the agarose was completely dissolved.  
For higher percentage gels, two different methods were applied: 
 The agarose was mixed with 1xTAE buffer with a magnet stirrer for 10 minutes before 
heating.  
 The 1xTAE buffer was chilled before use. The agarose powder was slowly sprinkled 
into the buffer while the solution was rapidly stirred. The solution was left on the 
bench for 15 minutes and then heated in the microwave oven on medium power for 2 
minutes. The solution was gently swirled and then reheated on high power until the 
solution came to a boil. The solution was kept at boiling point for 1 minute or until all 
of the particles were dissolved.  
2. The agarose solution was cooled to below 60ºC and 0.5 μg/ml ethidium bromide (EtBr) 
was added. The solution was poured into a moulding tray and a well-comb was placed in 
the chamber, to make wells in the gel. The solution was then allowed to cool in the tray 
until the solution was a solid gel.   
3. The solid gel was transferred to an electrophoresis chamber and the chamber was filled 
with 1xTAE buffer. 
4. 0.1 volume of 10x loading dye was added to the DNA containing samples. After mixing, 
the samples were applied to the wells in the gel. 
5. The gels were normally run at 90V until the fragments were sufficiently separated, but 
for higher percentage gels, 50V was usually applied. 
6. DNA-bands were visualized by UV-light using a GelDoc machine from BioRad.   
 
3.8.2 DNA extraction from agarose gels 
Fragments from PCR reactions and restriction cutting (see sections 3.7 and 3.9.2, 
respectively) were run on agarose gels, and agarose pieces containing the bands with correct 
size were excised from the gel with a scalpel and transferred to an eppendorf tube. The gel 
slices were weighed and DNA was isolated using the NucleoSpin Extract II kit, according to 







NucleoSpin Extract II, Purification of nucleic acids 
 Binding Buffer NT 
 Wash buffer NT3 
 Elution Buffer NE 
 
Procedure: 
1. For each 100 mg of agarose gel 200 µl of Buffer NT was added to the gel piece. For a 
gel containing more than 2% agarose, the volume of Buffer NT was doubled. The 
maximum amount of gel slice per NucleoSpin Extract II column was 400 mg for 
normal gels and 200 mg of high percentage gels (more than 2%). 
2. The sample was incubated for 5-10 minutes at 50ºC and the tube was vortexed every 
2-3 minutes, until the gel slice was completely dissolved.  
3. The sample was added to a NucleoSpin Extract II column placed in a collection tube. 
The tube was centrifuged for 1 min at 11 000 x g, in order to bind DNA to the column. 
The flow-through after centrifugation was discarded. 
4. To wash the silica membrane in the column, 700 µl Buffer NT3 was added and the 
sample was centrifuged for 1 min at 11 000 x g; the flow-through was discarded.  
5. The empty column was centrifuged for 2 minutes at 11 000 x g to remove Buffer NT3 
quantitatively. The column was removed from the collection tube without any contact 
with the flow-through. 
6. The column was placed into a clean eppendorf tube and 15-50µl Buffer NE was 
added. After incubation at room temperature for 1 minute the sample was centrifuged 
for 1 min at 11 000 x g to elute the DNA.  
 
3.9 Construction of novel plasmids 
In this study two main strategies were employed for the construction of new plasmids: 
 Conventional Topo-cloning of to-be-cloned fragments (see section 3.9.1), followed by 
restriction enzyme digestions and ligations of appropriate fragments and vectors. 
 In-Fusion cloning, PCR fragments with 15 bp ends overlapping with vector sequences 
were constructed for direct insertion into the desired vector. 
 
 





3.9.1 TOPO-cloning and transformation 
PCR products purified according to section 3.8.2 were cloned using the Zero Blunt® TOPO® 
PCR Cloning Kit from Invitrogen. TOPO-cloning uses topoisomerase instead of DNA ligase 
to insert the PCR fragment into the vector. TOPO-cloning was used because it is easier to get 
successful restriction digests when the PCR product is in a vector, compared to performing 
digests directly on the PCR products. Furthermore, the TOPO-vector can be used as storage 




BHI agar plates and liquid with kanamycin (50 μg/ml) 









 Chemically Competent TOP10 E. coli cells 
 
Procedure: 
1. The TOPO-cloning was set up as described in Table 3.6 and the reagents were added 
in the order shown. 
Table 3.6: Reagents in TOPO-reaction 
Reagent Volume 
Fresh purified PCR product 2 μl 
Salt solution 1 μl 





 0.5 μl 
 
2. The reaction mixture was briefly vortexed and centrifuged, and then incubated for 5 
minutes at room temperature. 
3. 50 μl TOP10 E. coli cells were transferred to Falcon tubes. After adding 2 μl of the 
TOPO-reaction mixture the cells were placed on ice for 30 minutes. 
4. The Falcon tubes were transferred directly from ice to a 42ºC water bath for 30 
seconds, to heat shock the E. coli cells. 
5. 250 μl of room temperature SOC medium was added to the reaction. 
6. The samples were incubated at 37ºC with shaking for minimum 1 hour. 
7. 100 μl of the solution was spread on pre-warmed agar plates containing BHI with 






8. The next day, colonies were picked with sterile toothpicks and grown in liquid BHI 
containing kanamycin in a shaking incubator overnight. The same colonies were 
checked for the desired gene with a PCR reaction with Taq DNA Polymerase and 
appropriate primers, described in section3.7.1. The PCR product was examined with 
agarose gel electrophoresis (see section 3.8).  
9. The next day, the plasmids were isolated from the E. coli cells, but only if the PCR 
reaction in step 8 gave products with the correct size. The plasmids were stored at  
-20ºC for further processing.   
 
3.9.2 Restriction endonuclease cutting 
Restriction endonucleases are enzymes that cleave double stranded DNA molecules at 
sequence specific locations. Each enzyme recognizes a specific (short) sequence that directs 
DNA binding and cutting. If the cuts are at the same position in the two strands the resulting 
new chain ends are referred to as blunt ends. If the enzyme cuts the two DNA strands at 
different positions, usually two or four nucleotides apart, sticky (cohesive) ends will be the 
result. A successful reaction with a restriction enzyme depends on several factors. The 
different enzymes have varying optimal working-temperatures, the reaction has to be carried 
out in a buffer that is well-suited for the restriction enzyme, and some enzymes require BSA 
as an adjuvant to function in the best possible manner. When two restriction enzymes are used 
simultaneously, it is often required to make compromises to ensure that both enzymes have 
satisfactory activity in the reaction. Alternatively, such digestions may be carried out in two 
separate steps.  
 
For a normal restriction enzyme cutting the following is needed: 
Materials: 
Restriction enzyme     Listed in Materials, section 2.3 
10x enzyme buffer     Listed in Materials, section 2.3 
BSA stock solution (Bovine serum albumin) For some enzymes  
 
Procedure: 
1. An appropriate amount of DNA (depending on use) was mixed with dH2O and the 
appropriate enzyme buffer (5 μl); BSA was added if it was recommended by the 
supplier. 





2. 2.5 μl of each of the two restriction enzymes were added to the reaction and after 
brief mixing, the reaction was incubated at the temperature recommended by the 
enzyme supplier (usually 37ºC) for 3 hours.  
3. After incubation, reaction products were separated and visualized on agarose gels as 
described in 3.8.1 and desired bands with the correct fragment size were cut out and 
purified as described in 3.8.2.   
 
3.9.3 DNA ligation 
DNA ligases are enzymes that catalyze the reaction which joins breaks in the sugar-phosphate 
backbone in double-stranded DNA. T4 DNA ligase is obtained from E. coli cells infected 
with T4 bacteriophage and it catalyzes the ATP-dependent formation of a phosphodiester 
bond between juxtaposed 5’ phosphate and 3’ hydroxyl termini in duplex DNA or RNA. 
Ligation of DNA strands was done either by setting up reactions with T4 DNA ligase (NEB) 
or by using the Quick Ligation
TM
 Kit (NEB).  
 
Materials: 
10x T4 DNA ligase reaction buffer 
T4 DNA ligase 
Quick Ligation
TM
 Kit (NEB) 
2x Quick ligation reaction buffer 
Quick T4 DNA ligase 
 
Procedure: 
For a typical ligation with T4 DNA ligase, the reagents were set up as described in Table 3.7 
Table 3.7: Reagents and their amounts for ligation with T4 DNA ligase 
Reagents Amount 
DNA 50ng vector + 3-fold molar excess of insert 
dH2O to 20 μl 
10x T4 DNA ligase reaction buffer 2 μl 
T4 DNA ligase 1 μl 
 
The reaction was mixed briefly and incubated at room temperature for 2 hours or at 16 º C for 









A typical ligation reaction with Quick T4 DNA ligase was set up as described in Table 3.8.  
Table 3.8: Reagents and their amounts for ligation with Quick T4 DNA ligase 
Reagents Amount 
DNA 50ng vector + 3-fold molar excess of insert 
dH2O to 20 μl 
2x Quick ligation reaction buffer 10 μl 
Quick T4 DNA ligase 1 μl 
 
The reaction mixture was mixed and centrifuged briefly followed by incubation at 25ºC for 5 
minutes. After the incubation, the samples were stored on ice prior to transformation. 
 
3.9.4 In-Fusion Cloning 
In-Fusion Cloning is based on an In-Fusion
TM
 enzyme which joins any two pieces of DNA 
that have 15 bp of identity at their ends, as shown in Figure 3.1. A typical use for this 
technology would be to clone PCR products into vectors, without the use of restriction 
enzymes, ligase or phosphatase. First in the In-Fusion method PCR primers are designed that 
share 15 bases of sequence overlap with the sequence at the ends of the linearized cloning 
vector. These primers are then used to PCR amplify the insert DNA. The resulting PCR 
product and the linearized vector are joined together in the In-Fusion reaction and then 
transformed into E. coli.  
 
 
Figure 3.1: The In-Fusion cloning method. First, PCR primers are designed to share 15 bp sequence overlap 
with the vector, and these are used to amplify the gene of interest. The PCR product and the linearized vector 
are joined together in the In-Fusion reaction, and the plasmid is transformed into E. coli. The figure is taken 
from In-Fusion
TM 
Advantage PCR Cloning Kit User Manual by Clontech.  





Splicing by Overlapping Extension PCR (SOE-PCR) is a technique where two DNA 
fragments are fused together by the use of special primers. The primer designed to bind at the 
end (that later are going to be linked to the other fragment), is constructed to have an overlap 
of 25 bases with the end of the other fragment. Two separately PCR reactions are performed 
(Figure 3.2) where each of the DNA fragments is extended by a new sequence, 
complementary to the other fragment. Once both DNA fragments are extended in such a 
manner, they are mixed and a PCR is carried out using only the primers for the far ends. The 
overlapping complementary sequences introduced will serve as primers, fusing the two 
sequences. 
 
Figure 3.2: Splicing by Overlapping Extension PCR (SOE-PCR). First, two separately PCR reactions are 
performed where each of the DNA fragments is extended by a new sequence that is complementary to the other 
fragment. The two DNA fragments are mixed and a PCR is carried out using only the primers for the far ends. 
The overlapping complementary sequences introduced will serve as primers, fusing the two sequences. 
 
Materials: 
TE Buffer (pH 8.0): 10 mM Tris-HCl 
   1 mM EDTA  
LB agar plate with ampicillin (100 μg/ml) 
BHI agar plates and liquid with erythromycin (200 μg/ml) 
Chemically Competent TOP10 E. coli cells (purchased or made as described in section 3.10) 
NucleoSpin Extract II 
In-Fusion
TM 
Advantage PCR Cloning Kit 
In-Fusion enzyme 
5x In-Fusion reaction buffer 






2 kb control insert (40 ng/μl) 
 
Procedure: 
1. A linearized vector was generated by using restriction enzymes as described in 
section 3.9.2 
2. In-Fusion primers were designed to generate PCR products containing ends that are 
identical to the ends of the linearized vector. The 5’ end of the primer contained 15 
bases that correspond to 15 bases at one end of the vector and the 3’ end of the primer 
contained sequence that was specific to the target gene. The 3’ portion of each primer 
was between 18-25 bases in length and had a GC-content between 40-60% and a 
melting temperature (Tm) between 58-65ºC. The last five nucleotides did not contain 
more than two guanines (G) or cytosines (C).  
3. The insert was made by PCR amplification with Phusion High-Fidelity DNA 
Polymerase as described in section 3.7.2. The PCR product was examined with 
agarose gel electrophoresis (see section 3.8.1) and it was purified by following the 
NucleoSpin Extract II protocol (see section 3.8.2)      
4. Step 3 was repeated with an appropriate sets of primers (the primers had 25 bp of 
homology between the anchor and the invasin protein), to join together the two inserts 
(anchor and protein) in a SOE-PCR reaction.  
5. The Qubit method, described in section 3.6, was used to determine the DNA 
concentration of the insert and vector solutions. In general, maximum cloning 
efficiency is achieved when a 2:1 molar ratio of insert:vector is used. Typically, 100 
ng of a 4-5 kb linearized vector plus 50 ng of a 1 kb PCR product is found to work 
well in In-Fusion reactions. The In-Fusion® Molar Ratio Calculator (available at: 
http://bioinfo.clontech.com/infusion/molarRatio.do) and the Qubit results were used 
to calculate the amount of insert and vector for the In-Fusion reaction.  
6. The In-Fusion cloning reaction was set up as described in Table 3.9    
Table 3.9: Reagents and amounts in an In-Fusion reaction 
 
* For reactions with larger volumes of vector and insert (>7 μl of vector + insert), the amounts of 
reaction buffer and enzyme were doubled and the total volume was adjusted to 20 μl.   
Reagents Amount 
dH2O  To 10 μl 
5x In-Fusion reaction buffer 2 μl 
Vector x μl * 
Purified PCR insert 
In-Fusion enzyme 
x μl * 
1 μl 





7. The reaction was incubated for 15 minutes at 37ºC, followed by 15 minutes at 50ºC, 
and then the reaction was placed on ice. 
8. After bringing the reaction volume up to 50 μl with TE buffer the solution were 
mixed thoroughly. 
9. 50 μl of competent TOP10 E. coli cells (purchased or made as described in section 
3.10) were transferred to Falcon tubes. After adding 5 μl of the diluted In-Fusion 
reaction to the E. coli cells, the mixture was placed on ice for 30 minutes. 
10. The Falcon tubes were transferred directly from ice to a 42ºC water bath for 30 
seconds, to heat shock the E. coli cells. 
11. 250 μl of room temperature SOC medium was added to the reaction. 
12. The samples were incubated at 37ºC with shaking for minimum 1 hour. 
13. 100 μl of the solution was spread on pre-warmed agar plates containing BHI with 
erythromycin. 100 μl of the solution with the positive control included in the In-
Fusion
TM
 Advantage PCR Cloning kit was spread on pre-warmed agar plates 
containing LB with ampicillin. The plates were incubated at 37ºC overnight. 
14. The next day, colonies were picked with sterile toothpicks and grown in liquid BHI 
containing erythromycin in a shaking incubator overnight. The same colonies were 
checked for the desired gene with a PCR reaction with Taq DNA Polymerase and 
appropriate primers, described in section 3.7.1. The PCR product was examined with 
agarose gel electrophoresis (see section 3.8).  
15. The next day, the plasmids were isolated from the E. coli cells, but only if the PCR 
reaction in step 14 gave products with the correct size. The plasmids were stored at -
20ºC for further processing.  
 
3.10 Preparation of chemically competent E. coli TOP10 cells  




2xTY medium: 15 g tryptone 
10 g yeast extract 
   5 g 10 mM NaCl 






0.05 M CaCl2  
0.05 M CaCl2 with 15% glycerol 
 
Procedure: 
1. A small amount of cells were scraped of the frozen TOP10 culture with a sterile 
toothpick and transferred to a tube containing 5 ml 2xTY medium. The culture was 
incubated at 37ºC overnight.   
2. The overnight culture was poured in a flask with 200 ml 2xTY medium and the 
bacteria were grown at 37ºC until the OD600 was 0.5. 
3. The culture was transferred to 50 ml centrifuge tubes.  
4. The tubes were incubated on ice for 10 minutes and then centrifuged at 4000 rpm at 
4ºC for 10 minutes.  
5. After discarding the supernatant, the pellet was resuspended in 10 ml cold 0.05 M 
CaCl2. The tubes were incubated on ice for 15-30 minutes followed by centrifugation 
at 4000 rpm at 4ºC for 10 minutes.  
6. After discarding the supernatant, the pellet was resuspended in 10 ml cold 0.05 M 
CaCl2 with 15% glycerol. The tubes were incubated on ice for 5-10 minutes. 
7. 200 μl aliquots of the competent cells were distributed into 1.5 ml eppendorf tubes; the 
cells were then stored at -80ºC (for maximum 6 months).    
 
3.11 Preparation of electro-competent L. plantarum  
Preparation of electro-competent L. plantarum cells were required before transforming 
plasmids into them, and was done according to the protocol of Josson et al. (1989). L. 
plantarum cells were grown in media containing high amounts of glycine, to increase 
transformability. The presence of high amounts of glycine in the medium leads to the 
replacement of L-alanine in the cell wall with glycine, which increases cell wall permeability 
(Holo & Nes 1989). Cells grown in this way were washed with PEG because this has been 




20% glycine (w/v) 
PEG1450 (polyethylen glycol) 
 






1. L. plantarum cells were transferred to a tube with 10 ml MRS and the culture was 
incubated at 37ºC overnight.  
2. A series of 10-fold dilutions were made in tubes with 10 ml of MRS containing 1% 
glycine and the dilutions were incubated at 37ºC overnight.  
3. The next day, the culture with an OD600= 2.5 ± 0.5 was diluted 1:20 in a tube with 
MRS containing 1% glycine. The culture was incubated at 37ºC until it reached the 
logarithmic phase and the OD600 was 0.7 ± 0.07. Then the culture was placed on ice 
for 10 minutes.  
4. The culture was centrifuged at 4500 rpm for 10 minutes at 4ºC and the supernatant 
was discarded. The cells were resuspended in 5 ml ice-cold 30% PEG1450 and the 
suspension was transferred to a chilled corex-tube. After adding 10 ml ice-cold 30% 
PEG1450 to the suspension the tube was kept on ice for 10 minutes followed by 
recentrifugation and discarding of the supernatant.  
5. The pellet was resuspended in 400 μl ice-cold 30% PEG1450.  
6. The cells were kept on ice and 40 μl portions of the suspension were transferred into 
sterile eppendorf tubes and the tubes were transferred immediately to dry ice. The 
tubes with L. plantarum cells were stored at -80ºC until use.    
 
3.12 Transformation of E. coli and L. plantarum 
 
3.12.1 Transformation of E. coli 
E. coli cells used for transformation were either purchased competent TOP10 cells or E. coli 
TOP10 cells were made competent as described in section 3.10. Transformation of E. coli was 
performed as followed:  
 50 μl of E. coli cells were thawed on ice and transferred to Falcon tubes incubated on 
ice. 
 5 μl of the sample with the plasmid or ligation mixture was added to the E. coli cells in 
the Falcon tube, and the mixture was placed on ice for 30 minutes.  
 The rest of the transformation was done according to the Invitrogen protocol described 








3.12.2 Transformation of L. plantarum 




Electro-competent L. plantarum (from section 3.11) 
MRSSM medium (see section 2.8) 
MRS agar with erythromycin (10 μg/ml)  
 
Procedure: 
1. 40 μl electro-competent L. plantarum cells were thawed on ice and then 5 μl of 
plasmid DNA was added. 
2. The mixture was immediately transferred to an ice-cold electroporation cuvette and 
the cuvette was gently tapped to mix and remove air bubbles from the mixture. 
3. Electroporation was performed with a BLA electroporator with the following setting: 
 Tension 1.5 kV 
 Capacitance  25 μF 
 Resistance 400 Ω 
4. The cuvette was placed in the electroporation handle and it was given the tension 
pulse. 
5. After adding 950 μl ice-cold MRSSM directly to the cuvette the mixture was 
transferred to an eppendorf tube.  
6. The eppendorf tube was incubated at 30ºC for at least 2 hours (normally 3-4 hours).  
7. 100 μl of the cell suspension was spread on MRS agar plates with erythromycin and 
the plates were incubated at 30ºC or 37ºC overnight.   
 
3.13 DNA sequencing  
All novel plasmids that were constructed in this study were sequenced to ensure that the 





 Terminator v3.1 Cycle Sequencing Kit 
125 mM EDTA 
70% and 96% ethanol  






1. The sequencing reaction was set up as shown in Table 3.10.  





2. The sequence reaction mixture was placed in a PCR machine and the settings shown 
in Table 3.11 were applied. 
Table 3.11: PCR-settings in DNA sequencing 
Temperature Time Number of cycles 






4 minutes  
 
25 
4ºC Until use  
 
3. The reaction mixture was transferred to a sequencing eppendorf tube. 2 μl of 125 mM 
EDTA and 62.5 μl of 96% ethanol were added to the sample and the reaction was 
mixed by inverting the tube 5 times.  
4. The reaction mixture was incubated at room temperature for 15 minutes followed by 
centrifugation at 16 100 x g for 30 minutes at 4ºC. 
5. The supernatant was immediately aspirated and 60 μl 70% ethanol was added to the 
sample, then the tube was centrifuged at 16 100 x g for 10 minutes at 4ºC. 
6. The supernatant was immediately aspirated and the tube was centrifuged in a vacuum 
centrifuge for 5 minutes to dry the pellet. 
7. The eppendorf tube was stored at -20ºC until sequencing.  
 
3.14 Harvesting of L. plantarum cells for analysis of invasin production 
L. plantarum harbouring the plasmid of interest was grown at 30ºC or 37ºC and gene 
expression was induced with an inducing peptide (SppIP). The subcellular localization of the 
produced protein was subsequently analyzed. 
 
Materials: 
MRS medium (See section 2.8) 
Erythromycin (10 mg/ml) 
Inducing peptide SppIP (100 μg/ml)  
Reagents Amount 
5x sequencing buffer 3 μl 
Plasmid DNA 3 μl 










TEN-buffer:  10 mM Tris-HCl, pH 8 
   1 mM EDTA, pH 8 
   100 mM NaCl 
10x PBS:   Dissolved the following in 800 ml distilled H2O.  
80 g of NaCl  
2.0 g of KCl  
14.4g of Na2HPO4  
2.4 g of KH2PO4  
Adjusted pH to 7.4 and adjusted the volume to 1 l with dH2O 
 
Procedure: 
1. The L. plantarum strain harbouring the desired plasmid was grown at 30ºC or 37ºC 
overnight in MRS medium containing 10 μg/ml erythromycin. 
2. The overnight culture was diluted in fresh MRS with 5 μg/ml erythromycin to an 
absorbance of OD600~0.1  
3. The diluted culture was incubated at 30ºC or 37ºC until the culture reached an OD600 
in the range 0.27-0.33. The cells were then induced by adding 25 ng/ml inducing 
pheromone (SppIP).  
4. The culture were incubated at 30ºC or 37ºC and harvested at different time points.  
5. 50 ml culture was harvested in a Centrifuge 5430R (eppendorf) by centrifugation at 
3000 x g for 10 minutes at 4ºC; the supernatant was discarded or stored at -20ºC for 
further analysis (see section 3.14.2). 
6. 10 ml TEN or 1xPBS buffer (PBS buffer was only used prior to staining of cells; see 
section 3.18.1, 3.18.2 and 3.21) was added and the tube was recentrifuged. 
Afterwards the liquid was discarded. 
7. The cells were then further processed or stored at -20ºC until the next day. 
 
3.14.1 Cell disruption to analyze intracellular L. plantarum proteins 
 
Materials: 
TEN buffer (see section 3.14) 
Glass beads (106 microns and finer) 
 
 






1. FastPrep tubes were filled with ~1.5 grams of glass beads and the tubes were placed 
on ice. 
2. The harvested cells were resuspended in 1 ml cold TEN buffer and the suspension 
was transferred to the FastPrep tubes. 
3. The cells were crushed mechanically by shaking them in a FastPrep-24 tissue and cell 
homogenizer at speed 6.5 for 45 seconds. 
4. Cell-debris and glass beads were removed by centrifugation at 13 000 rpm for 5 
minutes at 4ºC. 
5. The cell-free protein extract was transferred to an eppendorf tube and the tube was 
recentrifuged. 
6. The protein extract was transferred to new sterile eppendorf tube and kept on ice prior 
to SDS-PAGE (described in 3.15) or stored at -20ºC. 
 
3.14.2 TCA precipitation of proteins in supernatant 
For analysis of supernatants the proteins were precipitated with trichloroacetic acid (TCA) to 
concentrate and denature the proteins.  
 
Materials: 
50 mM PMSF (Phenylmethylsulphonyl fluoride) dissolved in isopropanol 
NaOH (6 M) 
Deoxycholate (20 mg/ml) 
100% (w/v) Trichloroacetic acid (TCA) 
Acetone 
Urea/Tiurea (7 M / 2 M) 
Amidosulfobetaine-14 (ASB-14) (20%) 
NuPAGE
®
 Reducing agent (10x) 
NuPAGE
®
 LDS Sample buffer (4x)  
 
Procedure: 
1. The procedure described in section 3.14 was followed and the supernatant from step 4 
was sterile filtrated (0.22 μM pore size) into a new tube. 1 mM PMSF (protease 







2. The supernatant was thawed on ice and 4 ml of the supernatant solution was 
transferred to a new tube. 
3. The supernatant was pH adjusted with 6 M NaOH to a pH above 7 (~8).    
4. Sodium deoxycholate was added to the supernatant to a final concentration of 0.2 
mg/ml, and the sample was incubated on ice for 30 minutes, to increase precipitation. 
5. TCA was added to the solution to a final concentration of 16% (v/v), and the tube was 
incubated on ice for minimum 20 minutes. 
6. 2 ml of the solution was transferred to a 2 ml tube and the tube was centrifuged at 
16 100 x g for 15 minutes at 4ºC; the supernatant was carefully removed. An 
additional 2 ml of the solution was transferred to the same tube, the tube was 
recentrifuged and the supernatant was carefully removed. 
7. 200 μl ice-cold acetone was added to wash the pellet. The solution was centrifuged at 
16 100 x g for 5 minutes at 4ºC; the supernatant was carefully removed. This step was 
repeated once. 
8. The supernatant was carefully removed and the pellet was dried in vacuum centrifuge 
for 5 minutes. 
9. The pellet was dissolved in 4 M Urea, 1.14 M Tiourea, 1% ASB-14, 1x reducing 
agent and 1x sample buffer. The sample was boiled at 95ºC for 10 minutes, and 
vortexed shortly every second minute until the pellet was dissolved. At the end of this 
ten minutes boiling step, the sample was centrifuged for 1 minute and stored at -20ºC 
or used for further analysis by SDS-PAGE as described in section 3.15, and western 
blotting as described in section 3.16. 
 
3.14.3 Preparation of cell wall fraction 
Gram-positive bacteria have a thick cell wall composed primarily of peptidoglycan, where the 
glycan chains comprise units of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc) linked through β-1,4 linkages. For preparation of the cell wall fraction 
mutanolysin, an enzyme that cleaves the β-1,4 linkage between MurNAc and GlcNAc, was 
utilized. By carefully and partially hydrolyzing the peptidoglycan cell wall, proteins 
associated to the cell wall may be solublizied. This procedure was based on protocols 
described by Fredriksen et al. (2010) and Mujahid et al. (2007). 
 
 






TES-buffer:   1 mM EDTA (pH 8.0) 
    50 mM Tris-HCl (pH 7.5) 
    25% Sucrose 
2x osmotic digestion buffer: 40 mM Tris-HCl 
    20 mM MgCl2 
    40% Sucrose 
    Adjusted to pH 7.0 
50 mM PMSF  
1 mM Pepstatin A 
200 mM 1,10-phenanthroline 
Mutanolysin (500 U) (Lysozyme, 40 mg/ml) 
 
Procedure: 
1. The harvested cells were washed once with 1.5 ml ice-cold TES buffer. The culture 
was centrifuged at 3000 x g for 5 minutes at 4ºC; the supernatant was discarded. 
2. The cell pellet was resuspended in 500 μl 2x osmotic digestion buffer. 1 mM (final 
concentration) PMSF, 1 μM (final concentration) Pepstatin A and 10 mM (final 
concentration) 1,10-phenanthroline (protease inhibitors) were added to the solution.  
3. 100 μl (or 50 μl) 500 U mutanolysin (or 60 U/ml mutanolysin and 15 mg/ml 
lysozyme if the resulting cells in step 5 are going to be stained as described in section 
3.18.1) was added to the reaction and the volume was adjusted to 1 ml with 2x 
osmotic digestion buffer.  
4. The sample was incubated at 37ºC for 2 hours (different incubations times were 
tested, but none gave a better result).  
5.  The sample was centrifuged at 14 000 x g for 5 minutes at 4ºC; the supernatant was 
transferred to a new eppendorf tube and recentrifuged. Alternatively, the sample was 
centrifuged at 3000 x g for 30 minutes, the supernatant was transferred to a new tube 
and the tube was centrifuged at 16 100 x g for 15 minutes at 4ºC. 
6. Proteins were precipitated using the procedure described in section 3.14.2 step 3-9. 
Prior to step 5 (addition of TCA), dH2O was added to a total volume of 1.5 ml, to 








3.15 Gel electrophoresis of proteins by SDS-PAGE 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a separation 
method routinely used to separate denatured proteins according to their molecular weight. 
Sample buffer and reducing agent are added to the protein sample prior to the electrophoresis. 
The sample buffer has a slightly alkaline pH (8.4) that provides the optimal conditions for 
reductions of protein disulfide bonds. The proteins are denatured by the anionic detergent 
Lithium dodecyl sulfate (LDS), which disrupts secondary and non-disulfide-associated 
tertiary structure (analogous to SDS). LDS ions coat the polypeptide chain, giving it a 
uniform negative charge. While the reducing agent, dithiothreitol (DTT), removes disulfide-
associated tertiary structure. After this treatment, every protein in the mixture is supposed to 
have a total charge of the protein proportional with its length. The samples are applied onto 
the gel and after application of power the denatured proteins will start moving towards the 
anode. The electrophoretic mobility of the protein molecules is only dependent on their length 
and short molecules will move faster than long molecules. The sizes of the proteins can hence 
be determined using a protein standard. The protein bands are visualized by staining them 
with a protein staining solution or by western blotting.  
 
Materials: 
NuPAGE® Novex® Bis-Tris Mini Gels 
NuPAGE
®
 LDS Sample buffer (4x)  
NuPAGE
®
 Reducing agent (10x) 
NuPAGE
®
 MOPS SDS Running Buffer (20x) 
NuPAGE® Novex® Pre-Cast Gel cassette 
 
Procedure: 
1. A desired amount of cell-free protein extract was added to a tube and sample buffer 
(final concentration on 1x), reducing agent (final concentration on 1x) and dH2O to a 
total volume of 10-25 μl were added.  
2. The samples were heated at 70ºC (in some cases at 95ºC) for 10 minutes. 
3. The plastic case and well-comb were removed from the pre-cast NuPAGE® Novex® 
Bis-Tris Mini Gel and the tape from the bottom of the cassette was peeled off.  
4. The equipment was put together and 1x NuPAGE® MOPS SDS Running Buffer was 
added.     





5. The Magic mark ladder and the protein samples were carefully applied to the gel 
wells. 
6. Electrophoresis was carried out by applying 200 volts for 50 minutes.  
7. The gel was removed and the plastic plates surrounding the gel were removed with a 
gel knife.  
8. After placing the gel in a rectangular Petri dish, the gel was washed with dH2O for 
minimum 5 minutes. The procedure described in 0 was then followed.  
 
3.16 Western blotting 
Western blotting is a method that utilizes antibodies to detect proteins. Electrophoretically 
separated proteins are made available for antibody hybridizations by transferring them from a 
gel to a membrane, by using an electric current. iBlot® Dry Blotting System was used to 
transfer the proteins to the membrane. The top and bottom stacks contain the necessary 
buffers and the bottom stack includes an integrated nitrocellulose or PVDF membrane (Figure 
3.3). The membrane has high affinity for proteins and needs to be blocked prior to antibody 
hybridization to prevent interactions between the membrane and the antibody. The membrane 
is then incubated in a solution of an antibody that specifically recognizes the protein of 
interest. Subsequently, a horseradish peroxidase (HRP)-linked secondary antibody is added 
which will bind specifically to the primary antibody. Subsequently, a chemiluminescent 
substrate is added that will be converted by HRP, yielding a detectable signal. The western 
blot detection principle is illustrated in Figure 3.4.    
 
Figure 3.3: Western blotting. The primary antibody recognizes the protein of interest. The secondary antibody 
conjugated with HRP recognizes the primary antibody. Chemiluminescent substrat reacts with HRP and the 
emitted light is captured on X-ray film. The figure is taken from The Phototope
®
-HRP Western Blot Detection 












Figure 3.5: The SNAP i.d.® Protein Detection System. The system is based on a vacuum-driven technology 
and a built-in flow distributor that actively drives reagents through the membrane. SNAP i.d. single well blot 
holder was used, but it exist three different sizes of blot holders. Two blot holders can be run in parallel in the 
system. The figure is taken from SNAP i.d.® Protein Detection System protocol by Millipore 
 
Materials: 
iBlot® Dry Blotting System 
Gel Transfer Device 
Cathode stack 
Anode stack (with nitrocellulose membrane) 
Filter paper 
Disposable sponge 
Figure 3.4: In iBlot® dry blotting. The proteins are transferred from the gel to the membrane by an electric 
current. The figure is taken from Invitrogen
TM
. 





pAb invasin PAS Bleed #3, primary antibody (see section 2.3) 
HRP-Goat Anti-Rabbit IgG (H+L), secondary antibody (see section 2.3) 
Bovine Serum Albumine (BSA) 
TBS buffer: 150 mM NaCl 
   20 mM Tris-HCl, pH 7.5 
TTBS buffer: TBS buffer containing 0.1% (v/v) Tween-20 
Super Signal
®
 West Pico Chemiluminescent Substrat kit 




1. The anode stack was placed in the transfer device and the SDS-PAGE gel from 
section 3.15 was placed on the membrane in the anode stack. A roller was used to 
remove air bubbles between the membrane and the gel. 
2. One filter paper was soaked in dH2O and placed on top of the gel, and a roller was 
used to remove air bubbles. 
3. The cathode stack was aligned on top of the filter paper and a gel roller was used to 
ensure proper contact between all sandwich components (Figure 3.3).  
4. The disposable sponge was placed in the lid of the transfer device. The lid was closed 
and blotting was carried out by using program 2 (on the iBlot machine from 
Invitrogen) for 9 minutes.  
5. The cathode stack, the filter paper and the gel were removed. After transferring the 
membrane to a rectangular Petri dish, the membrane was washed with dH2O for 
minimum 5 minutes. 
6. 0.2 g BSA was dissolved in 40 ml TTBS to make the TTBS/0.5% BSA solution. 3 ml 
of this solution was transferred into a new tube and 5 μl pAb invasin PAS Bleed #3 
primary antibody was added. Additional 3 ml of the TTBS/0.5% BSA solution was 
transferred into a new tube and 0.2 μl HRP-Goat Anti-Rabbit IgG (H+L) secondary 
antibody was added. The blocking solution containing TTBS with 1% BSA were 
made by solving 0.15 g BSA in 30 ml of the remaining TTBS/0.5% BSA solution.  
7. The inner white face of the SNAP i.d. single well blot holder was wetted with Milli-Q 
water until it turned gray, and any excess liquid was removed using the roller. 
8. The pre-wet blot membrane from step 5 was placed in the center of the blot holder, 






9. The spacer (wetting not necessary) was placed on top of the blot. The roller was used 
again to ensure complete contact of blot spacer with blot membrane. 
10. The blot holder was placed in the SNAP i.d. ® protein detection system chamber 
(Figure 3.5) with the well side up, and the blot holder tabs were aligned with notches 
of the chamber.  
11. 30 ml of blocking solution (TTBS with 1% BSA) was added to the blot holder. The 
vacuum was immediately turned on using the vacuum control knob(s) (Figure 3.5), 
and the blocking solution was driven through the membrane. 
12. The vacuum was turned off after the blot holder had emptied completely (10–20 
seconds).  
13. 3 ml TTBS containing 0.5% BSA and primary antibody was evenly added to the blot 
holder and the blot holder was left for 10 minutes at room temperature, with the 
vacuum off.  
14. With vacuum running continuously, the blot holder was washed with 3x 10 ml of 
TTBS where each wash took 10 to 20 seconds to complete. When the blot holder was 
empty, the vacuum was turned off.  
15. 3 ml TTBS containing 0.5% BSA and the secondary antibody was evenly added to 
the blot holder and the blot holder was left for 10 minutes at room temperature, with 
the vacuum off.  
16. Step 14 was repeated.  
17. The blot holder was removed from the SNAP i.d. system. With a forceps, the spacer 
was removed and discarded. After transferring the blot to a Petri dish 5 ml Stable 
Peroxid Solution and 5 ml Luminol/Enhancer Solution were added to the membrane 
followed by incubation on the bench for 5 minutes.   
18. The membrane was placed with the protein side down on a plastic foil piece and the 
foiled was folded around the membrane. The membrane was turned so the protein 
side was up and the membrane was placed in a film cassette. The rest of the procedure 
was carried out in a dark room. 
19. Kodak film was placed on the membrane in the film cassette. The cassette was shut 
and the film was exposed for some seconds. 
20. The film was transferred to a vessel containing developer solution and incubated until 
the bands were visible.   





21. The film was transferred to a vessel containing fixation solution and incubated for 2 
minutes.   
22. Finally, the film was washed for 1 minute in a vessel containing water and 
subsequently air-dried.   
 
3.17 Cell dot-blot 
A cell dot-blot is an antibody-detection method similar to western blotting, and was used in 
order to detect surface exposed proteins. Intact cells are applied to a membrane and the 
membrane is incubated with primary and secondary antibodies, after which the protein of 





PVDF or Trans-Blot Transfer Medium Pure nitrocellulose membrane (0.20 μm 
pore size) 
TES buffer or Ringers solution 
TBS buffer 
TBS-T buffer: TBS buffer containing 0.05% (v/v) Tween-20 
BSA/TBS-T: 0.1% BSA in TBS-T 
BSA 
pAb invasin PAS Bleed #3, primary antibody (see section 2.3) 
HRP-Goat Anti-Rabbit IgG (H+L), secondary antibody (see section 2.3)  
 
Procedure: 
1. The bacterial cells were harvested (from 50 ml culture) as described in section 3.14 
and the resulting pellet was suspended in 1 ml TES or Ringers solution.  
2. Pellet harvested at OD600=0.6 was resuspended in 50 μl of TES buffer or Ringers 
solution and pellets harvested at higher OD600-values were resuspended 
correspondingly increased in solution volumes (e.g. sample harvested at OD600=1.2 
would be resuspended in 100 μl solution. This was necessary in order to compare 
protein amounts in the samples.  
3. 5-fold and 25-fold dilutions of each sample were made.  
4. The PVDF membrane was soaked in methanol and the nitrocellulose membrane was 






5. 2 μl of each cell suspension was pipetted onto the membrane. It was important to do 
this immediately after the methanol/dH2O evaporated from the membrane in order to 
ensure proper cell binding.  
6. After air drying of the membrane, the membrane was transferred to a vessel with a 
blocking solution, 50 ml TBS containing 3% BSA, for 50 minutes. After removal of 
the blocking solution 10 ml TBS containing 3% BSA and 10 μl primary antibody 
(pAb invasin PAS Bleed #3) was added and the membrane was incubated in the 
solution for 50 minutes (method 1). Alternatively, the membrane was soaked in 50 ml 
5% BSA in TBS-T for 1 hour. After removal of the blocking solution 10 ml 
BSA/TBS-T containing 10 μl primary antibody (pAb invasin PAS Bleed #3) was 
added and the membrane was incubated in the solution for 30 minutes (method 2). 
7. The membrane was washed with TTBS for 2 x 10 minutes and TBS for 10 minutes. 
Alternatively, the membrane was washed three times with TBS-T for 3 x 5 minutes. 
Alternatively, this washing step was omitted (this gave best results).  
8. After removing of the washing solution 10 ml TBS containing 3% BSA and 0.5 μl 
secondary antibody (HRP-Goat Anti-Rabbit IgG (H+L)) was added and the 
membrane was incubated in the solution for 50 minutes (method 1). Alternatively, 10 
ml BSA/TBS-T containing 0.5 μl secondary antibody (HRP-Goat Anti-Rabbit IgG 
(H+L)) was added and the membrane was incubated in the solution for 30 minutes 
(method 2).  
9. After removing of the solution the membrane was washed in TTBS for 4 x 10 minutes 
(method 1). Alternatively, the membrane was washed three times with TBS-T, 1 x 15 
minutes and 2 x 5 minutes, and then once with TBS for 5 minutes (method 2).   
10. 5 ml Stable Peroxid Solution and 5 ml Luminol/Enhancer Solution were added to the 
membrane followed by incubation on the bench for 5 minutes. The procedure 
described in section 3.16, step 20-24 was followed. 
 
3.18 Immunofluorescence techniques 
In immunofluorescence techniques in general, antibodies are chemically conjugated to 
fluorescent dyes such as fluorescein isothiocyanate (FITC). These labeled antibodies will 
directly or indirectly bind to the antigen of interest. The fluorescence signal can then be 
quantified using a flow cytometer or visualized using fluorescence microscopy. In direct 
immunofluorescence, the fluorescent dye is conjugated to the primary antibody, which gives 





the advantage of shorter sample staining time, but the disadvantage of a weaker signal. In 
indirect immunofluorescence, the fluorescent dye is conjugated to the secondary antibody, 
which gives the advantage of greater sensitivity, but increases the risk of background signals. 
An overview of these procedures is given in Figure 3.6.   
Flow cytometry may be employed for identification of microorganisms. The flow cytometer 
forces a suspension of cells through a laser beam and measures the light they scatter or the 
fluorescence the stained cells emit as they pass through the beam. Each fluorescent cell should 
ideally be detected, counted and even separated from other cells in a suspension. The 
cytometer can also measure a cell’s shape, size, and content of DNA and RNA.    
Figure 3.6: Overview over direct and indirect immunofluorescence techniques. In direct 
immunofluorescence the fluorescent dye is conjugated to the primary antibody, while in indirect 
immunofluorescence the fluorescent dye is conjugated to the secondary antibody. The picture is taken from 
Connection Molecular Pathology Protocol by Dako. 
 
3.18.1 Primary antibody conjugated with FITC 
The primary antibody that binds epitopes on invasin was conjugated with FITC. Before the 




PBS buffer (see section 3.14) 
ShakeSkin Pleated Dialysis Tubing 
pAb invasin PAS Bleed #3 (primary antibody) (see section 2.3) 
Pierce
®
 FITC Antibody Labeling Kit 
 FITC (fluorescein isothiocyanate) 
 0.67 M Borate Buffer 
 Purification resin 







1. A piece of about 10 cm of ShakeSkin Pleated Dialysis Tubing was soaked in 5 liter of 
cold PBS buffer. The superfluous buffer was pressed out and a clip was put on in one 
end. 10 ml of primary antibody was added and a clip was put on in the outer end. 
2. The piece was attached to a magnet stirrer followed by stirring in the buffer in a cold 
room (4ºC). 
3. The buffer was chanced with fresh PBS (5 liters) after 4 and 8 hours followed by 
overnight stirring.   
4. The antibody solution from the ShakeSkin tube was transferred into a 15 ml tube and 
stored at -20ºC. 
5. The concentration of primary antibody in PBS was measured as described in section 
3.19 
6. All the reagents in the Pierce® FITC Antibody Labeling Kit were brought to room 
temperature. 
7. 40 μl of the 0.67 M Borate buffer was added to 0.5 ml of ~2 mg/ml primary antibody 
in PBS. If the protein concentration was >2 mg/ml, the concentration was adjusted to 
2 mg/ml with PBS.  
8. 0.5 ml of the protein solution from step 7 was added to a vial of FITC Reagent and 
the reagents were mixed by pipetting up and down 10 times until all the dye was 
dissolved. Brief vortexing steps were used if required.  
9. The vial was briefly centrifuged to collect the sample in the bottom of the tube. 
10. The reaction mixture was incubated for 60 minutes at room temperature, protected 
from light. 
11. Two spin columns were placed in separate collection tubes. 
12. The Purification Resin was mixed to ensure uniform suspension and 400 μl of the 
suspension was added into both spin columns. The samples were centrifuged for 30-
45 seconds at ~1000 x g to remove the storage solution. The used collection tubes 
were discarded and the columns were placed in new collection tubes.  
13. 250-270 μl of the labeling reaction was added to each spin column and the sample 
mixed by pipetting up and down or briefly vortexing. 
14. The columns were centrifuged for 30-45 seconds at ~1000 x g to collect the purified 
proteins. 





15. The labeled protein was stored protected from light at 4ºC for up to one month. 
Alternatively, labeled protein was stored in single-use aliquots at -20ºC (meaning that 
repeated freeze/thaw cycles were avoided).   
16. In order to concentrate the primary antibody conjugated with FITC, a Amicon® 
Ultra-05 Centrifugal Filter Device was placed in a collection tube, and 100 μl of 
primary antibody conjugated with FITC was added to the column. 
17. The sample was then centrifuged at 14 000 x g for 30 minutes. 
18. The column was turned upside down in a new collection tube and centrifuged at 1000 
x g for 2 minutes.  
19. The concentrated primary antibody conjugated with FITC was stored at -20ºC. 
 
3.18.2 Staining of cells with primary antibody conjugated with FITC 
 
Materials: 
pAb invasin PAS Bleed #3 (primary antibody) conjugated with FITC (see section 3.18.1) 
PBS buffer (see section 3.14) 
 
Procedure: 
1. The cells were harvested (from 50 ml culture) as described in section 3.14. 
2. The cell pellet (from 50 ml culture) was resuspended in 1 ml PBS 
3. Different amounts of resuspended cells, PBS and primary antibody conjugated with 
FITC were tested.  
4. The tubes were incubated protected from light at room temperature or at 37ºC for 30-
60 minutes followed by centrifugation at 3000 x g for 5 minutes; the supernatant was 
discarded.  
5. The cells were washed in 1 ml PBS and recentrifuged, and the supernatant was 
discarded. This step was repeated 1-3 times.  
6. The pellet was resuspended in PBS and the samples were analyzed using a 
fluorescence microscope. 
 
3.18.3 Staining of cells with secondary antibody conjugated with FITC  
 
Materials: 






Anti-Rabbit IgG (whole molecule)-FITC (secondary antibody) (see section 2.3) 




1. The cells were harvested (from 50 ml culture) as described in section 3.14. 
2. The cell pellet (from 50 ml culture) was resuspended in 1 ml PBS. Different amounts 
of cell suspension were transferred to an eppendorf tube (different amounts of cells 
were tried stained) 
3. The cells were washed with 1 ml PBS, the sample was centrifuged at 5000 x g for 2 
minutes, and the supernatant was discarded. 
4. 40 μl L. plantarum harbouring empty vector, 100 μl PBS with 2% BSA and 40 μl 
pAb invasin PAS Bleed #3 were mixed. The solution was incubated at 4ºC for 20 
minutes followed by centrifugation at 16 100 x g for 5 minutes. The supernatant was 
used as the primary antibody solution.   
5. The cells from step 3 were resuspended in 50 μl of PBS containing 2% BSA. 10 μl of 
the supernatant from step 4 was added and the reaction was incubated at 4ºC for 15-
30 minutes. 
6. The cells were washed with 1 ml PBS containing 2% BSA four times. The cells were 
collected by centrifugation at 5000 x g for 2 minutes between every wash. 
7. The cells were resuspended in 50 μl of PBS containing 2% BSA. 0.2 μl of Anti-
Rabbit IgG (whole molecule)- FITC was added and the reaction was incubated at 4ºC 
for 15-20 minutes. 
8.  Step 6 was repeated. 
9. The cells were finally resuspended in 50 μl PBS containing 2% BSA. The cells were 
analyzed using a fluorescence microscope or flow cytometry. 
 
3.19 Protein concentration measurement  
Total protein concentration (mg/ml) in cell-free protein extracts can be measured using 
BioRad’s protein assay reagent, which is based on Bradford’s method. The method involves 
the addition of an acidic dye to the protein solution and then the sample is measured at 595nm 
in a spectrophotometer. By comparing the samples to a standard curve, relative measurements 
of protein concentrations can be made.  






BioRad Protein Assay, Dye Reagent Concentrate 
 
Procedure: 
1 Different dilutions of the sample were prepared, to find a dilution that was inside the 
standard curve (1.2 μg/ml - 15 μg/ml). The standard curve was made using different 
dilutions of BSA. 
2 1 μl of cell-free protein was added to 800 μl PBS. Three parallels of each sample were 
made. 
3 200 μl BioRad Protein Assay was added to the samples and the samples were vortexed; 
the samples were incubated at room temperature for 5 minutes. It was important to make 
sure that all of the samples stood in this solution for approximately the same time, because 
the signal is rather unstable and absorbance will increase over time. 
4 1 ml PBS was added into a clean, dry test tube, and the absorbance at 595 nm was 
measured. This was repeated for the protein samples, where parallels had to be measured 
right after each other.   
 




MRS plates with erythromycin (10 μg/ml) 
 
Procedure: 
1. Cells were harvested (from 50 ml culture) as described in section 3.14.  
2. A series of dilutions were made, starting by transferring 100 μl of the culture, to 10 ml of 
Ringers solution. The tube was vortexed for about 15 seconds and 1 ml from that tube 
was transferred to 9 ml of Ringers solution. Then this next tube was vortexed and 1 ml 
was transferred to yet another 9 ml tube, and this was repeated for as many dilutions as 
necessary.     
3. 100 μl of the dilution was spread on a MRS plate, with minimum two replicates. 
4. After incubation at 37ºC overnight, the colonies on the plates were counted and the 







3.21 Staining of bacteria with FITC or CFSE 
To visualize bacterial cells after incubation with Caco-2 cells (to analyze internalization) in 
the microscope, the bacterial cells were strained with FITC or CFSE. FITC contains an 
isothiocyanate moiety and this moiety is very reactive with aliphatic amine groups. The result 
from this reaction is covalent attachment of FITC to cellular proteins (Parish 1999). 
Carboxyfluorescein diacetate, succinimidyl ester (CFDASE) is a highly membrane 
penetrating non-fluorescent molecule that is taken up by bacterial cells. Inside the cell 
esterases can remove the two acetate groups from CFDASE to yield fluorescent 
carboxyfluorescein succinimidyl ester (CFSE). CFSE is highly reactive with amino groups 
and can covalently couple carboxyfluorescein (CF) to intracellular molecules (Parish 1999). 
FITC will react with molecules on the surface (including invasin), but CFSE will only react 





PBS buffer (see section 3.14) 
 
Procedure: 
1. The cells were harvested as described in section 3.14.  
2. The cell pellet (from 50 ml of culture) was resuspended in 1 ml PBS. Different 
amounts of cell suspension were transferred to an eppendorf tube (different amounts 
of cells were stained). 
3. The cells were centrifuged at 5000 x g for 1-2 minute; the supernatant was discarded. 
4. The cells were resuspended in 400 μl of PBS containing 0.02 mg/ml FITC. 
Alternatively, the cells were resuspended in 400 μl of PBS containing 10 μM CFSE. 
5. The sample was incubated in the dark for 40 minutes in room temperature for FITC 
staining and in the dark at 37ºC and constant shaking for 20 minutes for CFSE 
staining. After incubation, the sample was centrifuged at 5000 x g for 1-2 minute.  
6. The cells were washed by adding 1 ml PBS followed by centrifugation at 5000 x g for 
1-2 minute; the supernatant was discarded. This was repeated minimum 2 times. 
7. The pellet was resuspended in a desired volume of PBS.   
 
 





3.22 Incubation of bacteria with Caco-2 cells to visualized the cells with CLSM  
Bacterial internalization was analyzed using CLSM (Confocal Laser Scanning Microscopy) 
and the procedure was based on protocols described in Agerer et al. (2004) and Innocentin et. 
al (2009).  
 
Materials: 
PBS buffer (see section 3.14) 
RPMI 1640 medium with L-glutamine and 10% fetal calf serum (FCS) 
CFSE (FITC) 
250 mM Biotin 
TRITC or Hoechst stain 
MRS plates with erythromycin (10 μg/ml) 
 
Procedure: 
1. The cells were harvested as described in section 3.14.  
2. The cell pellet (from 50 ml of culture) was resuspended in 1 ml PBS. Different 
amounts of cell suspension were transferred to an eppendorf tube (different amounts 
of bacteria were analyzed). 
3. The bacteria were stained with CFSE (or with FITC) as described in 3.21.  
4. An additional step was performed when the cells were TRITC stained; the cell pellet 
was resolved in 500 μl PBS with 7.5 mM Biotin and the reaction was incubated at 
room temperature for 30 minutes. The pellet was washed 5 times with 1 ml PBS, and 
between every wash the solution was centrifuged at 5000 x g for 2 minutes. 
5. After staining the bacteria the bacterial pellet was resuspended in 1.1 ml RPMI. 500 
μl of the cell suspension was added to each sample with Caco-2 cells, in duplo. 
6. The bacteria suspension was incubated with Caco-2 cells for 1 or 1½ hour at 37ºC. 
Subsequently, 400 μg/ml gentamicin was added to the sample and the samples were 
incubated under the same conditions for an additional hour. 
7. The reaction was washed and fixated on microscope slides (performed by Charlotte 
Kleiveland).  
8. The Caco-2 cells were stained blue using Hoechst stain (done by Charlotte 
Kleiveland). This step was not done if the cells were TRITC stained 
9. The Biotin-labeled bacteria were stained with TRITC (done by Charlotte Kleiveland). 






3.23 The gentamicin survival assay 
Bacterial invasiveness was also analyzed using the gentamicin survival assay. The procedure 
was based on the protocol described in Innocentin et al. (2009). In this assay the bacteria were 
incubated with Caco-2 cells, and then gentamicin was added. In theory only bacteria that have 
been internalized will survive the gentamicin treatment. 
 
Materials:  
PBS buffer (see section 3.14) 
RPMI 1640 medium with L-glutamine and 10% fetal calf serum (FCS) 
Gentamicin 
Triton 
MRS plates with erythromycin (10 μg/ml) 
 
Procedure: 
1. The cells were harvested as described in section 3.14.  
11. The cell pellet (from 50 ml of culture) was resuspended in 1 ml PBS. Different 
amounts of cell suspension were transferred to an eppendorf tube (different amounts 
of bacteria were analyzed). 
2. The sample was centrifuged at 5000 x g for 2 minutes and the supernatant was 
discarded. 
3. The pellet was resuspended in 1.5 ml RPMI.  
4. 1.4 ml of the bacterial suspension was added to each sample with Caco-2 cells. The last 
100 μl of the bacterial suspension was used to spread out on agar-plates to find the 
amount of viable cells in the suspension just prior to incubation.  
5. The cells were incubated at 37ºC for 3 hours.  
6. The solution above the Caco-2 cells was removed and the cells were washed by adding 
2 ml of PBS, three times. 
7. 2 ml RPMI containing 400 μg/ml gentamicin was added, and the reaction was 
incubated overnight (ca. 15 hours) 
8. The solution above the Caco-2 cells was removed, and the cells were washed by adding 
2 ml of PBS, three times. 
9. 300 μl PBS containing 0.1% triton was added to lyse the Caco-2 cells. 





10. The presence of bacteria in the lysates from the Caco-2 cells were quantified by plating 
out all of the solution in every well on MRS plates, 100 μl per plate, 3 plates in total. 








Construction of invasin expression vectors 
The main goal in this study was to express, secrete and anchor the invasin protein from Y. 
pseudotuberculosis in L. plantarum WCFS1 using the SIP-system (see introduction) 
(Mathiesen et al. 2008; Sørvig et al. 2003). The length of invasin that would give the best 
result in L. plantarum was not known, therefore two versions of invasin consisting of all 5 C-
terminal domains (Inv) (see Figure 1.8) or the 2 C-terminally domains (InvS), were selected. 
It was also uncertain which anchor length would expose the invasin protein in the best 
position for binding to β1-integin receptors. Two different lipo-anchors with variable lengths 
were selected. Initially, much time was spent on the use of traditional cloning strategies for 
vector construction. Because these traditional strategies were not successful for construction 
of invasin expressing vectors, focus was shifted towards using In-fusion cloning technologies, 
which lead to successful construction of the various expression vectors.   
 
Table 4.1 shows a list of the key expression vectors constructed in this study and their key 
properties. Further details about their construction are provided below, whereas technical 
details are provided in Table 2.4 and in the materials and method sections.  
 
Table 4.1: The constructed expression vectors and their key properties 
Plasmid Properties 
pLp_1261InvS The anchor sequence from the lipoprotein 1261 (originally from L. plantarum WCFS1) 
and the D4 and D5 domains from invasin (originally from Y. pseudotuberculosis) 
pLp_1261Inv The anchor sequence from the lipoprotein 1261 (originally from L. plantarum WCFS1) 
and the D1-D5 domains from invasin (originally from Y. pseudotuberculosis) 
pLp_1452InvS The anchor sequence from the lipoprotein 1452 (originally from L. plantarum WCFS1) 
and the D4 and D5 domains from invasin (originally from Y. pseudotuberculosis) 
pLp_1452Inv The anchor sequence from the lipoprotein 1452 (originally from L. plantarum WCFS1) 
and the D1-D5 domains from invasin (originally from Y. pseudotuberculosis) 
pCytInv This plasmid express the longer version of invasin (all five domains; D1-D5) without 












4.1 Construction of plasmid for intracellular invasin production 
First, a plasmid for intracellular production of invasin (pCytInv; Table 2.4 and 4.1) was 
constructed. This construct was used as a control in various settings, e.g. to check for cell 
lysis and in functional studies (where L. plantarum harbouring an intracellular version of 
invasin was compared to L. plantarum harbouring the constructs encoding lipo-anchored 
invasin).  
 
The inv gene was PCR amplified with the primers HRCytInvF and HRInvR (see Table 2.1 
and 2.2) using pTinvasin (see Table 2.4) as template. The PCR amplified invasin gene was 
cloned into an NdeI and EcoRI digested p2588sAmy vector (Table 2.4) (Mathiesen et al. 
2008) using the In-Fusion kit, yielding pCytInv (see section 3.9.4 for technical details). The 
pCytInv vector was transformed into E. coli cells prior to transformation into electro-
competent L. plantarum WCFS1 cells, like all plasmids constructed in this thesis. In this 
pCytInv vector the longer version of the invasin (all five domains) is expressed by the 
inducible PsppA promoter, and the protein is produced without any signals for secretion and 
anchoring.  
 
4.2 Selection of L. plantarum WCFS1 lipoproteins to use as lipo-anchor 
In the genome of L. plantarum WCFS1, 48 genes are predicted to encode lipoproteins 
(Boekhorst et al. 2006). Before selecting lipo-anchors, all of the predicted lipoproteins 
(Boekhorst 2006) were tested using LipoP 1.0 server prediction. LipoP 1.0 is a web-based 
program that predicts lipoproteins and their signal peptide cleavage sites (Juncker et al. 2003). 
Two different variants of L. plantarum lipo-anchors, with different lengths were selected to be 
studied further, namely the lipo-anchors from genes Lp_1261 and Lp_1452. Lp_1261 is 
predicted to be an ABC transporter and Lp_1452 is predicted to be a peptidylprolyl isomerase. 
Both were predicted by LipoP 1.0 to be cleaved by signal peptidase II with a high score (~25). 
Both Lp_1261 and Lp_1452 lipoproteins have been found on the surface of L. plantarum 
using proteiomics tool based on surface “shaving” (Unpublished data, Lasse Fredriksen). 
Surface “shaving” is a method where the surface of intact bacteria is treated with trypsin and 
the released peptides are identified with tandem mass spectrometry (MS/MS).  
 
Primers to PCR amplify the lipo-anchors were designed to amplify the N-terminal regions of 






following protein up to the start of the predicted enzymatic domains. The enzymatic domains 
were found in the overview of predicted lipoproteins in L. plantarum WCFS1 (Boekhorst 
2006). The enzymatic domain in Lp_1261 was predicted to begin at amino acid 76, therefore 
the 75 first amino acids from Lp_1261 were used as lipo-anchor (Figure 4.1). The enzymatic 
domain in Lp_1452 was predicted to begin at amino acid 143, therefore the 142 N-terminally 
amino acids were used as the anchor sequence (Figure 4.2). The length of the two lipo-
anchors differed substantially; the Lp_1452 anchor was considerable longer than the Lp_1261 
anchor.  
 
Figure 4.1: The amino acid sequence of Lp_1261. The enzymatic domain was predicted to start at residue no. 
76; therefore the 75 N-terminally amino acids (marked in pink) were used as the lipo-anchor. The lipobox is 
marked in purple.   
 
 
Figure 4.2: The amino acid sequence of Lp_1452. The enzymatic domain was predicted to begin at residue no. 
143; therefore the 142 N-terminally amino acids (marked in pink) were used as the lipo-anchor. The lipobox is 
marked in purple. 
 





4.3 Constructs for expressing invasin with lipo-anchors 
In order to construct plasmids that express invasin with lipo-anchor, an expression cassette 
that includes the lipo-anchor and the invasin sequence was created (see Figure 4.3). A short 
linker sequence was inserted between the anchor and invasin in order to reduce the risk of 
invasin misfolding. The linker sequence selected was copied from the original invasin 
sequence, based on the fact that this sequence actually is a linker in the invasion protein 
structure (Hamburger et al. 1999). The linker with the DNA sequence: GGT ACT ATC GCG 
GCG, encodes the amino acid sequence GTIAA. In order to make sure that the primers with 
the included linker sequence did not bind to the natural linker sequence in invasin, it was 
made some silent mutations in the linker sequence. The DNA sequence used for GTIAA 
linker sequence with silent mutation was: GGC ACG ATT GCG GCG where 3 bases 
diverged from the natural linker sequence. This linker sequence was included in the forward 
primers used for amplification of the invasin gene (see Table 2.1 and 2.2). Furthermore, in 
between this linker and the invasion a SalI site was inserted (analogous to what was done in 
previous studies on protein secretion in L. plantarum (Mathiesen et al. 2008)), to permit easy 
exchange of fragments.    
 
The invasin and the anchor were linked using a splicing by overlap extension (SOE) PCR (see 
section 3.9.4), meaning that the reverse primers used for anchor amplification and the forward 
primers used for invasin amplification had complementary parts. To permit In-Fusion cloning, 
the forward primers used for anchor amplification and the reverse primer used for invasin 
amplification had ends with the same sequence as the ends of vector (see section 3.9.4 for 
more details). The two lipo-anchors were amplified from the L. plantarum WCFS1 
chromosome with the primers HR1261F and 1261R (see Table 2.1 and 2.2) for the Lp_1261 
anchor and HR1452F and 1452R for the Lp_1452 anchor. Invasin with the 5 domains was 
PCR amplified from the pTinvasin using the primers HRInvR and SOE1261InvF primer for 
linking invasin to the Lp_1261 anchor, and HRInvR and SOE1452InvF for linking invasin to 
the Lp_1452 anchor. The last two domains in the C-terminus of invasin were amplified from 
the same plasmid but the forward primers were replaced with SOE1261InvSF and 









Figure 4.3: The modular lipo-anchor-linker-invasin cassette. This gene construct encodes a protein precursor 
consisting of a lipo-anchor fragment, the linker sequence, an additional Val-Asp linker corresponding to the SalI 
restriction site and the invasin protein. The length of the lipo-anchor domain determines how much of the target 
protein (In this case, invasin) is exposed to the environment outside the bacterial cell wall. MCS indicates a 
multiple cloning site (including EcoRI).  
 
Initially four PCR products were made (two anchors and two invasin). Subsequently, overlap 
extension (SOE) PCR was performed creating various variants of the expression cassette 
shown in Figure 4.3. The Lp_1261 anchor was linked together with invasin (Inv) and the short 
version of invasin (InvS) with the outer primers HR1261F and HRInvR in the SOE-PCR, 
while the Lp_1452 anchor was linked together with Inv and InvS with the outer primers 
HR1452F and HRInvR. The pSIP vector p2588sAmy (Mathiesen et al. 2008) was used as a 
vector for all the constructs (Figure 4.4). The signal peptide-Amy insert (2588sAmy) was 
removed by restriction digestion with NdeI and EcoRI, and the four different PCR inserts 
from SOE-PCR were directly cloned into the linearized p2588sAmy vector with the In-Fusion 
kit (for more details see section 3.9.4), yielding pLp_1261InvS, pLp_1261Inv, pLp_1452InvS 
and pLp_1452Inv. As an example, the pLp_1261Inv vector is shown in Figure 4.4. All PCR 
amplified sequences were verified by DNA sequencing, see section 3.13 for details.  







Intracellular invasin production in L. plantarum 
4.4 Intracellular invasin production in L. plantarum 
The vectors whose construction is described above were, without any problems, transformed 
to L. plantarum WCFS1 using the procedure described in section 3.12.2. In order to see if L. 
plantarum harbouring the different constructs actually produce invasin, intracellular proteins 
were analyzed by looking for the presence of invasin in cell free extracts. This is an easy and 
more rapid method for initial screening than detecting actual anchoring of invasin.  
 
L. plantarum WCFS1 cells harbouring plasmids pLp_1261InvS, pLp_1261Inv, 
pLp_1452InvS, pLp_1452Inv, pCytInv or pEV (plasmid without any target sequence, i.e. 
empty vector) were grown under standard conditions (see Methods, section 3.1) and gene 
expression was induced by adding 25 ng/ml SppIP at OD600 ~0.3. The cells were grown at 
30ºC and harvested four hours after induction (as described in Methods, section 3.14). The 
Figure 4.4: Overview of the construction of pLp_1261Inv. First, invasin (Inv) and lipo-anchor Lp_1261 were 
PCR-amplified with overlapping ends containing the linker sequence. Then, Lp_1261 anchor was fused with 
invasin in SOE-PCR. The fused PCR products are shown in the gel and the anchor-invasin PCR products was 
shown to be longer than invasin, indicating that the anchor is fused with invasin. Restriction enzymes (NdeI and 
EcoRI) were used to remove the signal peptide-Amy (2588sAmy) insert in the pLp_2588sAmy vector (basically 
leaving linearized pSIP401) and the lipo-anchor-linker-invasin insert was cloned into the vector using the In-
Fusion technology. The other plasmids were constructed by the same principle, except pCytInv which does not 






initial harvesting time of four hours after protein induction was chosen because previous 
studies on protein expression with the pSIP-system in L. plantarum had shown good protein 
levels at this time point (Fredriksen et al. 2010).  Cell-free protein extracts of the induced and 
harvested cultures of L. plantarum WCFS1 cells harbouring the plasmids were tested for 
invasin expression by SDS-PAGE and western blotting as described in section 3.15 and 3.16. 
Figure 4.5 shows that bands with invasin of expected size appear in all intracellular fractions 
from cells harbouring an invasin encoding vector. As expected no invasin was detected in 
extracts from cells harbouring the empty vector (pEV) nor in extracts from the wild-type 
bacterium (lacking plasmid). Interestingly, it seems that L. plantarum strains harbouring 
invasin with a lipo-anchor produce more intracellular invasin than L. plantarum harbouring 
the intracellular version of invasin (pCytInv). 
 
 
4.4.1 Intracellular invasin production at 1 to 4 hours after induction 
Figure 4.5: Intracellular production of invasin. The picture shows a western blot analysis of cell free protein 
extracts obtained from L. plantarum strains harbouring various expression vectors after growth at 30ºC for 4 
hours after induction of protein production. The size marker is located in lane 1. The other lanes show extracts 
from L. plantarum strains harbouring the following plasmids (predicted molecular mass of the invasin protein in 
parenthesis):  
2, pLp_1261InvS (~29kDa); 3, pLp_1261Inv (~60kDa); 4, pLp_1452InvS (~37kDa); 5,  pLp_1452Inv 
(~68kDa); 6, pCytInv (~52kDa); 7, pEV (empty vector; no signal expected); 8, wild-type L. plantarum with no 
plasmid.  
The arrows indicate invasin. The amount of cell-free protein extracts from each strain was adjusted according to 
the OD600-value at the time of harvest to ensure that the cell-free protein extracts loaded onto the gel were from 
approximately the same amount of cells. The cell free protein extracts were added on the SDS-PAGE gel as 
described in 3.15 and the western blotting was performed as described in 3.16.  
 





After the intracellular invasin production was detected 4 hours after induction, it was 
interesting to examine if invasin could be detected at an earlier time-point. The L. plantarum 
cells harbouring the plasmids of interest were grown at 30ºC, induced, and harvested 1 to 4 
hours after induction, as described in section 3.14. Cell free protein extracts were obtained 
using glass beads (as described in section 3.14.1) and analyzed with SDS-PAGE and Western 
blot (see section 3.15 and 3.16 for details). The amount of cell-free protein extracts from each 
strain was adjusted according to the OD600-value at the time of harvest to ensure that the cell-
free protein extracts loaded onto the gel were from approximately the same amount of cells. 
Figure 4.6 show that invasin was detected in the intracellular fraction at all time points within 
1 to 4 hours after pheromone induction for each stain carrying an invasion construct. 
Interestingly, Figure 4.6 demonstrates that intracellular invasin does not increase over time for 
the strains carrying constructs with an anchor, while the amount of invasin produced in the 
strain producing the intracellular version intracellular version (pCytInv) increases over time.  
 
 
 Figure 4.6: Intracellular production of invasin. The pictures shows western blot analysis of cell free protein 
extracts obtained from L. plantarum strains harbouring various expression vectors, after growth at 30ºC, 1 to 4 
hours (h) after induction of protein production. Size markers are shown in the non-labeled lanes. The other lanes 
show extracts from L. plantarum strains harbouring the following plasmids: (a) pLp_1261InvS; (b) 
pLp_1261Inv; (c) pLp_1452InvS; (d) pLp_1452Inv; (e) pCytInv or (f) pEV (empty vector; no signal expected). 
The arrows indicate the invasin protein; in all cases, the size of the marked band corresponds to the expected size 
given in the legend of Figure 4.5. The amount of cell-free protein extracts from each strain was adjusted 
according to the OD600-value at the time of harvest to ensure that the cell-free protein extracts loaded onto the 
SDS-PAGE gel (see section 3.15) were from approximately the same amount of cells. Western blot was 
performed as described in 3.16.  
 
4.4.2 Intracellular invasin production at 37ºC 
L. plantarum with pSIP vectors are normally grown at 30ºC (Mathiesen et al. 2008; 
Mathiesen et al. 2009; Sørvig et al. 2003; Sørvig et al. 2005), but because of the potential 
application of these constructs in a human vaccine, invasin production by the recombinant 






4.4.1 was performed at 37ºC to check the production level at this temperature. Figure 4.7 
show that invasin production at 37ºC is a similar to the production expression at 30ºC. All L. 
plantarum constructs produced invasin at all times within 1 to 4 hours. Interestingly, also at 
37ºC the amount of invasin increased over time in the intracellular version of invasin 
(pCytInv; Figure 4.7e). In addition, pLp_1261InvS shows some increasing of the invasin 
protein.   
 
 
    
4.5 Growth of L. plantarum harbouring different invasin constructs 
In order to study the effect of invasin production on growth of the host stain, growth of 
induced strains harbouring various plasmids was monitored at 30ºC (Figure 4.8) and 37ºC 
(Figure 4.9). 
 
L. plantarum harbouring the invasin encoding constructs grew slightly faster at 30ºC. The 
growth rates of the various recombinant strains showed major differences, which were similar 
at 30 and 37ºC. Interestingly, strains carrying the two invasin versions with the Lp_1452 
anchor showed minimal growth after pheromone induction. Stains carrying the Lp_1261 
anchor versions showed higher growth, especially for pLp_1261InvS. The strain carrying the 
intracellular version of invasin (pCytInv) grew almost at the same rate as the strain carrying 
Figure 4.7: Intracellular production of invasin. The pictures shows western blot analysis of cell free protein 
extracts obtained from L. plantarum strains harbouring various expression vectors, after growth at 37ºC, 1 to 4 
hours (h) after induction of protein production. Size markers are shown in the non-labeled lanes. The other lanes 
show extracts from L. plantarum strains harbouring the following plasmids: (a) pLp_1261InvS; (b) 
pLp_1261Inv; (c) pLp_1452InvS; (d) pLp_1452Inv; (e) pCytInv or (f) pEV (empty vector; no signal expected). 
The arrows indicate the invasin protein; in all cases, the size of the marked band corresponds to the expected 
size given in the legend of Figure 4.5. The amount of cell-free protein extracts from each strain was adjusted 
according to the OD600-value at the time of harvest to ensure that the cell-free protein extracts loaded onto SDS-
PAGE gel (see section 3.15) were from approximately the same amount of cells. Western blot was performed as 
described in 3.16.  
 
 





the empty vector (pEV). These differences in growth have been confirmed by repeated 









Figure 4.9: Growth of L. plantarum harbouring different constructs at 37ºC. The cell density of the 
bacteria was measured by recording OD600 at one to four hours after protein induction of the cells. 
Figure 4.8: Growth of L. plantarum harbouring different constructs at 30ºC. The cell density of the 












































Secretion and anchoring of invasin in L. plantarum 
4.6 Translocation of invasin with lipo-anchor across the cell membrane 
In the above section it was shown that the invasin proteins are successfully produced with all 
strains both at 30 and 37ºC and that the proteins could be detected over a period of at least 4 
hours after induction. On the basis of the potential application of these strains in a human 
vaccine, secretion and anchoring of invasin was analyzed only at 37ºC.  
 
The next step was to investigate invasin secretion by analyzing culture supernatants of L. 
plantarum cells harbouring inv containing plasmids. Although the proteins were designed to 
be anchored, an analyses of the culture supernatants makes sense, because shedding of 
lipoproteins is common; it was thus expected that invasin to some extent would be released 
from the cell surface (Antelmann et al. 2001; Tjalsma et al. 2008). Analyzing supernatants is a 
simpler procedure than detection of surface exposed invasin and was therefore performed 
before analysis of surface anchoring and exposure.  
 
The secretion of invasin in the recombinant L. plantarum strains was analyzed by growing the 
cultures to OD600 ~0.3, inducing the strains with SppIP (25 ng/ml) and harvesting 1 to 4 hours 
after induction of protein production, as described in section 3.14. The proteins in the 
supernatants were precipitated with 16% TCA (see section 3.14.2 for more details) and 
analyzed by SDS-PAGE. Initially, secretion of invasin was investigated for cultures that were 
harvested one hour after induction. Based on the OD600-value at the time of harvest, the 
amount of supernatant loaded onto SDS-PAGE gel originated from approximately the same 
number of cells.  
 
Figure 4.10 show that cultures of L. plantarum cells harbouring the plasmids pLp_1261Inv, 
pLp_1452InvS or pLp_1452Inv have detectable amounts of invasin in the supernatant one 
hour after induction. The invasin protein was not detected in the supernatants of the L. 
plantarum strains containing the plasmids pCytInv or pLp_1261InvS, one hour after 
induction. L. plantarum containing the plasmid pLp_1261InvS was therefore examined more 
carefully by analysis of supernatant fractions obtained after culturing the cells for longer 
times. Figure 4.11 shows that invasin is present in the supernatant of L. plantarum cells 
carrying the pLp_1261InvS construct at two to four hours after induction, and that the amount 
increases over time.   










Figure 4.10: Invasin proteins in the culture supernatants.  The picture show a western blot analysis of proteins 
in the supernatant obtained from L. plantarum strains harbouring various expression vectors 1 hour after induction 
of protein production. Size markers are shown in lane 1. The other lanes show proteins in the supernatant from L. 
plantarum strains harbouring the following plasmids: (2) pLp_1261InvS; (3) pLp_1261Inv; (4) pLp_1452InvS; 
(5) pLp_1452Inv; (6) pCytInv (no signal expected) or (7) pEV (empty vector; no signal expected). The arrows 
indicate the invasin protein; the size of the marked band corresponds to the expected size given in the legend of 
Figure 4.5. The approximate expected position of the invasin version from L. plantarum carrying the 
pLp_1261InvS construct is indicated with a blue arrow.  
Figure 4.11: Invasin protein in the culture supernatant of L. plantarum harbouring the plasmid 
pLp_1261InvS. The picture show a western blot analysis of proteins in the supernatant obtained from L. 
plantarum harbouring pLp_1261Inv 1 to 4 hours (h) after induction of protein production. Size markers are 
shown in non-label lane. The arrow indicates invasin; the size of the marked band corresponds to the expected 








4.7 Detection of surface-anchored invasin  
On the basis of the results for secretion of invasin, surface-anchoring of invasin was analyzed 
two hours after protein induction. Detection of invasin on the surface of L. plantarum is 
complicated and therefore, different strategies were used.  
 
The use of immunofluorescence techniques is one method to detect surface exposed proteins. 
In this technique primary or secondary antibodies are conjugated to a fluorescent dye and 
fluorescence can then be visualized using fluorescence microscopy or flow cytometry. Other 
techniques that can be exploited are based on the use of mutanolysin to cleave MurNac-
GlcNac linkages in cell wall peptidoglycan followed by analysis of the resulting cell wall 
fraction by western blotting. Finally, one may use western blotting-like procedure directly on 
cells (dot blot).  
 
4.7.1 Detection of surface-anchored invasin by immunofluorescence  
In order to analyze if invasin was present on the surface of the bacteria, the direct 
immunofluorescence method was examined. The primary antibody was specific for two 
epitopes on Y. pseudotuberculosis invasin (pAb invasin PAS Bleed #3, see section 2.3). The 
primary antibody has been conjugated with FITC (as described in section 3.18.1). This 
antibody will bind directly to invasin and the binding can be detected by fluorescence 
microscopy and flow cytometry.  
 
The bacterial cells were stained approximately as described in 3.18.2, but optimization was 
necessary and several variants of the protocol were tested. One problem using direct 
immunofluorescence is a weak signal. Another known problem is the background signal, due 
to unspecific binding of the primary antibody. The optimizations were done to increase the 
signal without increasing the background signal. Since it is difficult to predict the optimal 
ratio between primary antibody and amount of cells several ratios were tested. When the 
antibody concentration was increased to detect a visible signal, background signal on the 
negative controls occurred. In an attempt to reduce the background signal different antibody 
concentrations and a BSA concentration gradient were tested. In addition, different incubation 
times, different incubation temperatures, incubation with or without shaking and different 
amount of washing step were tested. Most experiments did not yield any stained L. plantarum 
cells (data not shown). In some cases, minor fractions of stained cells were observed for 





strains carrying constructs encoding lipo-anchored invasin but this was also the case for the 
negative controls (L. plantarum harbouring pCytInv or pEV, as well as wild-type L. 
plantarum) (Appendix, Figure A.1).  
 
Since the experiments with FITC-labeled primary antibody did not yield satisfying results 
despite extensive optimization attempts, studies with a FITC labeled secondary antibody 
(Anti-Rabbit IgG (whole molecule)- FITC) were initiated. Secondary antibody conjugated 
with FITC would give a stronger signal than primary antibody conjugated with FITC because 
several molecules of secondary antibody will bind to one primary antibody, which binds to 
the antigen of interest (invasin). The cells, grown for two hours after protein induction, were 
stained approximately as described in section 3.18.3, but, again, extensive fine-tuning of the 
protocol was necessary. The optimal ratio between the amount of bacteria, primary antibody 
and secondary antibody was a challenge, and several different ratios were tested. The 
optimizations were done to decrease the background signal from the negative controls (L. 
plantarum harbouring pEV or pCytInv) without losing the signal from the strains carrying 
constructs encoding lipo-anchored invasin. In order to reduce the background signal, the 
bacteria were resuspended and washed with different concentrations of BSA (a gradient in the 
range 2 to 5%). Different incubation times with primary and secondary antibody, and different 
number of washing step in between antibody incubation were tested. Most experiments did 
not yield any strained L. plantarum cells, or the staining signal between L. plantarum strains 
harbouring constructs encoding lipo-anchored invasin and strains carrying constructs 
encoding pEV or pCytInv showed no significant differences (data not shown).  
 
The optimization strategies described above did not remove the background signal, indicating 
unspecific binding of the primary or secondary antibody to the surface of L. plantarum. The 
primary antibody is from rabbit serum and polyclonal; it is therefore conceivable that some of 
the antibodies bind to other molecules than invasin. Therefore, a special pre-treatment of the 
primary antibody was tested (for details, see step 4 in section 3.18.3). In this treatment, the 
primary antibody was first incubated with cells of L. plantarum harbouring the empty vector 
(pEV) which does not produce invasin, with the aim of fishing out antibodies that bind 
unspecifically to the cells. The cells, grown for two hours after induction were stained with 
primary antibody or pre-treated primary antibody, followed by staining with secondary 






antibody removed a significant portion of the background signal; therefore, this pretreatment 
of the primary antibody was done in the following experiments.  
 
L. plantarum strains harbouring the different constructs were harvested two hours after 
induction. After washing the cells, the cells were resuspended in 50 μl PBS containing 2% 
BSA and 10 μl pre-treated primary antibody, followed by incubation for 30 minutes at 4ºC. 
The cells were washed four times with PBS containing 2% BSA. After resuspending the cells 
in 50 μl PBS containing 2% BSA 0.2 μl secondary antibody conjugated with FITC was added 
followed by incubation for 15 minutes at 4ºC. The cells were washed four times with PBS 
containing 2% BSA, resuspended in 50 μl PBS containing 2% BSA and analyzed using 
fluorescence microscope (for more details, see section 3.18.3). The result is shown in Figure 
4.12 and shows green spots on all of the L. plantarum strains containing constructs encoding 
lipo-anchored invasin except for L. plantarum harbouring the pLp_1452InvS construct. 
Strains carrying pCytInv or the empty vector (pEV) showed very few green spots. Some of 
the green spots on the figure could be from cell lysis. Especially, on the image of L. 
plantarum harbouring the pLp_1261Inv construct are several green spots present without any 
bacteria cell. Generally, these experiments were difficult to repeat and, therefore, other 
methods to detect surface-located invasin were tested. In the next step, the samples shown in 













     
Figure 4.12: Detection of surface-anchored invasin. The images show L. plantarum strains harbouring the 
following constructs: (1) pLp_1261InvS; (2) pLp_1261Inv; (3) pLp_1452InvS; (4) pLp_1452Inv; (5) pCytInv 
or (6) pEV (empty vector). The cell amount was adjusted after OD600 at the harvesting time to stain 
approximately the same amount of cells. The images were achieved by using indirect immunofluorescence and 
analysis by fluorescence microscopy.  The images represent one representative image of three random images 
that was taken of the different strains. The arrows demonstrated where there are green spots on the bacteria 






The flow cytometer detects bound fluorochrome-conjugated antibodies, such as secondary 
antibody conjugated with FITC, on cells. The result can be visualized by single-parameter 
histograms where the x-axis display the fluorescence intensity (FITC-A) and the y-axis 
display the number of events (hits/particles). More intense fluorescent signal (more 
fluorescence molecules on the surface of the cell) is indicated by a peak shift to higher 
fluorescent intensity (FITC-A). In theory, a sample containing no stained bacteria will yield 
one narrow peak at 0 (no fluorescence intensity).  
 
The samples shown in Figure 4.12 were analyzed with flow cytometry and the result is shown 
in Figure 4.13. Figure 4.13 shows that generally, strains harbouring constructs encoding lipo-
anchored invasin (no. 1-4) have a higher fluorescent intensity compared to strains carrying the 
negative controls (pCytInv and pEV; no. 5-6 respectively). Ideally, samples with L. plantarum 
strains harbouring the constructs pCytInv or pEV should have a narrow peak at 0, but instead 
the peaks are shifted to a higher FITC-A, especially for the L. plantarum strain containing 
pCytInv. This peak shift shows the present of stained bacteria on the strains carrying the 
negative controls. Generally, these experiments were difficult to repeat, and a significant 
difference between the strains containing constructs encoding lipo-anchored invasin and 
strains containing constructs encoding the negative controls were difficult to obtain.    
 
Figure 4.13: Flow cytometry analysis of various recombinant L. plantarum strains. The figure shows single-
parameter histograms for cells of L. plantarum harbouring various constructs and stained with indirect 
immunofluorescence. The x-axis displays the fluorescent intensity (FITC-A) and the y-axis displays the number 
of events. The graphs represent L. plantarum harbouring the constructs: pLp_1261InvS, pLp_1261Inv, 
pLp1452InvS, pLp_1452Inv, pCytInv or pEV (empty vector). For each sample 10 000 cells were analyzed in the 
Flow cytometer.   





    
In order to identify if invasin is more difficult to detect on the surface of L. plantarum than 
other surface-anchored proteins, L. plantarum harbouring another construct encoding two 
surface-anchored tuberculosis antigens (pLp_3050Ag85B-E6Cwa2 construct; (Tjåland 2011)) 
was studies, using appropriate antibodies. In this case, many stained bacteria were observed, 
while negative controls showed only few stained cells (data not shown). The primary antibody 
used in this study is monoclonal, which may explain why better signal-to-noise ratios could be 
obtained. Monoclonal antibodies are homogeneous with a defined specificity, which gives 
considerable less background signal. The primary antibody to invasin is polyclonal and it is 
not unusual that polyclonal antibodies give higher background signals (Lea 2006).  
 
One possible explanation for the weak signals obtained when staining L. plantarum strains 
harbouring constructs encoding invasin could be that the primary antibody has insufficient 
access to epitopes on invasin. This can be caused by the epitopes being covered in the invasin 
structure. Therefore, L. plantarum containing the different constructs were incubated at 70ºC 
for 5 minutes before staining, to “open up” the invasin structure by protein unfolding. L. 
plantarum strains containing the various constructs and heat-treated in this manner were 
analyzed with fluorescence microscopy and three pictures were taken at random for every 
strain (see Appendix, Figure A.2). The result showed no significant difference between L. 
plantarum harbouring the constructs encoding lipo-anchored invasin compared to L. 
plantarum harbouring the constructs encoding pCytInv or pEV, except for L. plantarum 
containing the pLp_1452Inv construct, which showed considerably more stained bacteria than 
all other samples.   
 
The weak signal from staining of the L. plantarum stains could also be due to the invasin 
proteins being buried in the cell wall, which could hinder binding of the antibodies. The 
samples were pre-treated with mutanolysin or mutanolysin together with lysozyme, prior to 
staining of the cells, to analyze if invasin was buried in the cell wall. Mutanolysin and 
lysozyme are enzymes that will cut specifically between the N-acetylmuramyl-β(1-4)-N-
acetylglucosamine linkage (MurNac-GlcNac) of the cell wall polymer peptidoglycan-
polysaccharide (Lichtman et al. 1992; Stan Tsai 1997). The challenge in these experiments 
was to remove some of the cell wall without lysis of the bacteria cells. A control for cell lysis 






signal for secretion or anchoring of invasin (invasin stays intracellularly). Cell lysis of the 
strain containing pCytInv would make the invasin protein available to react with the 
antibodies, resulting in green spots. The various recombinant L. plantarum strains were 
always threaded the same; therefore green spots on the L. plantarum harbouring pCytInv 
would indicate lysis of the other strain cells as well. To avoid cell lysis, different incubation 
times (20, 30 and 60 minutes) and concentration of the enzymes were tested.  
 
In experiments with only mutanolysin, the greatest difference in number of stained cells 
between strains carrying constructs encoding lipo-anchored invasin and strains carrying 
constructs encoding pCytInv or pEV was from a pre-treatment of 50 U/ml mutanolysin 
incubated for 20 minutes, prior to staining of the cells (see section 3.14.3 for more details) 
(the result is shown in Figure A.3, in the appendix). Still, this result showed no significant 
difference between L. plantarum harbouring constructs encoding lipo-anchored invasin 
compared to L. plantarum harbouring pCytInv or pEV. However, the result did indicate that 
L. plantarum containing the pLp_1261Inv or pLp_1452Inv constructs could have more 
stained bacteria than the other strains.   
 
In experiments with L. plantarum harbouring various constructs, pre-treated with mutanolysin 
and lysozyme, the staining results showed many stained bacteria for L. plantarum containing 
constructs encoding lipo-anchored invasin, but the same was observed for L. plantarum 
containing the intracellular version of invasin (pCytInv). Further optimization led to a 
procedure where the cells were treated with 60 U/ml mutanolysin and 15 mg/ml lysozyme for 
30 minutes. This result showed no significant difference between L. plantarum containing 
constructs encoding lipo-anchored invasin compared to L. plantarum harbouring pCytInv or 
pEV. However, the result did indicate some more stained bacteria for L. plantarum containing 
the pLp_1261Inv or pLp_1452Inv constructs; the same as the experiment with pre-treatment 
of 50 U/ml mutanolysin for 20 minutes.  
 
All in all, the immunofluorescence-based methods indicate surface-anchoring of invasin. 
Figure 4.12 indicates that L. plantarum harbouring the pLp_1261InvS, pLp_1261Inv or 
pLp_1452Inv plasmid have surface-anchored invasin, and the result in Figure 4.13 indicates 
that L. plantarum harbouring the pLp_1452InvS plasmid also have surface-anchored invasin. 
The results were promising, but few significant differences between the strains carrying 





constructs encoding lipo-anchored invasin and strains carrying the pCytInv or pEV constructs 
(negative controls) were observed, and no conclusive evidence was obtained. Therefore, other 
analytical methods were tested as well.  
 
4.7.2 Detection of surface-anchored invasin by isolating the cell wall fraction 
L. plantarum has a thick cell wall composed primarily of peptidoglycan which has glycan 
chains with units of N-acetylglucosamine (GlcNac) and N-acetylmuramic acid (MurNac) in a 
β-1,4 linkage. Cell wall fractions of L. plantarum strains may be analyzed and this provides 
another method to detect if invasin is located in the cell wall. This method was performed as 
described in 0 and involved incubation of the cells with mutanolysin to cleave the MurNac-
GlcNac linkage of the cell wall polymer peptidoglycan-polysaccharide (Lichtman et al. 1992). 
Despite repeated attempts to optimize the method, with different concentrations of 
mutanolysin and incubation times, every experiment yielded an invasin signal in the negative 
control (L. plantarum harbouring pCytInv). Figure 4.14 shows a typical result. Invasin bands 
with expected sizes are observed for all invasion expressing strains, including negative control 
(lane 5).  
 
Figure 4.14: Detection of surface-anchored invasin by analysis of cell wall fractions.  The picture shows a 
western blot analysis of the cell wall fraction obtained from L. plantarum strains harbouring various expression 
vectors. The size marker is located in lane 1. The other lanes show extracts from L. plantarum strains 
harbouring the following plasmids (predicted molecular mass of the invasin protein in parenthesis):  
2, pLp_1261InvS (~29kDa); 3, pLp_1261Inv (~60kDa); 4, pLp_1452InvS (~37kDa); 5, pLp_1452Inv 
(~68kDa); 6, pCytInv (~52kDa); 7, pEV (empty vector; no signal expected). 
The arrows indicate invasin. After harvesting the cells two hours after induction of protein production, the cells 
were treated with mutanolysin as described in section 3.14.3. The solution was precipitated with TCA (see 
section 3.15.2 for more details). The amount of protein extracts from each strain was adjusted according to the 
OD600-value at the time of harvest to ensure that the protein extracts loaded onto the SDS-PAGE gel (see 
section 3.15) were from approximately the same amount of cells. Western blotting was performed as described 






4.7.3 Detection of surface located invasin with cell dot-blot 
Since the methods described above did not give a conclusive result, a third method was tested, 
namely the cell dot-blot method (procedure described in section 3.17). Various recombinant 
L. plantarum strains were harvested four hours after induction of protein production. The 
samples were suspended in volumes of buffer that were proportional to the different OD600-
values for the sample at the harvesting time, to make sure that approximately the same 
amount of cells was studied. The cell suspensions were applied to a membrane and incubated 
with antibodies. After hybridization with the primary and secondary antibody (see section 
3.17 for details) a positive result will give black spots on the film, indicating that invasin is 
anchored on the surface of the bacteria.  
 
The challenge using the cell dot-blot method was to avoid a background signal. Optimization 
was necessary and several variants of two different protocols were tested. The method was 
optimized by changing of buffer, membrane, incubation time, concentration of antibodies and 
BSA, and the number of times the membrane was washed. Most experiments yielded a totally 
black membrane (data not shown), or if it was possible to see the spots, all the spots were 
black, i.e. positive (data not shown). Generally, it was difficult to see a significant difference 
between the L. plantarum strains carrying constructs encoding lipo-anchored invasin and the 
controls.  
 
One optimized experiment yielded a quite good dot-blot, which is shown in Figure 4.15. The 
figure shows two degrees of black, dark black spots that represent cells and lighter black spots 
around the dark spots that represent the buffer signal. The figure shows a difference between 
L. plantarum harbouring the constructs encoding lipo-anchored invasin and L. plantarum 
containing the pCytInv or pEV constructs and the wild-type bacterium (negative controls). 
However, the negative controls all had quite dark spots and are certainly not really negative. 
Ideally, the negative controls would not show any visible spots. In addition, it seems like 
wild-type L. plantarum (lacking plasmid) has a black spot in the undiluted sample similar to 
the positive control. Generally, results from this dot-blot procedure were difficult to repeat 
and thus hardly conclusive.   






Figure 4.15: A cell dot-blot of different L. plantarum strains. The cell dot-blot was performed on a PVDF 
membrane (Procedure described in section 3.17, 1 μl/ml primary antibody and 0.05 μl/ml secondary antibody 
were used). All samples are intact cells suspended in TES-buffer, except for lane 1, which contains proteins from 
glass bead disrupted L. plantarum cells harbouring pCytInv (positive invasin control). Cells were harvested 4 
hours after induction and applied undiluted (A), as well as diluted 5 (B) and 25 (C) times. The resuspension 
volume adjusted to the OD600-value at the time of harvest to make the number of cells similar in all samples. The 
spots contain 2 µl of undiluted (A) or diluted (B, C) cell suspension of L. plantarum harbouring the following 
plasmids: (2) pLp_1261InvS, (3) pLp_1261Inv, (4) pLp_1452InvS, (5) pLp_1452Inv, (6) pCytInv, (7) pEV 
(empty vector) and (8) wild-type of L. plantarum.  
 
Internalization of L. plantarum strains by Caco-2 cells 
4.8 Analysis of internalization of L. plantarum strains by Caco-2 cells 
Although the experiments described in section 4.7 did not convincingly show the presence of 
anchored invasin on the surface of L. plantarum cells, they do provide strong indications that 
this indeed may be the case. Therefore, the internalization of these bacteria into human 
intestinal cells was analyzed. The studies were performed with non-polarized Caco-2 cells 
which are known to have β1-integrin receptors on their apical sides and which do not have 
microvilli. Thus, these cells to some extent resemble M-cells and can be used as a model for 
those. Invasin binding to the β1-integrin receptor normally results in internalization of the 
bacteria, but it requires a high density of invasin molecules on the bacterial surface (Leo & 
Skurnik 2011).  
 
First a preliminary experiment was performed to analyze the internalization of L. plantarum 
strains harbouring various constructs into Caco-2 cells. The various recombinant L. plantarum 
strains were harvested two hours after protein induction and stained with either FITC or CFSE 








methods. After staining of the bacterial cells L. plantarum harbouring various constructs were 
incubated with Caco-2 cells for one hour. After the incubation, the samples were washed and 
then fixated on microscope slides. The slides were stained with Hoechst stain to visualize the 
nuclei to the Caco-2 cells (the Caco-2 cells were stained blue) (done by Charlotte Kleiveland). 
The samples were analyzed using Confocal Laser Scanning Microscopy (CLSM). The CLSM 
analysis was done by Lene Olsen and Charlotte Kleiveland. The result showed that the L. 
plantarum strains were better visualized in the microscope with CFSE compared to FITC. 
Since this was a preliminary experiment only a few images were taken of some of the 
recombinant L. plantarum strains. Figure 4.16 shows the images of L. plantarum harbouring 
the pLp_1261Inv or pLp_1452Inv, to demonstrate that the number of bacteria cells incubated 
with Caco-2 cells was observed to differ between the recombinant strains. In addition, it was 
difficult to determine if the bacteria were outside or inside the Caco-2 cells because the 
membrane to the Caco-2 cells was difficult to detect. Therefore optimization of the procedure 
was necessary.    
 
Figure 4.16: CLSM images of Caco-2 cells and L. plantarum harbouring the different invasin constructs: 
(A) pLp_1261Inv or (B) pLp_1452Inv. The recombinant L. plantarum strains were harvested two hours after 
pheromone induction and the bacterial cells were stained green with CFSE. The various L. plantarum strains 
were incubated with Caco-2 cells at 37ºC for one hour. The sample was fixed on microscope slides and the 
Caco-2 cells were stained blue with Hoechst stain. The images shows only the blue channel, only green channel, 
no color, and green and red channel together (down in right corner) The images show that the number of 
bacterial cells in the samples differs and that it was difficult to detect bacterial cells inside Caco-2 cells.     
 
 
In order to compare the Caco-2 internalization for the different recombinant L. plantarum 
strains it was necessary to add approximately the same amount of viable bacterial cells to each 





sample with Caco-2 cells. The experiment depicted in Figure 4.16 shows that the relation 
between OD600 and viable cells varied between cultures of L. plantarum harbouring the 
different constructs. Figure 4.16B shows a considerably higher amount of bacteria (green) 
compared to image A despite the fact that, judged by OD600, the same amount of bacteria was 
added. Therefore, the relation between OD600 and CFU/ml was checked for L. plantarum 
harbouring all the different constructs. The results showed that for the L. plantarum strains 
harbouring the pLp_1452InvS or pLp_1452Inv constructs the amount of viable cells (CFU) 
decreased over time after induction (Appendix, Figure A.4 ). L. plantarum harbouring the 
other constructs increased in amount of cells. The relation between OD600 and CFU/ml for L. 
plantarum containing empty vector (pEV) (Appendix, Figure A.5) was used to calculate the 
amount of cells for all constructs except pLp_1452InvS and pLp_1452Inv for which the graph 
in Figure A.4 in the Appendix was used. 
 
Internalization of recombinant L. plantarum strains into Caco-2 cells were difficult to observe 
because it was difficult to discriminate between bacteria inside or outside Caco-2 cells in the 
microscope. In order to analyze the internalization of the bacteria, one other possible method 
is the gentamicin survival assay (Innocentin et al. 2009). In theory, the gentamicin (an 
antibiotic) will kill non-internalized bacteria while bacteria inside the Caco-2 cells are 
protected from the antibiotic and would therefore survive the treatment. Gentamicin was 
chosen as the most optimal antibiotic because this antibiotic cannot permeate mammalian 
cells (Critchley-Thorne et al. 2006).  To be able to apply this method, first, concentrations of 
gentamicin were tested to find appropriate amount of gentamicin that is needed to kill L. 
plantarum. It was found that 400 μg/ml gentamicin killed L. plantarum without harming the 
Caco-2 cells.   
 
The gentamicin survival assay was performed as described in section 3.23. In short, the cells 
were harvested two hours after induction of invasin production, washed and resuspended in 
1.5 ml RPMI 1640 medium with L-glutamine and 10% fetal calf serum (FCS). To find the 
start concentration of bacterial cells before incubation with Caco-2 cells, 100 μl of the 
suspensions were spread out on MRS plates. The rest of the suspensions (1.4 ml) were 
incubated with Caco-2 cells in microplates for 3 hours (based on the protocol of Innocentin et 
al. (2009)). After adding antibiotic (400 μg/ml gentamicin), the cells were incubated over 






triton was added in order to cell lyse the Caco-2 cells. Subsequently, the entire solution with 
Caco-2 cells was spread out on agar-plates (100 μl on three different plates). The result yield 
no significant differences between L. plantarum strains carrying constructs encoding lipo-
anchored invasin and L. plantarum harbouring the pCytInv or pEV constructs (negative 
controls). Some optimization of the procedure was done in order to see if it was possible to 
detect a difference between the various recombinant strains, but none gave a better result. The 





 bacteria, yielding ratios between Caco-2 cells and bacteria at 1:5000 and 
1:50 respectively. The results are reported in Table 4.2 and 4.3 and show a very low survival 
percents, high standard errors and no significant difference between the recombinant strains; 
L. plantarum strains carrying constructs encoding lipo-anchored invasin did not show an 
increased internalization into Caco-2 cells compared to the negative controls. As a control, the 
triton treatment was tested on L. plantarum cells to examine if 0.1% triton could induce cell 
lysis of L. plantarum cells, but L. plantarum harbouring the different constructs survived 
treatment with 0.1% triton (data not shown).   
 
Table 4.2: The gentamicin survival assay performed with a start amount of ~10
8
 bacteria, giving 
a ratio between Caco-2 cells and bacteria at ~1:5000. Percent survival is calculated after how many 










Table 4.3: The gentamicin survival assay performed with a start amount of ~10
6
 bacteria, giving 
a ratio between Caco-2 cells and bacteria at ~1:50. Percent survival is calculated after how many 









Constructs Start amount 
CFU/ml 
Average amount of 
survivors CFU/ml 
Percent survival/ml 
pLp_1261InvS 4.1 * 10
8
 1900 6.6 * 10
-4 
± 2.4 * 10
-4
 
pLp_1261Inv 2.8 * 10
8
 450 2.3 * 10
-4 
± 1.4 * 10
-4
 
pLp_1452InvS 1.7 * 10
8
 40 3.3 * 10
-5 
± 1.7 * 10
-5
 
pLp_1452Inv 4.5 * 10
8
 280 8.8 * 10
-5 
± 1.2 * 10
-5
 
pCytInv 1.2 * 10
8
 1700 2.1 * 10
-3 
± 1.5 * 10
-3
 
pEV (empty vector) 1.8 * 10
8
 1180 9.1 * 10
-4
 ± 4.2 * 10
-4
 
Constructs Start amount 
CFU/ml 
Average amount of 
survivors CFU/ml 
Percent survival/ml 
pLp_1261InvS 9.6 * 10
6
 340 3.5 * 10
-3 
± 2.2 * 10
-3
 
pLp_1261Inv 2.5 * 10
6
 55 2.1 * 10
-3 
± 1.5 * 10
-3
 
pLp_1452InvS 2.4 * 10
6
 0 0 
pLp_1452Inv 3.8 * 10
6
 0 0 
pCytInv 2.0 * 10
7
 305 1.5 * 10
-3 
± 6.5 * 10
-4
 
pEV (empty vector) 2.2 * 10
7
 120 5.5 * 10
-4
 ± 2.3 * 10
-4
 





The gentamicin survival assay is based on recovery of viable bacteria after internalization by 
Caco-2 cells. In this assay an incubation time of ~18 hours was used, this could be too long 
and L. plantarum cells could lyse before the solution is spread on agar-plates. Therefore, this 
assay was complemented with a microscopic evaluation of L. plantarum containing the 
different constructs; in this method, the step of lysing the Caco-2 cells is omitted.  
 
The various recombinant L. plantarum strains were harvested 1 ½ hour after induction, 
stained with CFSE (see section 3.21) and then treated with Biotin (see section 3.22). In this 
method the CFSE is transferred into the bacteria and binds to intracellular proteins, which 
makes all bacteria green, while biotin binds to the surface of the bacteria. After the treatment, 
the bacteria were incubated with Caco-2 cells for 1 hour and then with antibiotic (400 μg/ml 
gentamicin) for another hour to kill bacteria outside Caco-2 cells. After the gentamicin 
treatment TRITC was added to the Caco-2 cells. The TRITC will bind to biotin and is 
visualized as a red color. Thus, bacteria inside Caco-2 cells will be green, due to the CFSE 
staining, but the bacteria outside will react with TRITC and become yellow/orange, due to 
mixing of the green CFSE signal and the red TRITC signal. After the TRITC staining, the 
internalization of the L. plantarum strains was analyzed with CLSM by Lene Olsen and 
Charlotte Kleiveland and representative microscopy images are shown in Figure 4.17.  
 
Figure 4.17 shows only some of the recombinant L. plantarum strains because only a few 
images were taken. The negative controls are not included in the figure because of lack of 
images but the samples were observed in the microscope. For L. plantarum harbouring the 
pCytInv or pEV constructs (negative controls), some bacteria were observed bound to Caco-2 
cells but in clearly lower numbers than for strains carrying constructs encoding lipo-anchored 
invasin. L. plantarum harbouring the pLp_1261InvS construct (image A and B in Figure 4.17) 
was observed to be the strain where most bacteria bound to the Caco-2 cells and one Caco-2 
cell had two green spots inside that could possibly be bacteria. L. plantarum harbouring the 
pLp_1261Inv construct was observed to bind many Caco-2 cells and one bacterium (image C 
in Figure 4.17) was observed to be both green and orange; could be penetrating the Caco-2 
cell membrane. L. plantarum harbouring the pLp_1452InvS construct was observed to bind 
well to the surface of Caco-2 cells (image D in Figure 4.17) but no bacteria were observed to 
be inside the Caco-2 cells. L. plantarum harbouring the pLp_1452Inv construct was not 






treatment. Interestingly, in this experiment strains containing constructs encoding lipo-
anchored invasin had increased affinity for the Caco-2 cells than strains without lipo-anchored 
invasin. It must be noted that this experiment was done only once.  
 
 
Figure 4.17: CLSM images of Caco-2 cells and L. plantarum harbouring different invasin constructs. (A) 
and (B) pLp_1261InvS, (C) pLp_1261Inv and (D) pLp_1452InvS. The bacteria are stained green with CFSE 
and treated with Biotin, incubated with Caco-2 cells and then with antibiotic and stained with TRITC. This made 
bacteria located outside Caco-2 cells yellow/orange while bacteria inside Caco-2 cells stained green. The 
antibiotic treatment should ideally kill all bacteria outside Caco-2 cells. The images shows only the green channel, 
only red, no color, and green and red channel together (down in right corner)  







Construction of invasin expression vectors 
The production and cell-wall anchoring of an M-cell binding protein in L. plantarum WCFS1 
utilizing the pSIP-system could be a new way of delivering mucosal vaccines. In this study 
invasin was used since this protein binds to receptors on M-cells; first step was to anchor the 
invasin protein to the surface of L. plantarum to hopefully in the end achieve binding and 
uptake to M-cells (Palumbo & Wang 2006). L. plantarum WCFS1 was selected as host 
because (1) it is a GRAS bacterium that is persistent in the GI tract (Seegers 2002), (2) its 
genome sequence is known (Kleerebezem et al. 2003), (3) gene expression systems are 
available (Sørvig et al. 2003), and (4) the research group where this project was carried out 
has much experience with this bacterium (e.g. Mathiesen et al. 2008).     
 
5.1 Selection of an invasive protein and a suitable anchoring strategy 
Invasin from Y. pseudotuberculosis is an M-cell binding protein. It has been shown that 
invasin binds to β1-integrin on the apical surface of M-cells and can mediate uptake of 
bacteria (Palumbo & Wang 2006). Harms et al. (2009) and Critchley-Thorne et al. (2006) 
have shown that recombinant E. coli expressing invasin could efficiently enter cells that 
expressed β1-integrin. Suzuki et al. (2006) demonstrated that a non-invasive Shigella mutant 
that expressed invasin became an effective invasive Shigella vaccine. Invasin gives the 
impression of being an attractive choice for enhancing immune responses to bacteria, since it 
delivers the antigen to M-cells, trigger transport of the antigen-expressing bacteria across the 
epithelial barrier into organized lymphoid structures. However, invasin could also be a 
virulence factor and insertion in L. plantarum may introduce safety issues. Alternatively, 
invasin may have desired effects only and the invasin-expressing bacteria can be used to 
deliver protective antigens.   
 
The 5 domains that binds the β1-integrin receptors and promote uptake of the bacterium are in 
the C-terminal end of invasin, and the last 2 C-terminal domains comprise the minimal 
invasin fragment required for binding (Hamburger et al. 1999). Since the binding site of 
invasin is in the C-terminal end, it is necessary to select an anchor that is fused to the N-






are covalently anchored to the cell membrane via their N-terminal part (Kovacs-Simon et al. 
2011). So far, lipoproteins have only rarely been utilized for surface display of proteins 
(Samuelson et al. 2002). Lipo-anchors from two lipoproteins previously found extracellularly 
(Fredriksen, unpublished) in L. plantarum, where the length of the two lipo-anchors differed 
substantially, were selected to anchor invasin. It was desirable to have a signal peptide and 
anchor that were homologous (i.e. from L. plantarum itself), since this limits the use of 
foreign DNA and may lead to a more efficient secretion (Mathiesen et al. 2009). The results 
from Lipo1.0 predicted that the lipoproteins, Lp_1261 and Lp_1452, were cleaved by Spase 
II. Even though LipoP is trained on target sequence from Gram-negative bacteria, it has been 
shown to predict lipoproteins with >90% overall accuracy in Gram-positive bacteria (Rahman 
et al. 2008), therefore it was reasonable to assume that the predicted anchors of these 
lipoproteins were suitable as lipo-anchors in this study. In addition, the Lp_1452 lipoprotein 
has a predicted function as a peptidylprolyl isomerase, which is involved in extracellular 
folding of secreted proteins (Tjalsma et al. 2000; Wahlstrøm et al. 2003). This is interesting 
since the anchor most likely will have a length that makes invasin surface exposed. The 
Lp_1261 lipoprotein has a predicted function as ABC transporter and a shorter anchor 
sequence that probably will keep invasin more buried in the cell wall.  
 
5.2 The plasmids 
The cloning process was challenging, but using the In-Fusion cloning strategy, which is based 
on homologous recombination, the five plasmids, pLp_1261InvS, pLp_1261Inv, 
pLp_1452InvS, pLp_1452InvS and pCytInv were successfully constructed.  
 
The constructed expression plasmids have an antibiotic resistance gene against erythromycin 
to achieve stable maintenance of the plasmids. In a vaccine, an antibiotic resistance gene 
should not be included because this gene can be transferred to other species e.g. pathogenic 
bacteria (Detmer & Glenting 2006). Accordingly, the need to identify and develop 
alternatives to antibiotic resistance marker genes becomes apparent in the development of the 
vaccine. A food-grade variant of the pSIP-system has very recently been constructed where 
the L. plantarum WCFS1 alanine racemase gene (alr) is the selection marker instead of an 
antibiotic marker (Nguyen et al. 2011). Even with food-grade selection markers, the release of 
genetically modified bacteria to the environment raises safety concerns. It is essential to make 
sure that the bacterial vaccine does not survive outside the human body, because the 





consequences of spreading live bacterial vaccines into the environment are unknown and of a 
considerable concern. To overcome this challenge it is possible to use the strategy published 
by Steidler et al. (2003) where an essential gene for bacterial survival was replaced. They 
exchanged the thyA gene with the expression cassette for human IL-10. This made the L. 
lactis strain dependent on thymidine or thymine to grow and survive; thus it would not be able 
to survive outside the human body (Steidler et al. 2003).        
 
Intracellular invasin production in L. plantarum 
5.3 Intracellular production of invasin with lipo-anchor  
The invasin proteins with the Lp_1261 or the Lp_1452 lipo-anchor were successfully 
produced intracellularly. The presence of invasin in cell free extracts was detected 1 to 4 
hours after induction of protein production at both 30 and 37ºC (Figure 4.5, Figure 4.6 and 
Figure 4.7). The western blot analysis in Figure 4.5 indicated that L. plantarum strains 
carrying constructs encoding lipo-anchored invasin produce more invasin than L. plantarum 
harbouring the construct encoding the intracellular version of invasin (pCytInv). The 
difference of invasin production could be related to the fact that L. plantarum harbouring 
various constructs contains different versions (length) of invasin and anchor. Since the 
proteins differ, the production of them would also be expected to be different. Sørvig et al. 
(2003, 2005) observed that the expression efficiencies (at the protein level) obtained with the 
SIP-system differed from protein to protein in a rather unpredictable manner. Figure 4.6 and 
Figure 4.7 further show that the invasin bands from L. plantarum strains containing constructs 
encoding lipo-anchored invasin are approximately the same size throughout all the hours that 
were tested. In contrast, the L. plantarum strain containing the pCytInv construct (without 
anchor), the invasin band is gradually accumulated in size over time. Still, after four hours 
when the invasin production has increased over time for L. plantarum harbouring the pCytInv 
construct, the intensity on the band is still weaker than for L. plantarum carrying constructs 
encoding lipo-anchored invasin that do not increase significant over time (Figure 4.5). This 
indicates that the production of the lipo-anchored invasin proteins is better than production of 
the invasin protein without anchor.  
 
The observation that the intracellular amounts of invasin from strains harbouring constructs 
encoding lipo-anchored invasin do not increase over time (Figure 4.6 and Figure 4.7) may 






long as the protein is produced the amount of protein inside the cell will increase except if the 
protein is secreted out of the cell, or degraded at the same speed as production. The lipo-
anchored invasin proteins could potentially be proteolytically degraded intracellularly to a 
higher degree than invasin without anchor, but then proteolytic products should have been 
visible in the western blot. Proteolytic products are normally detected below the main band in 
the western blot. Even when no such bands are detected there could be proteolytic products 
present, because invasin could be degraded in the C-terminal end where the primary antibody 
recognize epitopes on invasin (see section 2.3), which makes the proteolytic products non-
detectable. However, all in all the analysis of intracellular invasin levels indicate that invasin 
is exported, meaning that it also may become lipo-anchored.      
 
5.4 Growth of L. plantarum harbouring the different plasmids 
L. plantarum with the pSIP system are normally grown at 30ºC (Sørvig et al. 2003), but 
because of the potential application of the various recombinant L. plantarum strains in a 
human vaccine, evaluation of the strains at 37ºC as well, was important. Figure 4.8 and Figure 
4.9 shows that the induced cultures of L. plantarum harbouring the various constructs grew 
slightly faster at 30ºC; the recombinant strains grow nearly as well at 37ºC as at 30ºC. The 
growth rates of the various recombinant strains showed major differences, which were similar 
at 30 and 37ºC. The fact that the growth rate of the L. plantarum strains containing construct 
encoding lipo-anchored invasin decreased substantially after induction compared to L. 
plantarum harbouring pEV or pCytInv constructs, indicates that secretion and anchoring of 
the invasin protein could be stressful for the bacteria. This decrease in growth rates after 
induction of the target protein production in a recombinant strain compared to the wild-type 
bacterium has been observed previously (Bolhuis et al. 1999; Lulko et al. 2007; Mathiesen et 
al. 2008). In addition, there seems to be a clear difference between the two lipo-anchor 
versions, especially at 37ºC. L. plantarum harbouring the Lp_1452 anchor constructs hardly 
grew. In addition, L. plantarum harbouring the Lp_1452 anchor constructs the amount of 
viable cells (CFU) decreased over time after induction (Appendix, Figure A.4). This 
decreasing of viable cells may be because the Lp_1452 constructs contain a quite long anchor 
which can cause problems, for example by affecting the folding of the protein. L. plantarum 
harbouring the pLp_1261InvS plasmid is the strain with highest growth compared to the other 
strains carrying constructs encoding lipo-anchored invasin. This strain has the shortest lipo-
anchor-invasin protein that could be less stressful to (produce and) secrete and anchor for the 





bacteria. However, if bacterial growth is just dependent on size of the invasin protein, it 
would be expected that L. plantarum harbouring pLp_1452Inv construct would grow slowest, 
but this was not the case. Therefore, the size of the invasin protein is not the only reason for 
slow growth. Based on these results it is reasonable to assume that the Lp_1261 anchor is a 
better choice than the Lp_1452 anchor, at least in terms of growth viability of the recombinant 
bacteria.     
 
Secretion and anchoring of invasin in L. plantarum 
5.5 Translocation of invasin with lipo-anchor across the cell membrane 
Translocation of invasin in L. plantarum cells harbouring inv containing plasmids across the 
membrane is interesting because it indicates that the protein is potentially anchored. Since 
shedding of lipoproteins is normal (Antelmann et al. 2001; Tjalsma et al. 2008), it was 
expected that invasin to some extent would be released from the cell surface. Therefore, 
presence of invasin in culture supernatants was analyzed. 
 
For L. plantarum harbouring the plasmids pLp_1261Inv, pLp_1452Inv or pLp_1452InvS, the 
invasin proteins were detected in the supernatant fraction one hour after induction of invasin 
production (see Figure 4.10). L. plantarum encoding the pCytInv construct showed no invasin 
protein in the supernatant, which reduce the possibility that detected invasin in the 
supernatant, is the result of cell lysis. It should be noted though that, L. plantarum containing 
constructs encoding lipo-anchored invasin may be more stressed as indicated by the growth 
analysis (Figure 4.8 and Figure 4.9), which could lead to increased cell lysis for these strains. 
Since the L. plantarum strains containing the Lp_1261 lipo-anchor constructs grow quite well, 
the result from these constructs is more reliable than the result from the strains harbouring the 
Lp_1452 lipo-anchor constructs. For L. plantarum harbouring the plasmid pLp_1261InvS the 
protein was not detected in the supernatant one hour after induction (see Figure 4.10). The 
reason for this is unclear. One possible explanation is that L. plantarum harbouring the 
pLp_1261InvS construct has an invasin version that leads to less shedding, compared to the 
other recombinant strains. Since only two different lipo-anchors were used it is difficult to 
conclude if these are the best alternative. However, both lipoproteins were predicted by 
SignalP 3.0 (Bendtsen et al. 2004) to have the typical N-terminal, H domain and C-region for 
a signal peptidase cleavage site, and since all the anchored proteins are secreted; it seems that 







Choosing signal peptides that give high secretion efficiency is challenging since optimal 
secretion requires an optimal combination between the signal peptide and the target protein 
(Brockmeier et al. 2006; Mathiesen et al. 2009). One of the goals in the present study was to 
anchor the protein, not just to secrete it. Testing of several signal peptides could result in 
higher secretion efficiency with more surface-anchored invasin protein, which could be 
essential for internalization of the bacteria. However, high secretion efficiency is a 
disadvantage for internalization of L. plantarum if the invasin protein is just secreted and not 
anchored. Because secreted invasin molecules that are not attached to the bacteria can bind 
and occupy integrin receptors, making the receptors less available for surface-anchored 
invasin on L. plantarum.   
 
5.6 Detection of surface-anchored invasin  
Most proteins involved in invasion are anchored to the surface of the bacteria (Niemann et al. 
2004). Invasin has to be surface-anchored to L. plantarum cells to achieve internalization by 
M-cells or other β1-integrin exposing cells. A strategy with two lipo-anchors and two invasin-
versions with different lengths was utilized to hopefully achieve cell-membrane anchoring of 
invasin with the binding site at four different distances away from the anchoring site (two 
anchor lengths times two invasin lengths).  The length of the target proteins can influence 
how exposed the proteins are on the surface of the bacteria. 
 
In order to evaluate surface-anchoring of invasin, immunofluorescence techniques were used. 
Staining of the bacterial cells with the direct immunofluorescence method was challenging, 
since only one primary antibody will bind to each invasin molecule. Therefore, if few invasin 
molecules were on the surface of the bacteria it would be difficult to see the fluorescent signal 
from the FITC stained antibody. With direct immunofluorescence a low percentage staining 
has been shown. McCarthy & Culloty (2011) showed that only 10-35% of E. coli cells were 
stained with direct immunofluorescence, depending on the detection method and antibody 
used. The antibody concentration is a relevant factor for staining of bacteria; significant 
difference in the number of cells stained with different concentration of the antibody was 
shown (McCarthy & Culloty 2011). This matches the observations described in this thesis 
(data not shown).  
 





In theory, an indirect immunofluorescence method will give stronger fluorescent signals than 
direct immunofluorescence, because several FITC molecules will bind to each primary 
antibody that binds to invasin. The problem with this method was background signals, which 
was most likely not caused by technical problems. The primary antibody to invasin (pAb 
invasin PAS Bleed #3) is from rabbit serum and serum contains different antibodies against 
different antigens. Only 5-10% of antibodies in serum are specific for the immunogen used in 
the immunization (Lea 2006). Therefore, it is not unusual that use of polyclonal antibodies 
leads to unspecific interactions, leading to a background signal.  
 
A difference between L. plantarum carrying constructs encoding lipo-anchored invasin and L. 
plantarum harbouring the intracellular invasin (pCytInv) or empty vector (pEV) constructs 
(Figure 4.12) was observed. Despite that this difference was only seen clearly once, the result 
indicates that three of the strains, L. plantarum harbouring the plasmids pLp_1261InvS, 
pLp_1261Inv or pLp_1452Inv, have invasin on the surface. L. plantarum harbouring the 
pLp_1452InvS construct showed no stained cells. This result indicates that L. plantarum 
encoding pLp_1452InvS do not have invasin on the surface. Interestingly, this is the same 
strain that grows slowest (Figure 4.9) and the amount of viable cells (CFU) decreased over 
time after induction (Appendix, Figure A.4). The invasin protein from L. plantarum 
containing the pLp_1452InvS construct is detected intracellularly and in the culture 
supernatant. It could be that for L. plantarum harboring the pLp_1452InvS construct secretion 
and anchoring is more stressful than for L. plantarum harbouring the other constructs; 
therefore the invasin protein was not detected on the surface of this strain.  
 
For the L. plantarum strain containing the pCytInv construct, very few weakly stained 
bacteria were seen. The stained bacteria could be due to cell lysis, because this bacterium 
produces invasin intracellularly; after cell lysis the invasin protein from this strain could react 
with the fluorescent antibodies. Some cell lysis could also occur for L. plantarum strains 
harbouring the constructs encoding lipo-anchored invasin. Especially, on the image of L. 
plantarum harbouring the pLp_1261Inv construct it seems like there could be some cell lysis, 
because there are several green spots present without any bacteria cell. The observation of 
some green L. plantarum cells harbouring empty vector (pEV), indicates that some of the 






are stained. This was as expected, since others have shown that not all bacteria are stained 
with the use of this method (Cortes-Perez et al. 2007).  
 
The same samples examined in Figure 4.12 were analyzed using flow cytometry. Figure 4.13 
shows the same difference between L. plantarum harbouring the constructs encoding lipo-
anchored invasin and L. plantarum harbouring the negative controls, except that this analysis 
also indicates anchoring of invasin for L. plantarum harbouring the pLp_1452InvS plasmid. 
Because L. plantarum strains containing constructs encoding lipo-anchored invasin (no. 1-4 in 
Figure 4.13) several bacteria had a higher fluorescent intensity (FITC-A) than L. plantarum 
strains harbouring the negative controls (no. 5-6 in Figure 4.13). The fluorescence signals 
from L. plantarum strains carrying constructs encoding lipo-anchored invasin did not show a 
very narrow distribution of the fluorescence intensity, which indicates that the cells vary in 
the amount of expressed invasin protein (Nhan et al. 2011). It should also be noted that 
background signals were detected, since L. plantarum harbouring the pEV construct did not 
yield a narrow peak at 0 as expected after flow cytometry analysis. The peak was shifted 
towards some fluorescent signal, but not as much as for the L. plantarum strains containing 
constructs encoding lipo-anchored invasin. Therefore, it is not likely that the entire 
fluorescent signal observed for the strains expressing anchored invasin is a background signal. 
In addition, others have shown a negative control that was not a narrow signal at 0, but a 
signal surrounding 0, and that the signal from analyzed samples were shifted towards more 
fluorescence intensity (FITC-A) (Nhan et al. 2011). L. plantarum harbouring the pCytInv 
construct shows a quite high peak at 0, so many bacteria are not stained, but it also shows a 
high peak with a higher fluorescent signal (FITC-A), which indicates that some bacteria were 
stained. Invasin resulting from cell lysis would most likely be washed away in the staining 
procedure, but it could be some remains in the samples. The results from Figure 4.12 and 
Figure 4.13 are promising and provide a strong indication that invasin is surface-anchored.   
 
Since the above methods gave weak signals and reproducibility problems, they could not 
provide more than indications concerning the possible surface anchoring of invasin. 
Therefore, additional strategies for invasin detection were tested. The reason for the weak 
signal from staining of the bacterial cells could be due to the primary antibody having 
problems reaching the epitopes on invasin; caused by the epitopes being covered in the 
invasin 3D-structure. Therefore, the cells were incubated at 70ºC for 5 minutes before staining 





to “open up” the invasin structure. This gives the antibodies better access to the epitops, 
which could lead to better binding. The result showed no significant differences between the 
L. plantarum stains and no increased signal strength. The result could indicate that the 
epitopes is not covered in the invasin structure, but it could also indicate that the method did 
not work; the invasin structure was not unfolded or cell lysis occurred.   
 
Another hypothesis could be that the burying in the cell wall itself shields invasin from the 
primary antibody. The various recombinant L. plantarum strains were pre-threaded with 
mutanolysin or mutanolysin and lysozyme before staining of the cells. Interestingly, the 
results obtained were best for L. plantarum strains harbouring the pLp_1261Inv or 
pLp_1452Inv construct. Since these strains consist of the invasin version with all 5 domains 
and are thus expected to protrude further out of the cell membrane, these observations may be 
taken to indicate that the weak signals indeed are caused by invasin being buried in the cell 
wall. 
 
In order to get a stronger indication or a confirmation of invasin being surface exposed other 
methods were tested. Isolation of cell wall fractions of L. plantarum strains harbouring 
various constructs was tested. Invasin is among the cell wall-associated proteins if invasin is 
detected in the cell wall fraction from L. plantarum strains carrying lipo-anchored constructs 
and not in the cell wall fraction from L. plantarum containing the pCytInv construct. Every 
experiment with this method yield an invasin signal in the negative control (pCytInv, no 5 in 
Figure 4.14). Therefore the observed invasin signal from strains expressing anchored invasin 
could be because of cell lysis.  
 
Another method tested was the cell dot-blot. Unfortunately, the experiments gave often high 
background levels, but one cell dot-blot gave results (see Figure 4.15). This dot-blot showed a 
difference between L. plantarum containing constructs encoding lipo-anchored invasin and L. 
plantarum containing intracellular invasin (pCytInv) or empty vector (pEV), and the wild-
type L. plantarum (without plasmid). However, all the negative controls had quite dark spots, 
while no visible spots were expected. In addition, it seemed like wild-type L. plantarum has a 
black spot in the undiluted sample similar to the positive control. This sample could be 






the antibodies. Since the strains harbouring the negative controls did not give a clear negative 
result, the result from the cell dot-blot was uncertain.     
 
The most frequently used strategy to surface-anchor proteins in Gram-positive bacteria is the 
use of a C-terminal cell wall anchor that includes a conserved LPXTH motif, and most 
experiences with detection of surface-anchored proteins are based on this anchor (Samuelson 
et al. 2002). Few other studies have used lipo-anchors to surface-anchor a protein and 
detection of invasin when it is anchored to the cell membrane with a lipo-anchor has been 
difficult to confirm in other experiments. Acheson et al. (1997) linked invasin together with a 
cell membrane (DppE) lipoprotein in B. subtilis. DppE is secreted and will most likely remain 
attached to the cytoplasmic membrane by a lipoprotein-anchor together with the invasin 
protein (InvS). When binding to the surface was examined, the antibody bound to both wild-
type B. subtilis and B. subtilis with the DppE-Inv192 fusion protein to approximately the 
same extent. Acheson et al. (1997) showed that when most of the cell wall was removed by 
lysozyme, it was a fourfold increase in antibody binding to the recombinant strain compared 
to the wild-type. The result indicated that the DppE-inv192 protein was attached to the cell 
membrane but the protein was covered by the thick cell wall of the Bacillus. This could be the 
reason for the weak staining signal from L. plantarum containing constructs encoding lipo-
anchored invasin, but since some difference between the strains were detected, all invasin 
proteins is most likely not entirely buried in the cell wall.  
 
The time of harvest could have affected the amount of surface-anchored invasin. L. plantarum 
harbouring the different constructs were always harvested two hours after induction of gene 
expression to analyze surface anchoring. Harvesting of the strains after two hours was chosen 
because a considerable amount of invasin was detected in the culture supernatant at that time. 
Since the strains harbouring the Lp_1452 lipo-anchor constructs decreased in amount of 
viable cells, the harvesting of the cells could not be to long after induction of the target 
protein. It is possible that higher amounts of surface-anchored invasin could be obtained if 
longer culturing times were used. This is something that could be interesting to analyze. 
Tjåland (2011) showed that the Lp_1261 anchor used to anchor another protein gave a 
stronger staining signal when the L. plantarum strain was harvested 24 hours after induction 
compared to 2 hours. This indicates that the weak signal from invasin on the surface could be 
due to that the cells were harvested at a too early time point. Alternatively, it could be that the 





invasin proteins are just secreted and never anchored to the cell membrane, thus all invasin 
proteins ends up in the growth medium. The staining signals achieved in Figure 4.12 and 4.13 
could be due to invasin on its way out of the cell instead of anchored invasin.  
 
Another method that could be used to detect invasin on the bacterial surface is to use indirect 
immunogold labeling combined with electron microscopy, but this method will most likely 
not give a strong signal if invasin is buried in the cell wall.  
 
Despite considerable uncertainty, all results combined indicate anchoring of invasin on L. 
plantarum. An indirect way to analyze surface-anchoring of invasin is to analyze if L. 
plantarum harbouring constructs encoding lipo-anchored invasin enhance internalization by 
Caco-2 cells with β1-integrin.   
 
Internalization of L. plantarum strains by Caco-2 cells 
5.7 Analysis of internalization of L. plantarum strains by Caco-2 cells  
L. plantarum carrying constructs encoding lipo-anchored invasin are hopefully going to be 
used in a vaccine where they could promote internalization of the bacteria by M-cells. Since 
M-cells are very difficult to generate, a non-polarized human Caco-2 intestinal cell line was 
used to study internalization of the invasion-expressing strains. Because analysis of various 
recombinant L. plantarum strains after incubation with Caco-2 cells was unknown territory, 
direct visualization of the cells was performed to get an overview of challenges to overcome. 
The results in Figure 4.16 show that analysis of the relations between OD600 and CFU/ml for 
the strains was necessary, in addition to a better staining method to discriminate between 
bacteria inside or outside Caco-2 cells.     
 
The gentamicin survival assay was used to estimate bacterial survival. After incubation with 
Caco-2 cells and gentamicin treatment, cell lysis of the Caco-2 cells and subsequent counting 
of viable bacteria (CFU) were performed. Ideally, only bacteria protected from the antibiotic 
inside Caco-2 cells will survive and grow on the agar-plates. Innocentin et al. (2009) 
demonstrated that L. lactis expressing invasin genes (from L. monocytogenes or 
Staphylococcus aureus) showed a clear difference in uptake (about 1000 fold higher uptake 
rate) in the gentamicin survival assay compared to the wild-type, but the wild-type showed 








of L. lactis expressing internalin (InlA) from L. monocytogenes was higher (about 100 fold) 
invasiveness compared to the wild-type. In this study, the wild-type was also shown to 
demonstrate some uptake. However, the difference is not significant with or without an 
invasin gene when internalization of Caco-2 cells was examined. For example, Guimaraes et 
al. (2005) showed that L .lactis expressing internalin (InlA) was only marginally more 
efficient for DNA delivery (about 1% of the Caco-2 cells had the delivered gene). 
 
In the present study, the gentamicin assay yield no significant differences between the L. 
plantarum containing the negative controls (pCytInv and pEV) and L. plantarum carrying 
constructs encoding lipo-anchored invasin (shown in Table 4.2 and 4.3). It is known from 
previous studies that addition of too many bacteria may lead to formation of biofilms in which 
the bacteria are protected from the antibiotic treatment although they are not internalized 
(Innocentin et al. 2009). Therefore, adding of more bacteria to the Caco-2 cells would 
probably not give a better internalization result. The amount of bacteria that survived in this 
experiments was very low, which indicates that the internalization was very low or absent. 
 
The gentamicin survival assay is based on recovery of viable bacteria after internalization by 
Caco-2 cells, which is not representative if the bacterial cell lyse inside the Caco-2 cells 
before the incubation is over. L. plantarum is assumed not to survive inside Caco-2 cells for a 
long time; therefore it could be that the gentamicin survival assay did not show any 
internalization of the bacteria because the incubation time was too long. This assay was 
complemented with microscopic evaluation, using staining techniques. The staining method 
was set up in such a way that the bacteria inside Caco-2 cells stayed green while bacteria 
outside turned into a yellow-orange color. In the microscopic evaluation, more bacteria were 
observed bound to Caco-2 cells when L. plantarum encoded anchored invasin plasmids; the 
strains had increased affinity for the Caco-2 cells, but it should be noted that this experiment 
was done only once, which makes the results uncertain. However, the result indicates that 
invasin promotes binding to Caco-2 cells. The experiment did not convincingly show that L. 
plantarum strains promoted internalization, since only three bacteria were observed to 
probably be inside Caco-2 cells (compared to several hundred bacteria in the samples, 
combined). These three bacteria were L. plantarum harbouring the pLp_1261InvS or 
pLp_1261Inv constructs (Figure). L. plantarum containing these constructs have a better 





result than L. plantarum containing the Lp_1452 anchor, which showed no bacteria inside 
Caco-2 cells. This is in line with the rest of the result in this thesis.  
 
Internalization of L. plantarum strains carrying constructs encoding lipo-anchored invasin into 
Caco-2 cells was not shown, which could be because the invasin proteins are not anchored to 
the cell-membrane, or they could be anchored but to buried in the cell wall to manage to react 
with β1-integrin receptors. One other reason could be that few invasin proteins are one the 
surface of the bacterial cells since invasin binding to the β1-integrin receptor requires a high 
density of invasin molecules on the cell surface (Leo & Skurnik 2011). Alternatively, it could 
be the Caco-2 cells used here did not have β1-integrins receptors on the apical surface. Non-
polarized Caco-2 cells are supposed to express β1-integrin but this was never tested; lack of 
β1-integrin receptors could be the reason for lack of uptake. The present of β1-integrin 
receptors could be checked by using β1-integrin specific antibody on the Caco-2 cells. If the 
problem is that there are no β1-integrins on the surface of the Caco-2 cells, other cells need to 
be used to analyze internalization. Options include the use of an M-cell/FAE model, where 
Caco-2 cells are co-cultured with Peyer’s patch lymphocytes or a Raji human lymphocyte cell 
line (Corr et al. 2008).  
 
5.8 Conclusions and perspectives 
This thesis describes successful cloning, production and secretion of invasin together with the 
lipo-anchors from the lipoproteins Lp_1261 and Lp_1452 in L. plantarum. In addition, the 
result showed that invasin was most likely lipo-anchored. Internalization of L. plantarum 
harbouring the construct encoding lipo-anchored invasin into Caco-2 cells was not 
convincingly shown, but more experiments are needed to reach a final conclusion. Of the four 
anchor constructs described in this thesis is it not recommended to go further with the two 
constructs that had the anchors from Lp_1452 (pLp_1452InvS and pLp_1452Inv) because 
these strains have problems with growth and survival, and because there were no indications 
whatsoever that L. plantarum harbouring these constructs enhanced internalization of the 
bacteria. The two L. plantarum strains harbouring anchors from Lp_1261 (pLp_1261InvS and 
pLp_1261Inv) are more promising, especially pLp_1261InvS. Based on the result 
accumulated so far, invasin produced by the pLp_1261InvS containing strain is likely 






may indicate some Caco-2 internalization; Figure 4.17). Furthermore, it is the strain with best 
growth (Figure 4.9) and intracellular invasin production (Figure 4.5).  
 
The results showed that better experimental methods and alternative strategies to obtain M-
cell translocating of lactobacilli should be considered. For example, it could be that invasin is 
anchored to the cell membrane, but that lipo-anchoring is not the best option due to shedding 
and burial of invasin inside the cell wall. It is recommended to exchange the anchor to another 
N-terminal anchor (such as N-terminal transmembrane anchor or anchor from other 
lipoproteins) which could lead to increased surface display of invasin. The lipo-anchors have 
been exchanged with other N-terminal anchors recently and the results are promising (Lasse 
Fredriksen, unpublished). It would be interesting to see if this would give a better exposing of 
invasin and subsequently a better internalization result.  
 
Targeting of M-cells does not necessary have to be with invasin from Y. pseudotuberculosis; 
there are other invasive proteins that could be used. The results in this thesis do not indicate 
that the invasin protein should be replaced, but if it should appear that an alternative to invasin 
is required, other potential candidates are available. For example, the Shigella species have an 
invasin complex (IpaB, IpaC and IpaD) which is secreted upon host cell contact and seems to 
exploit β1-integrin receptors (Palumbo & Wang 2006). Other receptors on M-cells that can be 
exploited includes glycoprotein 2 which recognizes FimH. FimH is a component of type I pili 
and transcytosis of FimH expressing bacteria through M-cells has been shown (Hase et al. 
2009). However, invasin from Yersinia is the most studied invasive protein and it appears that 
it is the most common invasive protein used for therapeutic delivery application.      
 
When it comes to using Lactobacillus as a delivery-vehicle for therapeutic proteins, it is an 
attractive strategy to target M-cells in order to achieve a better immune response. Although 
the results in this thesis did not convincingly show specific L. plantarum internalization into 
Caco-2 cells this strategy is still useful. Other anchoring strategies or other invasive proteins 
could be utilized instead which could lead to increased uptake in vivo. It should be noted that 
the fact that we were able to express and secrete invasin in itself is a major step forward and 
that several strategies for improved surface-display still can be tested. On the basis of the 
result described here and the general picture merging from the literature, there certainly is no 
reason to abandon the overall strategy underlying the present study.  






Assuming that invasin gives increased internalization of the L. plantarum, L. plantarum must 
then also express an antigen against the target disease to hopefully get a successful initiation 
of the mucosal immune responses. To achieve this, the need for a different selection marker 
than antibiotics becomes apparent. One alternative to the antibiotic marker is the L. plantarum 
WCFS1 alanine racemase gene (alr) as the selection marker (Nguyen et al. 2011). In addition, 
it could be that constitutive expression of the antigens is more practical in a vaccine than the 
present inducible expression. Such optimized invasive L. plantarum strains may be ideal oral 
vaccines since they are non-pathogenic, and target M-cells to deliver antigens directly to 
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Figure A.1: (A) L. plantarum harbouring the pLp_1261InvS construct and (B) wild-type of L. plantarum, 
both stained with primary antibody conjugated with FITC to detect surface exposed invasin. Since the 
amount of cells is unclear and most likely not the same in the two images, the result is inconclusive. 
 
Figure A.2: Detection of surface-anchored invasin. The images show L. plantarum strains harbouring the 
following constructs: (1) pLp_1261InvS; (2) pLp_1261Inv; (3) pLp_1452InvS; (4) pLp_1452Inv; (5) pCytInv or 
(6) pEV (empty vector). The strains were incubated at 70ºC for 5 minutes before staining of the cells. The 
images were achieved by using indirect immunofluorescence and analysis by fluorescence microscopy.  The 
images represent one representative image of three random images that was taken of the different strains. The 
arrows demonstrated where there are green spots on the bacteria (manual inspection).        







Figure A.3: Detection of surface-anchored invasin. The images show L. plantarum strains harbouring the 
following constructs: (1) pLp_1261InvS; (2) pLp_1261Inv; (3) pLp_1452InvS; (4) pLp_1452Inv; (5) pCytInv or 
(6) pEV (empty vector). The cell amount was adjusted after OD600 at the harvesting time to stain approximately 
the same amount of cells. The strains were treated with 50 U/ml mutanolysin and incubated at 37ºC for 20 
minutes before staining of the cells. The images were achieved by using indirect immunofluorescence and 
analysis by fluorescence microscopy.  The images represent one representative image of three random images 
that was taken of the different strains. The arrows demonstrated where there are green spots on the bacteria 
































Figure A.4: CFU/ml, 1 to 3 hours after induction of invasin production, for L. plantarum harbouring the 
pLp_1452InvS or pLp_1452Inv constructs. The figure shows the average results from three parallels and each 




Figure A.5: The relationship between OD600 and CFU/ml for L. plantarum harbouring empty vector 
(pEV). This relationship was used to calculate approximately the same number of cells based on the OD600-value 
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